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Summary 
The function of alpha globin in the context of oxygen transport in erythroid cells is well 
described. There is growing evidence, however, that alpha globin is involved in processes 
other than tissue oxygen supply. Recently the expression of alpha globin has been shown to 
be induced upon specific apoptotic stimuli like cytokine deprivation or cisplatin treatment in 
the IL-3 dependent hematopoietic pro B cell line, FL5.12. In the current work we confirm for 
the first time that the upregulation of alpha globin is not restricted to the transcript, but is also 
observed at protein level. Different from erythroid cells, which bear globin proteins at 14 kD, 
alpha globin displayed two distinct bands of 14 and 14.5 kD molecular weight under normal 
growth conditions. In healthy cells both forms of alpha globin were localized to the 
cytoplasm, whereas in apoptotic cells the 14 kD alpha globin was partially localized to the 
cytoskeleton. In contrast to alpha globin, beta globin was expressed at a very low level, while 
other globins or globin-like genes were not expressed at all. Further, we found that alpha 
globin was not associated with its prosthetic group heme. Apoptotic cells neither produced 
hemoglobin nor displayed a phenotype of cells differentiating down the erythroid lineage. 
Very interestingly, also other cell lines of variable differentiation status including NIH3T3, 
HeLa, and K562 upregulated alpha globin during treatment with apoptosis-inducing agents 
indicating that alpha globin upregulation in apoptosis is not unique to FL5.12 cells. 
Enrichment of FL5.12 cells ectopically expressing GFP-alpha globin turned out to be difficult 
even in the presence of IL-3. Under IL-3-deprived apoptotic conditions, GFP-alpha globin 
accelerated the progression of cell death in a comparable fashion to GFP-Bax. In particular, 
caspase-8, -9 and -3 as well as the proapoptotic factors Bid, Bax, and cytochrome c were 
activated. In contrast, the expression of an antisense alpha globin construct exhibited a minor 
effect on the progression of apoptotic cell death. Taken together these data indicate that alpha 
globin is a new and crucial factor in apoptosis especially supporting the mitochondrial 
pathway, and its upregulation is a widespread phenomenon in apoptosis. 
To study how the transcription of alpha globin is placed in the broader context of apoptosis, 
we searched for transcription factors, which were concomitantly upregulated with alpha 
globin. In cytokine-deprived FL5.12 cells transcription factor GATA-2, containing binding 
sites for regulatory sequences of globin and virtually all erythroid genes, was the most 
prominently upregulated candidate as assessed by gene chip arrays and RT QPCR. GATA-1 
was expressed at low levels and weakly induced, while GATA-3 was completely absent. In 
FL5.12 cells treated with cisplatin or doxorubicin, GATA-2 levels remained unchanged. By 
investigating other cell lines, which induced alpha globin in apoptosis, we found that GATA-
2 was also upregulated in NIH3T3 but not K562 and HeLa cells. To evaluate the influence of 
GATA-2 on alpha globin expression and cell viability we overexpressed GATA-2 in FL5.12 
and NIH3T3 cells. Interestingly, high expression of GATA-2 resulted in immediate cell death 
in FL5.12 cells and caused a severe but transient stress phenotype in NIH3T3 cells. We 
further found that alpha globin levels were indeed elevated in GATA-overexpressing FL5.12 
but not NIH3T3 cells. Transduction of antisense GATA-2 in FL5.12 cells reduced both the 
increase of GATA-2 and alpha globin under apoptotic conditions and delayed cell death. In 
summary, our results suggest that the mechanisms to induce alpha globin under apoptotic 
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conditions differ depending on the death stimulus and the cell line. The fact that 
overexpressed GATA-2 promoted, while antisense GATA-2 delayed cell death in FL5.12 
cells, suggests that the function of GATA-2 is not restricted to maintenance and proliferation 
of immature hematopoietic progenitors but is also critical in apoptosis. 
Publications: 
Brecht, K.; Simonen, M.; Brachat, A.; Heim, J.; „Upregulation of alpha globin promotes 
apoptotic cell death in the hematopoietic cell line FL5.12“, Cell Death and Differentiation, 
2004, submitted for publication. 
Brecht, K.; Simonen, M.; Kamke, M.; Heim, J.; „Hematopoietic transcription factor GATA-2 
promotes expression of alpha globin and cell death in FL5.12 cells“, Cell Death and 
Differentiation, 2004, submitted for publication. 
Brachat, A.; Pierrat, B.; Xynos, A.; Brecht, K.; Simonen, M.; Brungger, A.; Heim, J. “A 
microarray-based, integrated approach to identify novel regulators of cancer drug response 
and apoptosis”, Oncogene, 2002. 
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1 Introduction 
1.1 Apoptosis: an overview 
1.1.1 Apoptosis, necrosis, autophagy 
Apoptosis or programmed cell death (PCD) is a physiological process that has been described 
in all multicellular organisms studied so far, including plants, slime molds, nematodes, 
insects, and vertebrates (Ellis and Horvitz, 1986; Vaux et al., 1994). There is growing 
evidence that some form of PCD also exists in unicellular organisms like trypanosomes and 
bacteria (Yarmolinsky, 1995). PCD is a fine-tuned process, controlled by many extra- and 
intracellular signals, that coordinates the removal of hazardous or damaged cells (Savill et al., 
1993) in order to maintain tissue homeostasis (Thompson, 1995). Disturbance of the apoptotic 
homeostasis is known to cause severe pathological conditions. Diseases linked with 
suppression of apoptosis include cancer (Zornig et al., 2001) or viral infections (Gregory et 
al., 1991) whereas increased apoptosis is observed in ischemic injury or neurodegenerative 
disorders (Pravdenkova et al., 1996). 
In the early seventies Kerr and coworkers provided evidence that at least two distinct types of 
cell death exist. On the one hand necrosis was described as an accidental, uncontrolled type of 
degeneration that affects large cell populations. Morphologically, necrosis is characterized by 
cytoplasm swelling, destruction of organelles, disruption of the plasma membrane, and non-
specific degradation of DNA leading to the release of intracellular contents and inflammation 
(Kerr et al., 1972). On the other hand apoptotic cells are characterized by cell shrinkage, 
maintenance of organelle integrity, exposure of phosphatidylserine on the plasma membrane, 
membrane blebbing, lamin degradation (Rao et al., 1996), chromatin condensation and 
internucleosomal cleavage of DNA (Wyllie, 1980) followed by ordered removal through 
phagocytosis (Fadok et al., 1992). However, there are exceptions to this simple model, and 
there is growing evidence for alternative cell death pathways such as autophagy (Seglen and 
Bohley, 1992), as well as for intersections between intracellular mechanisms involved in 
distinct forms of cell death. Autophagy is a process that controls the turnover of organelles in 
many eukaryotic cell types and also in protozoas (Bera et al., 2003). Organelles and other 
cellular components are sequestered and degraded in lysosomes (Dunn, Jr., 1990) in order to 
resist starvation or as part of cell remodeling during differentiation, aging, and cell death 
(Klionsky and Emr, 2000). For example, MCF-7 breast carcinoma cells lacking caspase-3 
were found to undergo autophagy rather than apoptosis after tamoxifen treatment (Bursch et 
al., 1996). Neurons of the substantia nigra in Parkinson patients displayed features of both 
autophagy and apoptosis (Anglade et al., 1997). Similarly, apoptotic and necrotic pathways 
have been reported to overlap to some extent. As an example, antiapoptotic Bcl-2 and caspase 
inhibitors were both able to delay necrotic cell death induced by cyanide or antimycin A 
(Shimizu et al., 1996). Further, internucleosomal fragmentation of DNA has also been 
observed during necrosis (Dong et al., 1997). In summary, the existence of alternative forms 
of cell death and possible intersections between these pathways hamper an easy classification.  
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1.1.2 Caspases 
One of the first organisms in which apoptosis was studied is the nematode Caenorhabditis 
elegans (C. elegans). Cell death defective (ced) genes play a critical role in the execution 
steps of apoptosis. Ced-3 and -4 promote PCD (Ellis and Horvitz, 1986), whereas Ced-9 
inhibits the onset of apoptosis (Hengartner et al., 1992). The mammalian homologues are 
interleukin converting enzyme (ICE), apoptotic protease activating factor (Apaf-1), and Bcl-2, 
respectively. The Ced-3 protein belongs to a class of cysteine proteases that specifically 
cleaves after aspartate residues, which is why they are called caspases (cysteine aspartyl 
protease). According to phylogenetic analyses, all caspases can be divided into three 
subfamilies which differ significantly in substrate specificity and caspase function: (1) the 
ICE subfamily of cytokine processors including caspase-1 and its homologues caspase-12, -
13, and -14, and further caspase-4, -5, and -11, (2) the ICH-1/Nedd-2 subfamily of apoptotic 
initiators comprising caspase-2, -8, -9, and 10 and the (3) CPP32 subfamily of apoptotic 
executioners, caspase-3, -6, and -7 also referred to as “downstream” or “effector” caspases 
(Alnemri et al., 1996; Van de et al., 1997). In general, caspases are synthesized as inactive 
proenzymes (zymogens) composed of three domains: an N-terminal prodomain, and the p20 
and p10 domains. The prodomains of initiator caspases are long compared to the prodomains 
found in caspase-3, -6, and -7 and play an important role in caspase regulation and function as 
signal integrators for apoptotic signals (Harvey et al., 1997). Caspase-8 and -10 for instance 
contain a death effector domain (DED) that mediates the interaction via an adaptor molecule 
with the cytoplasmic tail of members of the tumor necrosis factor receptor (TNF-R1) family. 
Upon binding of Fas ligand or TNF alpha to their respective receptors, Fas (CD95) and TNF-
R1, apoptosis is triggered by the recruitment of a cytosolic adaptor molecule, FADD 
(MORT1), to the plasma membrane. FADD contains a DED that binds to the N-terminal DED 
prodomain of caspase-8 also called FLICE. (Muzio et al., 1996). Caspases-1, -2, -4, and -9 
possess a prodomain called caspase recruitment domain (CARD) which most probably 
derives from the same ancestral domain as DED and mediates the interaction and activation of 
caspases with upstream regulators (Hofmann et al., 1997). 
During caspase activation the prodomain is removed and the zymogen is further 
proteolytically cleaved between the p20 domain containing the catalytic cysteine residues and 
the p10 domain which determines substrate specificity (Walker et al., 1994). The mature 
caspase is a heterotetramer consisting of two p20/p10 heterodimers (Earnshaw et al., 1999). 
While initiator caspases are activated via oligomerization-induced autoprocessing (Butt et al., 
1998), executioner caspases are activated by initiator caspases (Green, 1998) or by non-
caspase proteinases such as granzyme B, a serine protease, which is introduced into cells by 
cytotoxic T-lymphocytes and natural killer cells (Darmon et al., 1995). 
In some cases PCD has been reported to occur independently of caspase activation. Apoptosis 
inducing factor (AIF) for instance triggers cell death slightly differently from the standard 
apoptotic process and appears to act independently of caspase activation (Susin et al., 1999b). 
Alternatively, cell death involving the activation proteases other than caspases, such as 
calpain or cathepsins, has been observed (Squier et al., 1994; Deiss et al., 1996). Very 
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recently cathepsins have been found to cleave pro-apoptotic Bid and to mediate cytochrome c 
release (Cirman et al., 2004).  
There is growing evidence that the role of caspases is not exclusively restricted to apoptosis. 
Caspase-14 for instance exerts caspase-specific functions but is involved in terminal 
differentiation of keratinocytes and in normal skin formation (Van de et al., 1998; Lippens et 
al., 2003). Weakly activated caspase-9 partially cleaves RasGAP and generates an N-terminal 
fragment that exhibits potent anti-apoptotic signals. Strong caspase-9 activation results in 
RasGAP cleavage products that efficiently promote cell death (Yang and Widmann, 2001). 
1.1.3 Intrinsic and extrinsic apoptotic signaling 
Depending on the origin of the death signal and the initiator caspases involved, two major 
pathways can be distinguished: (1) the intrinsic or mitochondrial pathway that requires de 
novo transcription and translation and (2) the extrinsic or death receptor signaling pathway 
which is independent of macromolecule synthesis. The intrinsic apoptotic process occurs as a 
consequence of cellular stress and is mediated by the release of cytochrome c from the 
mitochondria. It additionally requires the induction of specific genetic programs by 
transcription factors. The extrinsic apoptosis is signaled via death receptors and occurs via 
recruitment and activation of caspases. Caspases, which exist as unprocessed zymogens and 
become cleaved and activated upon induction of apoptosis, play a central role in this pathway 
(Cerretti et al., 1992). In the extrinsic pathway, the mitochondrion-dependent signaling can be 
employed as an amplification loop (Kuwana et al., 1998). 
Induction of apoptosis triggered by stress of the endoplasmatic reticulum and involving 
caspase-12 has been proposed as a third death pathway (Nakagawa et al., 2000). 
Various signals can trigger the mitochondrial pathway via release of harmful proteins such as 
AIF, Smac/DIABLO (direct inhibitors of apoptosis (IAP) binding protein), Endonuclease G, 
procaspases or cytochrome c from the mitochondrial intermembrane space. Released AIF 
translocates to the nucleus and induces chromatin condensation in a caspase-independent 
manner (Susin et al., 1999b). Smac/DIABLO binds and inhibits IAPs which in turn lose their 
ability to bind and inactivate both procaspases and active caspases (Verhagen et al., 2000). 
Released procaspase-2, -3 and -9, are processed to generate enzymatically active caspases 
(Susin et al., 1999a). Under normal growth conditions cytochrome c acts as a specific and 
efficient electron transfer mediator of the mitochondrial respiratory chain. However, when 
apoptosis is induced cytochrome c becomes part of the apoptosome, a complex consisting of 
Apaf-1, dATP or ATP, and procaspase-9 (Li et al., 1997). While Apaf-1 was initially thought 
to be only transiently required for caspase-9 activation, it has been suggested that the Apaf-
1/caspase-9 complex is the active form of caspase-9 (Rodriguez and Lazebnik, 1999). In this 
model the caspase-9 holoenzyme activates the downstream caspase effector cascade involving 
caspase-3, -6, and -7. In cell-free systems caspase-2, -8, and -10 were also found to be 
activated by caspase-9 (Slee et al., 1999). Recent co-immunoprecipitation results demonstrate 
that regulatory proteins such as Smac/DIABLO associate with the apoptosome and regulate 
the activity of native apoptosomes, whereas cytochrome c is not stably associated with the 
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complex (Hill et al., 2004). Also very recently caspase-2 has been found to directly trigger 
mitochondria-mediated cytochrome c release and this independently of its enzymatic activity 
(Robertson et al., 2004). 
One feature of the mitochondrial pathway that is now understood is the caspase-dependent 
drop of mitochondrial inner transmembrane potential, ∆ψm, following the cytochrome c 
release (Zamzami et al., 1995; Goldstein et al., 2000). The collapse of ∆ψm indicates the 
opening of a large conductance channel, the mitochondrial permeability transition pore (PTP), 
which includes both inner membrane proteins such as the adenine nucleotide translocator 
(ANT), and outer membrane proteins, such as porin also known as voltage-dependent anion 
channel (VDAC). 
Several competing models exist to explain mitochondrial membrane permeabilization and 
subsequent release of pro-apoptotic molecules during apoptosis (Martinou et al., 2000). Two 
models claim the outer mitochondrial membrane rupture to be the result of the mitochondrial 
matrix swelling. The first model involves opening of the permeability transition pore (PTP) 
protein complex spanning the inner and outer mitochondrial membranes by PTP openers like 
Bax (Marzo et al., 1998). The other model postulates a defect in ATP/ADP exchange as a 
result of closing of VDAC, causing hyperpolarisation of the inner mitochondrial membrane 
and mitochondrial swelling (Green and Kroemer, 1998). 
As an alternative to the mitochondrial membrane damage models, the formation of membrane 
pores has been proposed. Again different hypotheses were made to explain pore formation 
and subsequent release of cytochrome c and other apoptotic molecules. The first model 
assumes that oligomers of Bax form a channel in the mitochondrial membrane (Schlesinger et 
al., 1997). According to Basanez and colleagues, Bax destabilizes the phospholipid bilayer 
structure and forms lipidic pores (Basanez et al., 1999). The last model suggests that Bax 
binds VDAC and changes its conformation leading to the formation of a cytochrome c-
permeable channel (Shimizu et al., 1999). 
All models share the common prediction that cytochrome c release is controlled by proteins of 
the Bcl-2 family which are also found in the outer mitochondrial membrane. Those that 
inhibit cell death, Bcl-2 and Bcl-xL, prevent the release of cytochrome c whereas those 
promoting cell death like Bax and Bak, induce its release (Pan et al., 1998) (see below). 
Death receptor signaling represents the second major apoptotic pathway. Death receptors 
belong to the tumor necrosis factor receptor (TNF) superfamily consisting of approximately 
30 proteins, which are involved in a broad range of biological functions including regulation 
of apoptosis and survival, differentiation and immune response (reviewed in (Ashkenazi and 
Dixit, 1998; Walczak and Krammer, 2000)). In general, mammalian TNF-R family members 
are primarily type I transmembrane proteins and share similar extracellular cysteine-rich 
domains. Several death receptors like TNF-R1, Fas/APO-1/CD95, DR3, DR6, TRAIL-
R1/DR4 and TRAIL-R2/DR5 possess a common cytosolic domain of about 80 amino acid 
referred to as death domain (DD) (Itoh and Nagata, 1993). The death domain is essential for 
transmitting the death signal from the cell surface to intracellular signaling pathways. In 
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contrast, death receptors such as TNF-R2, CD40, LT-βR, CD27 or CD30 lack this cytosolic 
death domain and are believed to synergistically enhance TNF-R1-induced cytotoxicity 
(Tartaglia et al., 1993; Grell et al., 1999). In addition to typical membrane-spanning death 
receptors, soluble forms are generated by both alternative splicing (Cascino et al., 1995) and 
by proteolytic processing (Schall et al., 1990). Functional TNF-Rs are typically oligomeric, 
most probably trimeric complexes stabilized by disulfide bonds (Song et al., 1994). An N-
terminal extracellular domain called pre-ligand binding assembly domain (PLAD) mediates 
receptor self-association before ligand binding (Chan et al., 2000) leading to the assumption 
that TNF-Rs exist as pre-formed complexes rather than individual receptor subunits that 
oligomerize after ligand binding. 
Ligands of the TNF-R superfamily, except for lymphotoxin alpha, are synthesized as nascent 
type II membrane-associated proteins. Most ligands act as trimeric or multimeric membrane-
bound proteins, however, also soluble forms can be generated by limited proteolysis by 
metalloproteinases (Tanaka et al., 1996). The ligands share a characteristic region of 150 
amino acids towards the C-terminus called TNF homology domain. This region is responsible 
for receptor binding and subsequent activation. Further, agonistic antibodies can activate 
death receptor signaling and induce apoptosis (Ni et al., 1994). 
The best-characterized death receptors comprise (1) CD95, (2) TNF-R1, and (3) TRAIL-R1/2. 
By referring to these three receptors major features of the death receptor pathways will be 
described in the following paragraphs: 
(1) The biological role of the CD95/CD95L (Fas or APO-1) apoptotic pathway is best 
understood in the immune system where it is implicated in clonal depletion of T-lymphocytes, 
cytotoxic response or B-cell apoptosis induction. Upon binding of CD95L to its receptor, 
formation of a death-inducing signaling complex (DISC) is initiated. The CD95-DISC 
contains the cytoplasmic adapter, FADD, and procaspase-8 or -10 (Kischkel et al., 1995). 
CD95-mediated clustering within the DISC results in autoproteolytic processing of the 
procaspases by induced proximity and release of active caspases. Concerning DISC 
downstream signaling two types of cells can be distinguished: In type I cells processed 
caspase-8 alone is sufficient to activate other caspases (Scaffidi et al., 1998; Scaffidi et al., 
1999). In contrast, CD95 signaling in type II cells depends on an amplification loop via 
mitochondria relying on caspase-8 that mediates cleavage of pro-apoptotic Bid (Kuwana et 
al., 1998). Truncated Bid, tBid, translocates to mitochondria and promotes conformational 
change, oligomerization and recruitment of Bax to the mitochondria (Eskes et al., 2000). 
Subsequently, cytochrome c is released and the apoptosome is formed initiating a 
mitochondrial feedback loop (Luo et al., 1998). In addition, cleavage of caspase-6 
downstream of mitochondria may initiate a positive feedback to the receptor pathway by 
cleaving caspase-8 (Cowling and Downward, 2002). 
Interestingly, FADD and other DED containing proteins are not restricted to their function as 
adapter molecules in the cytosolic DISC complex. It has been recently reported that a nuclear 
localization signal in their DED recruits these proteins into the nucleus suggesting an 
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independent, direct role in apoptosis (Stegh et al., 1998; Schickling et al., 2001; Gomez-
Angelats and Cidlowski, 2003). 
Naturally occuring inhibitors of the CD95 as well as TNF-R1 death signaling pathway are 
viral and cellular FLICE inhibitory proteins, the v- and c-FLIPs (Thome et al., 1997; Irmler et 
al., 1997). Human c-FLIP exists in two isoforms, FLIPS and FLIPL, both of which are 
recruited to the CD95 DISC in a stimulation-dependent manner. FLIPS inhibit apoptosis by 
blocking caspase-8 activation. Another way cells inhibit death ligand induced apoptosis is via 
the soluble CD95 decoy receptor, DcR3. DcR3 has been shown to bind to CD95L and to 
inhibit CD95L-induced apoptosis (Pitti et al., 1998). 
(2) TNF is a well characterized cytokine which exists as a homotrimer and is primarily 
produced by activated macrophages (Fransen et al., 1985). TNF signals through TNF-R1 and 
-2 and results in the activation of two pleiotropic transcription factors, nuclear factor kappa B 
(NF-κB) and c-Jun. The two transcription factors induce expression of genes that are 
implicated in diverse biological processes such as cell growth and death, development, 
oncogenesis, immune and stress response. Hence, inappropriate production of TNF is 
responsible for the pathogenesis of a wide range of human diseases, including rheumatoid 
arthritis, sepsis, cancer, and autoimmune response. 
Upon engagement of TNF to its cognate receptor, the inhibitory protein, silencer of death 
domain (SODD), is released from the TNF-R1. This enables TNF to bind to the TNF-R-
associated death domain (TRADD). TRADD in turn recruits additional adapter proteins such 
as receptor-interacting protein (RIP), TNF-R-associated factor 2 (TRAF2), and FADD. These 
adaptors further recruit key enzymes that initiate the signaling events. While the protein 
kinase RIP degrades IκB (inhibitor of NF-κB) thereby activating NF-κB and suppressing 
apoptosis, FADD recruits caspase-8 and initiates autocatalytic cleavage which activates the 
caspase cascade. TRAF2 (Rothe et al., 1994) in contrast attracts inhibitory apoptosis 
molecules like cellular inhibitor of apoptosis protein 1 and 2 (cIAP-1/-2), which act as 
endogenous inhibitors of caspases (Rothe et al., 1995). TRAF2 is further believed to activate 
a cascade of kinases that finally increases the transcriptional activity of c-Jun. In summary the 
outcome of TNF signaling can either be pro- or antiapoptotic, and depends on the availability 
of activating and inhibitory proteins and their relative affinities to the TNF-R signaling 
complex. 
(3) TRAIL (TNF-related apoptosis-inducing ligand, APO-2L) is expressed in a wide range of 
tissues and transmits the death signal via TRAIL-R1/DR4 and TRAIL-R2/DR5 (Wiley et al., 
1995). Similarly to CD95-mediated cell death TRAIL signaling results in receptor 
trimerization and clustering of death domains leading to the formation of a DISC and 
subsequent activation of caspase-8 (Bodmer et al., 2000) and  -10 (Kischkel et al., 2001). 
TRAIL-R3 and TRAIL-R4 have been identified as decoy receptors that lack any functional 
death domain and are therefore unable to induce cell death (Pan et al., 1997). Instead they 
prevent TRAIL binding to DR4 and DR5. The existence of decoy receptors and the 
observation that TRAIL has different affinities to the TRAIL receptors may explain why some 
cells are preferentially killed by TRAIL whereas others are not (Truneh et al., 2000). 
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1.1.4 Bcl-2 family: regulators of apoptosis 
Bcl-2 and related intracellular proteins are key regulators of apoptosis both in the intrinsic and 
extrinsic apoptosis signaling pathways. To date, more than 25 Bcl-2 family members have 
been identified (Adams and Cory, 1998; Borner, 2003). These can be divided into two 
classes: members that inhibit and members that promote cell death. Homeostasis is ensured by 
strictly controlling the amount of active pro- and antiapoptotic family members. Cellular 
stress disrupts this balance between pro- and anti-apoptotic proteins and leads to apoptosis. 
Unrelated to their role in apoptosis, all Bcl-2 family members contain at least one of four 
conserved Bcl-2 homology (BH) domains, designated BH1 to BH4. These domains do not 
exhibit enzymatic activity but mediate the interaction of the Bcl-2 family members with other 
proteins. Many Bcl-2 proteins are further characterized by a hydrophobic C-terminal domain 
(TM) which is responsible for membrane anchorage and cellular localization (Nguyen et al., 
1993). According to the BH and TM domains the following classification of the Bcl-2 family 
can be made: The anti-apoptotic members such as Bcl-2, Bcl-xL and Bcl-W show sequence 
conservation in all four BH domains and possess the TM domain. All pro-apoptotic proteins, 
in contrast, lack at least the BH4 domain. Further sequence homology studies lead to division 
into three groups: first, members containing the BH1, BH2, BH3 and the TM domain like 
Bax, Bak, and Bok; second, the “Bcl-alone” proteins possessing the BH3 and the TM 
domains (BNip, Blk); and third, the “BH3-only” proteins having only the BH3 domain (Bad, 
Bid, Bim) (Figure 1). 
Figure 1: Schematic classification of Bcl-2 family proteins. Proteins are represented in linear 
forms. Bcl-2 homology domains are indicated by BH1 - BH4, the hydrophobic, C-terminal 
transmembrane domains by TM. 
Anti- and pro-apoptotic proteins display different patterns of membrane localization. For 
instance, Bcl-2 is mainly membrane-bound and resides on the cytoplasmic face of 
mitochondrial outer membrane, the endoplasmic reticulum (ER), and the nuclear envelope 
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(Krajewski et al., 1993). Especially mitochondrial membrane anchorage plays a key role in 
regulating mitochondrial membrane integrity and preventing apoptosis. Bcl-xL is found on 
membranes as well as in the cytoplasm (Gonzalez-Garcia et al., 1994). In contrast, Bax is 
predominantly localized in the cytosolic fraction. Upon apoptosis induction, however, Bax 
exposes its membrane-anchoring domain and redistributes to the mitochondria and promote 
cytochrome c release (Hsu et al., 1997). 
Three Bcl-2 family members, Bcl-2, Bcl-xL, and Bax were more closely investigated in the 
context of the present thesis and will be briefly described in the next paragraph. The proto-
oncogenic activity of Bcl-2 was first discovered in B-lymphoid cells. Rather than promoting 
cell proliferation or inhibiting differentiation like other oncogenes, it suppresses lymphocyte 
apoptosis (Vaux et al., 1988). Beside the ability of Bcl-2 to inhibit apoptosis by preventing 
cytochrome c release from mitochondria, two other mechanisms have been discussed. In 
analogy to findings in C. elegans, where CED-9, the nematode homologue of Bcl-2, has been 
found to interact directly with CED-4 and inhibit apoptosis, a direct role of Bcl-2 as well as 
Bcl-xL in regulating the activation of caspases has been suggested (Chinnaiyan et al., 1997). 
Further, Bcl-2 plays an important role in calcium homeostasis in the endoplasmic reticulum. 
Maintenance of ER calcium by Bcl-2 has been found to promote cell proliferation and to 
inhibit apoptosis (He et al., 1997). Interestingly, Bcl-2 is targeted and cleaved by caspase-3 
during apoptosis. The generated C-terminal cleavage product itself promotes apoptosis and is 
therefore part of a positive feedback loop within the death machinery (Kirsch et al., 1999). 
Bcl-x encodes two polypeptides arising from alternative splicing. The longer mRNA encodes 
the death-suppressing Bcl-xL that has high functional similarity to Bcl-2. It is transcriptionally 
activated by NF-κB (Lee et al., 1999) or by STAT5 (Silva et al., 1999). The shorter Bcl-xS 
lacks the BH1 and BH2 and acts as a negative regulator of Bcl-xL and Bcl-2 (Boise et al., 
1993). 
Additional regulation of the apoptotic process is provided by the interaction of anti-apoptotic 
Bcl-2 and Bcl-xL with the BH3 domain of the pro-apoptotic members of the Bcl-2 family 
(Chittenden et al., 1995). For instance, Bax and Bcl-2 form heterodimers and the ratio of 
Bcl-2 to Bax determines survival or death following an apoptotic stimulus (Oltvai et al., 
1993). Bcl-xL is bound and antagonized by Bak (Sattler et al., 1997). However, mutation and 
deletion studies elucidated that both Bax and Bak are able to promote apoptosis by a 
heterodimerization-independent mechanism (Zha and Reed, 1997; Simonian et al., 1997). Bad 
heterodimerizes with Bcl-xL and Bcl-2 and thereby displaces Bax from the anti-apoptotic 
proteins and promotes cell death (Yang et al., 1995). 
Bax is the prototype of cell death-mediating Bcl-2 family members. The mechanism of Bax 
and Bak-mediated cell death was unknown for a long time. The current opinion is that they 
undergo conformational changes in response to a death signal, causing translocation, 
mitochondrial membrane insertion and homodimerization that finally results in cell death 
(Gross et al., 1998). One candidate responsible for the conformational changes of Bax 
(Desagher et al., 1999) and Bak (Wei et al., 2000) is the BH3 only protein, Bid. Bid is cleaved 
after induction of apoptotic cell death by CD95 death receptor signaling (see above). 
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Interestingly, the human and mouse bax genes contain a p53 and p73 consensus binding site. 
Both transcription factors have been shown to mediate the expression of Bax after DNA 
damage (Miyashita and Reed, 1995). Further, the pro-apoptotic BH3 only proteins Noxa (Oda 
et al., 2000) and PUMA (p53-upregulated modulator of apoptosis) (Nakano and Vousden, 
2001) have been described to be regulated by p53 and recently also by E2F1 transcription 
factor (Hershko and Ginsberg, 2004). Very recently PUMA has been identified as the 
transcriptional target of p73 and as an inducer of Bax translocation from the cytosol to the 
mitochondria (Melino et al., 2004). 
1.1.5 Survival and apoptotic signaling in hematopoietic FL5.12 cells 
In 1985 McKearn and colleagues generated the murine IL-3 dependent pro B cell line, FL5.12 
(McKearn et al., 1985). B cells generate from pluripotent hematopoietic stem cells in the liver 
during mid-to-late fetal development and in the bone marrow after birth. FL5.12 cells are 
enriched mouse fetal liver cells that respond to interleukin 3 (IL-3), a multilineage 
hematopoietic growth factor. Fetal liver cells display high frequencies of multipotential 
erythroid and myeloid precursors (colony-forming unit mix, CFU-mix) or restricted erythroid 
and myeloid precursors such as granulocyte and macrophage CFU and erythroid burst-
forming unit as well as precursors that differentiate to become mature B lymphocytes. The B-
lymphocyte precursors can be cloned in single-cell cultures in the presence of IL-3. The 
doubling time is about 12 h. Growth of these clones can be maintained for more than six 
months in the presence of IL-3. During culture IL-3 tightly controls IL-3R alpha and beta 
chain expression and the cells maintain their capacity to differentiate to mature B 
lymphocytes (Algate et al., 1994). 
The PI3K/Akt signaling pathway is of central importance for maintenance of cell survival in 
FL5.12 cells (Minshall et al., 1996). Briefly, upon cytokine stimulation the p85 regulatory 
subunit of phosphatidylinositol 3-kinase (PI3K) associates with the IL-3 RβC chain and 
becomes phosphorylated. This results in activation of the p110 catalytic subunit of PI3K 
which phosphorylates membrane lipid phosphatidylinositol (4,5)-bisphosphate. The generated 
phosphatidylinositol (3,4,5)-tris-phosphates (PI(3,4,5)P3) serve to localize and activate 
phosphatidylinositol-dependent kinase (PDK-1) in the vicinity of the cell membrane. In turn 
Akt also called protein kinase B (PKB) is targeted to the lipid-rich cell membrane and 
becomes phosphorylated on T308 in the catalytic domain and S473 in the C-terminal domain 
(Wick et al., 2000). Akt prevents apoptosis by phosphorylating several downstream targets 
including Bad (Datta et al., 1997), forkhead transcription factor (Foxo-3) (Brunet et al., 1999), 
and caspase-9 (Cardone et al., 1998). Akt has also been found to inhibit the conformational 
changes of Bax and its redistribution to the mitochondrial membranes (Yamaguchi and Wang, 
2001). While phosphorylated caspase-9 inhibits procaspase-9 processing in the apoptosome, 
phosphorylated Bad and Foxo-3 are sequestered by members of the 14-3-3 protein family in 
the cytosol. IL-3 deprivation results in dephosphorylation of Bad and Foxo-3 which in turn 
triggers the subsequent release of Bad and Foxo-3 from 14-3-3 and their activation. Tumor 
suppressor phosphatase and tensin homologue deleted on chromosome 10, shortly PTEN, 
reduces intracellular PI(3,4,5)P3 levels by dephosphorylation and thereby negatively regulates 
the PI3K/Akt signaling pathway (Stambolic et al., 1998). 
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Beside the PI3K/Akt signaling pathway, other pathways including the Ras/Raf/MEK/ERK 
and the Jak/STAT pathways are activated by IL-3. Central downstream phosphorylation 
targets of the first pathway are members of the p90 ribosomal S6 kinase family (p90S6K, 
Rsk) which phosphorylate and inhibit Bad as well as phosphorylating and transactivating the 
transcription factor cAMP response element-binding protein (CREB) (Bonni et al., 1999). 
CREB drives the expression of anti-apoptotic Bcl-2 family members (Wilson et al., 1996). 
The latter pathway signals phosphorylation and activation of cytoplasmic STAT transcription 
factors which translocate to the nucleus and induce genes essential for cytokine-regulated 
processes such as cellular proliferation, differentiation as well as survival (Mui et al., 1995). 
Intersections between different signaling pathways have been reported (Shelton et al., 2003). 
For instance, Raf has been shown to be recruited to the plasma membrane by Ras and to be 
then phosphorylated by Jak upon growth hormone stimulation. Raf has additionally been 
shown to be phosphorylated by Akt which results in inhibition of the Raf/MEK/ERK pathway 
(Zimmermann and Moelling, 1999). On the other hand it has been reported, that apoptosis 
suppression by Raf-1 and MEK1 requires both MEK- and PI3K-dependent signals (von Gise 
et al., 2001). 
Figure 2: Proposed model for the PI3K/Akt survival signaling pathway. Activation of a 
receptor tyrosine kinase by a growth factor or of a cytokine receptor by the corresponding 
cytokine leads to recruitment and activation of PI3K. Activated PI3K generates 3`phospho-
inositides (grey and black circles) that in turn mediate the recruitment of Akt to the plasma 
membrane. Akt is then phosphorylated (phosphates are depicted with red circles) by PDK 1 
and probably by other so far unidentified kinases. Activated Akt now mediates its intracellular 
survival effects, e.g. by phosphorylation and inhibition of Foxo, caspase-9 or Bad. PTEN 
limits the activation of Akt by dephosphorylating PI(3,4,5)P3; protein phosphatase 2A 
(PP2A) inhibits by direct dephosphorylation of Akt (redrawn and modified from (Brazil and 
Hemmings, 2001)). 
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1.2 Globin protein family and hematopoietic transcription 
factors 
1.2.1 The globin protein family - Expression and function of alpha 
globin in erythroid cells 
Globin proteins have been found in many taxa including bacteria, plants, fungi, and 
vertebrates and belong to the large group of heme-containing proteins (Hardison, 1996). 
Heme is a protoporphyrin IX molecule with an iron ion bound in the middle of its flat, planar 
structure. Heme biosynthesis takes place in almost all animal cells except mature erythrocytes 
which lack a nucleus and all subcellular organelles. Heme synthesis requires four cytoplasmic 
and four mitochondrial enzymes including for example delta aminolevulinic acid synthetase 
(ALA-S), ferrochelatase or porphobilinogen deaminase (PBGD) (Sassa, 1976). 85% of all 
heme is synthesized in erythroid cells where it reversibly binds oxygen. In erythroid cells the 
iron transporter transferrin is the only physiological iron source for heme synthesis (Ponka, 
1997). 
So far, the globin protein family comprises hemoglobins, myoglobin, neuroglobin, and the 
recently discovered cytoglobin (Burmester et al., 2002). Hemoglobin was the first complex 
protein whose three-dimensional structure was solved (Muirhead et al., 1967) and alpha 
globin (α-globin) the first gene to be cloned (Rabbitts, 1976). All hemoglobins are 
heterotetramers consisting of two alpha-globin-like and two beta-globin-like chains. Each 
globin chain binds one molecule of heme in a precise fashion in its hydrophobic pocket. 
Synthesis of hemoglobin occurs in the erythroblast and reticulocyte stages of erythrocyte 
development. Depending on the developmental stage the following forms of hemoglobin can 
be distinguished: 
In the first 1-3 months of human fetal life two different types of embryonic hemoglobin are 
expressed in primitive erythroblasts, Hb Portland and Hb Gower1. Hb Portland consists of 
two alpha-like zeta chains (ζ), and two beta-like gamma chains (ζ2γ2), Hb Gower1, the 
predominant form of hemoglobin, consists of two zeta and two beta-like epsilon (ε) chains 
(ζ2ε2) (Adachi et al., 2002). Later in definitive erythropoiesis the embryonic globins are 
replaced by fetal globin, HbF composed of two alpha and two gamma chains (α2γ2). Both the 
embryonic and the fetal forms of hemoglobin have a higher affinity for oxygen than the 
maternal hemoglobin, thus ensuring sufficient oxygen supply of the fetus (Dow et al., 1995). 
From one month before birth until the age of three months HbF is replaced by adult 
hemoglobin, HbA or Hb0, consisting of two alpha and two beta globin chains (α2β2). 
Myoglobin (Mb) acts as a monomeric, 153 amino acid long protein and facilitates oxygen 
transport in the skeletal as well as cardiac muscles (Wittenberg et al., 1975). It has recently 
been reported that myoglobin may also function in detoxification of NO (Flogel et al., 2001). 
Neuroglobin (NGB) is expressed in the human and mouse brain and shares little sequence 
homology with Hbs and Mb. NGB is believed to represent a distinct globin protein family that 
diverged early in evolution. However, NGB displays oxygen-binding properties comparable 
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to those of myoglobin. This led to the suggestion that neuroglobins enhance oxygen supply in 
the brain (Burmester et al., 2000). 
Cytoglobin (CYGB) is the most recently found globin type protein and is ubiquitously 
expressed in vertebrate tissues (Burmester et al., 2002). First findings concerning the 
physiological function indicate a role in collagen synthesis and tissue-protective functions 
after hypoxic insults (Schmidt et al., 2004; Fordel et al., 2004). Interestingly, CYGB localizes 
to the nucleus and this suggested a possible function of globin-folded proteins as 
transcriptional regulators (Geuens et al., 2003). 
1.2.2 The globin gene locus, transcriptional regulation, and mRNA 
stability 
High-level differential expression within the globin gene clusters during erythroid 
development and formation of functional hemoglobin requires precise regulatory 
mechanisms. These appear to involve a complex interplay of chromatin structure, regulatory 
DNA sequences, and transcription factors. The promoters of all globin genes share 
remarkable homology. For instance, all globin promoters contain three major regulatory 
elements, the TATA, CCAAT, and CACC boxes, which are the target sequences of several 
ubiquitous transcription factors including TATA binding proteins, CP1, and CAC box binding 
proteins, respectively (Myers et al., 1986). However, unique patterns have been identified also 
within the promotor sequences. Especially erythroid-specific transcription factors are likely to 
determine developmental stage specificity of each promoter. 
The human alpha-like globin gene cluster spans about 80 kb and lies close to the telomer of 
the short arm of chromosome 16 (Buckle et al., 1988). The globin genes are arranged in order 
of their developmental expression: 5`-ζ2-ψζ1-ψα2-ψα1-α2-α1-θ-3` (Feng et al., 2001) 
(Figure 3). Sequence analysis found two identical alpha globin genes, α1 and α2, as well as 
two human alpha globin pseudogenes, ψα1 and ψα2, which do not encode for globin peptides 
(Proudfoot and Maniatis, 1980; Hardison et al., 1986). Differently from the human alpha-like 
gene cluster, the mouse gene cluster is located internally on chromosome 11. The arrangement 
of the mouse alpha-like gene reflects the temporal order of expression as observed for the 
human genes. The detailed organization of the globin genes, however, varies between human 
and mouse. For example, there is only a single ζ gene in mouse. However, in mouse the entire 
ψα-α-θ block has been duplicated; in human only the alpha globin gene has been duplicated. 
Recently, a third ψα-α-θ gene set has been identified on mouse chromosome 17 (Tufarelli et 
al., 2004). This suggested that the duplication occurred after human and mouse diverged from 
a common ancestor. 
The 5` flanking region of the alpha globin gene cluster is GC-rich and associated with 
unmethylated CpG (cytosine and guanine connected by a phosphodiester bond) islands. CpG 
islands are deficient in histone H1, contain hyperacetylated histones H3 and H4, and include 
nucleosome-free DNA segments indicating an open accessible chromatin structure 
(euchromatin) for constitutive high-level expression of the alpha globin gene. This indicates 
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that the alpha globin gene locus displays the characteristics more of a ubiquitously expressed 
housekeeping gene than a tissue-specific gene (Smith and Higgs, 1999). 
Furthermore, human alpha globin expression is regulated by the erythroid-specific DNase I 
hypersensitive site, HS-40 also known as alpha globin positive regulatory element (αPRE). 
HS-40 is the major enhancer and control element of the alpha globin gene family located 
40 kb upstream of the ζ-globin gene (Higgs et al., 1990; Sharpe et al., 1992). The HS-40 core 
element displays various erythroid-specific and ubiquitous DNA-binding protein sites for 
GATA, AP1/NF-E2, and CACC binding proteins which behave as enhancers (Loyd et al., 
2003). 
A comparable element in the mouse alpha globin locus lies 26 kb upstream of the ζ-globin 
gene. It is therefore called HS-26 and is thought to have similar functional properties as the 
human HS-40. In contrast to deletions of human HS-40 which resulted in severe down-
regulation of alpha globin gene expression, deletion of mouse HS-26 exhibited only mild 
reduction indicating important differences in human and mouse alpha globin regulation 
(Anguita et al., 2002). In general, HSs are essential regions for DNA-protein interactions and 
modeling of the chromatine structure. HSs are believed to facilitate access of regulators and to 
lower the threshold for activation of linked genes. 
 
Figure 3: Organization and distal regulatory element of the human alpha globin 
gene cluster (redrawn from (Hardison, 1998)). 
Similar to the alpha globin locus, the genes encoding the beta- and beta-like subunits are 
present in a cluster in the genome and are arranged in the order they are expressed during 
development in mammals. For example, the human beta globin gene cluster is organized in 
the following order: 5`-ε-Gγ-Aγ-ψη-δ-β-3` (Figure 4). In contrast to the human beta globin 
gene cluster which contains only one sequence for beta globin , the mouse cluster contains 
two separate sequences, beta globin major (Hbb-b1) and beta globin minor (Hbb-b2). Hbb-b1 
and Hbb-b2 share high nucleotide (96%) and protein (93%) sequence homology. Both genes 
are closely linked and coordinately expressed (Konkel et al., 1979). The mammalian DNA 
sequence in the 5` region of the cluster includes four erythroid-specific DNase I 
hypersensitive sites, HS-1 to HS-4 which together are referred to as the locus control region 
(LCR), and a further upstream site, HS-5 (Curtin et al., 1989), which act to open the 
chromatin in erythroid cells. While chromatin opening does not appear to play a role in 
regulation of alpha globin genes, it is the key initial step in the regulation of beta globin 
genes. The HS-5 is ubiquitously and constitutively on, whereas HS-1 to HS-4 are necessary to 
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reach full activity. Similar to HS-40 in the alpha globin gene locus, each HS of the LCR 
exhibits binding sites for transcription factors AP-1/NF-E2, Sp-1, and GATA-1 (Lowrey et 
al., 1992). 
 
 
Figure 4: Organization and distal regulatory element of the human beta globin 
gene cluster (redrawn from (Hardison, 1998)). 
The alpha globin and globin mRNAs in general belong to the most stable mRNAs with 
estimated half-lives ranging from 24-40 h (Volloch and Housman, 1981; Ross and Sullivan, 
1985). The major regulatory sequences within the alpha globin gene are three C-rich elements 
(CRE) located in the 3`UTR at nucleotide positions 25-31, 37-40, and 55-66 from the stop 
codon (Weiss and Liebhaber, 1995). An RNA-protein complex, called alpha-complex 
(α-complex) assembles at the minimal α-complex binding site, the alpha RNAmin 
(αRNAmin), within the CRE of the alpha globin 3`UTR (Wang et al., 1995). Binding of the 
α-complex protects alpha globin mRNA from cleavage by erythroid-enriched endoribo-
nuclease (ErEN) (Rodgers et al., 2002). Alpha globin poly (C)-binding protein 1 and 2 
(α-CP1, α-CP2) were the first two proteins identified in the α-complex. Since then additional 
proteins have been found to associate with this complex: poly-A binding protein (PABP), 
AU-rich destabilizing elements binding/degradation factor (AUF-1) and two so far 
unidentified proteins. PABP binds to the poly-A tail of alpha globin and thereby prevents 
deadenylation and subsequent degradation of alpha globin mRNA (Wang and Kiledjian, 
2000). Binding of α-CP to PABP promotes both the binding of α-CP to αRNAmin and 
binding of PABP to the poly-A tail. In the absence of α-CP and PABP, ErEN has access to the 
ErEN site and cleaves the RNA. So far it is not known whether these two pathways function 
independently from one another or whether they are functionally linked. Further, the factors 
that degrade the mRNA after ErEN cleavage are not elucidated. 
1.2.3 GATA transcription factor family 
Binding sites for numerous transcription factors including Sp1 (Pondel et al., 1995), 
AP-1/NF-E2 (Loyd et al., 2003) (Martin et al., 1998), CP-2 (Lim et al., 1992), NF I (Zorbas et 
al., 1992), and the GATA transcription factor family have been found in promotor and 
enhancer elements of the alpha-like globin genes in erythroid cells. Some of these 
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transcription factors such as Sp1, NF-E2 or the GATA factors have also been shown to 
regulate the expression of the beta-like globin genes. Besides shared/common transcription 
factors, there are transcriptional regulators that seem to exhibit preferences for the beta gene 
locus, for instance EKLF (Spadaccini et al., 1998) or FOG-1 (Tsang et al., 1997). 
GATA factors also known as GF-1, NF-E1, or Eryf 1 have been identified as key molecules 
in globin gene regulation during erythroid cell differentiation (Tsai et al., 1989). They contain 
two zinc fingers that recognize and bind to the DNA cis-element consensus motif, 
(A/T)GATA(A/G). Six different GATA members have been identified in vertebrates so far 
and can be divided into two subfamilies (Yamamoto et al., 1990). While GATA-4, -5, and -6 
are expressed in various mesoderm- and endoderm-derived tissues such as heart, gut 
(Laverriere et al., 1994), liver, and gonad, where they regulate tissue-specific gene expression 
(Molkentin, 2000), GATA-1, -2, and -3 exhibit unique but overlapping patterns of expression 
in hematopoietic tissues (Weiss and Orkin, 1995a). GATA binding sites of the latter 
subfamily have been initially found in globin gene promoters and enhancers but later in cis-
regulatory elements of virtually all erythroid-cell-expressed genes (Orkin, 1992). GATA-1 is 
abundantly and exclusively expressed in erythroid, eosinophilic, mast, and megakaryocytic 
lineages and multipotential progenitors. It is required for survival of erythroid progenitors and 
terminal differentiation of erythroid precursors into red blood cells and for maturation of 
megakaryocytes to platelets. The second member, GATA-2, is present in early hematopoietic 
progenitors, mast cells, and megakaryocytes, and is crucial for the maintenance and 
proliferation of immature hematopoietic progenitors (Ohneda and Yamamoto, 2002). 
GATA-2 is additionally expressed in a limited subset of nonhematopoietic tissues (Yamamoto 
et al., 1990). GATA-3 is abundantly expressed in T lymphocytes and the brain (Ting et al., 
1996). 
GATA-1 has structural domains, that enable it to self-associate as well as to heterodimerize 
with other activators and transcription factors including multitype zinc finger protein FOG 
(Tsang et al., 1997), Krueppel family proteins Sp-1 and EKLF (Merika and Orkin, 1995), 
NF-E2 (Andrews, 1998) or CBP/p300 (Blobel et al., 1998). These interacting domains, 
however, were found to be less conserved in GATA-2 (Orkin, 1992). Closer examination 
revealed a cross-regulatory mechanism by which GATA-1 can control the expression of 
GATA-2 and vice versa, possibly via essential GATA binding sites in their cis-acting 
elements (Ohneda and Yamamoto, 2002; Crossley et al., 1995). Based on these observations 
and the expression profile in erythroid cells, a model emerged in which GATA-2 activates 
GATA-1 in the early stage of erythroid differentiation and GATA-1 replaces GATA-2 to 
promote an autoregulatory loop (Orkin, 1995) (Figure 5). Based on this theory GATA-1 is 
believed to be the critical protein for erythroid gene transactivation in erythroid cells. 
However, GATA-1 knock out experiments have shown that GATA-2 could successfully 
substitute functions believed to be exclusive for GATA-1 (Weiss and Orkin, 1995b). In 
summary, GATA-1 and GATA-2 are believed to transactivate similar sets of genes, where 
one or the other is in control depending on the developmental stage as well as the cellular 
context. 
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Figure 5: Expression levels of GATA-1 and GATA-2 during erythroid cell 
development with potential auto- and cross-regulatory effects. In this model, 
GATA-2 transactivates GATA-1 gene expression, while GATA-1 represses GATA-2 
expression. GATA-1 has been shown to induce its own gene expression (redrawn 
from (Ohneda and Yamamoto, 2002)). 
1.2.4 Assembly of hemoglobin and globin diseases 
Under physiological, healthy conditions the translation of globins into their respective 
polypeptide chains is followed by the assembly into αβ-dimers. This is known to be the rate-
limiting step in hemoglobin assembly (Adachi et al., 2002) and to be driven by electrostatic 
attraction of the negatively charged beta chain (Adachi et al., 1998). Further dimerization into 
α2β2 tetramer results in functional adult HbA. 
Expression of mutated, nonfunctional globin polypeptides lead to severe disorders such as 
sickle cell anemia (Lewis et al., 1966) or thalassemia (Bank et al., 1969; Ingram, 1989). In the 
“classical” thalassemia, the beta-thalassemia, excess of alpha chains, which cannot build 
heterotetramers with beta chains, precipitate and form inclusion bodies early during 
differentiation of young nucleated erythroid cells in the bone marrow (Fessas et al., 1966; 
E.Rachmilewitz and St.Schrier, 2001). Alpha globin and its oxidized forms, methemoglobin 
and hemochrome, increase membrane rigidity and apoptosis in pathologic erythrocytes 
(Fortier et al., 1988; Advani et al., 1992). Under these pathologic conditions alpha globin has 
been found to form complexes with spectrin and its membrane attachment protein, ankyrin 
(Kannan et al., 1988). These complexes are believed to be responsible for membrane 
instability and hemolysis of red blood cells. 
1.2.5 Heme and globin detoxifying proteins, HO-1 and AHSP 
Heme oxygenase 1 (HO-1) also called heat shock protein Hsp32, exerts important functions in 
the context of hemoglobin degradation and prevention of cellular damage. Heme oxygenase 
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exists in three isoforms. HO-1 is dramatically induced upon cellular stress caused by agents 
such as free heme, heavy metals, UV, low oxygen levels, heat (Shibahara et al., 1987) or anti-
inflammatory factors such as IL-6 and IL-10 (Ricchetti et al., 2004) and it remains high for 
hours (Ferris et al., 1999). HO-2, however, is constitutively expressed and has significant 
heme oxygenase activity (Ewing and Maines, 1991). HO-3 is closely related to HO-2 but is a 
poor heme oxygenation catalyst (McCoubrey, Jr. et al., 1997). HO-1 is a microsomal enzyme 
and contains a hydrophobic segment at its C-terminus that is essential for anchorage to the 
membrane of microsomes. Heme is catabolized in a so called “substrate-assisted” reaction in 
which it serves as both cofactor and substrate (Schuller et al., 1999). In concert with NADPH, 
oxygen, and cytochrome P450 reductase, heme oxidizes to biliverdin, ferrous iron, and carbon 
monoxide (CO). Biliverdin reductase in turn converts biliverdin to bilirubin. Through the 
Fenton reaction Fe2+ promotes the generation of hydroxyl radicals that damage proteins and 
lipids. This prooxidant action is limited by ferrous ion inducing the iron chelator, ferritin, as 
well as by iron pumps that release Fe2+ in the extracellular space (Ferris et al., 1999). CO is a 
signaling molecule with a wide spectrum of biological functions in neurons, smooth muscle 
cells, platelets, macrophages, and endothelial cells. CO has been reported to promote 
vasodilatation, to inhibit inflammation and to suppress apoptosis (Brouard et al., 2000). 
Recently alpha globin stabilizing protein (AHSP) has been described to form stable 
complexes with alpha but not beta globin independently of heme. AHSP prevents 
precipitation of alpha globin and oxidation of the heme-bound iron (Kihm et al., 2002). AHSP 
also known as erythroid association factor (ERAF) is an erythroid-specific, 104 amino acids 
long protein, expressed in all fetal and adult hematopoietic tissues i.e. bone marrow, spleen, 
and fetal liver (Gell et al., 2002). Erythroid transcription factor GATA-1 has been shown to 
strongly upregulate AHSP. In a competitive reaction the alpha globin:AHSP complex is 
immediately disrupted when beta globin is added to form HbA (Kihm et al., 2002). Previously 
AHSP has already been described as erythroid differentiation-related factor (EDRF) and has 
been found to be transcriptionally downregulated in spleens of animals with transmissible 
spongiform encephalopathie like Scrapie and bovine spongiform encephalopathy (BSE) 
(Miele et al., 2001). 
1.2.6 Recent findings on novel functions of alpha globin 
During the past few years, alpha globin has been reported to be involved in processes other 
than oxygen transport in erythrocytes. Very recently Wride and collegues reported that alpha 
globin is expressed in lens fibres in normal lenses and is downregulated in the pre-cataractous 
lens. Lenses undergo an apoptosis-like process during development, which results in removal 
of organelles and nuclei from lens fibre cells. In cataractous lenses the organelles are not 
properly removed. This suggests a role of alpha globin in lens fibre differentiation (Wride et 
al., 2003). 
Three years ago Yoshida and colleagues found that extraerythrocytic hemoglobin played a 
novel role in wound healing. Hemoglobin and globin but not heme or protophorphyrin IX 
were able to stimulate plasminogen activator biosynthesis and to increase fibrinolytic activity 
in human fibroblasts (Yoshida et al., 2001). 
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We have previously performed gene expression profiling of FL5.12 cells upon induction of 
apoptosis using cDNA microarrays (Brachat et al., 2000). In FL5.12 cells undergoing 
apoptosis in the absence of IL-3 alpha globin was the most prominent upregulated gene. We 
further found alpha globin to be slightly upregulated in FL5.12 cells treated with cisplatin and 
methotrexate but not staurosporine, camptothecin, or paclitaxel. Devireddy and co-workers 
independently reported the dramatic increase of alpha but not beta globin in FL5.12 cells after 
IL-3 deprivation (Devireddy et al., 2001). FL5.12 cells retrovirally transduced with 
N-terminal FLAG-tagged alpha globin displayed accelerated apoptosis progression and 
increased caspase-3 activity (Brachat et al., 2002). The pro-apoptotic effect of FLAG-alpha 
globin was significantly prevented in an FL5.12 cell line stably transfected with Bcl-2. 
However, the death accelerating effects of FLAG-alpha globin could not be consistently 
reproduced, nor FLAG-alpha globin expression confirmed on transcript or protein level by 
RT QPCR or Western blot analysis, respectively. 
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2 Aims of the thesis 
It is now more than 30 year ago that Kerr and Currie described a common type of 
programmed cell death that the authors repeatedly observed in various tissues and cell types 
and finally termed apoptosis (Kerr et al., 1972). The authors observed that these dying cells 
shared many morphological features, which were different from features seen in cells dying of 
necrosis. They suggested that the shared morphological characteristics might underlie a 
common, conserved endogenous cell death program. Since then, apoptosis research has 
evolved to one of the most investigated areas in modern biology. In recent years, central 
hallmarks of programmed cell death have been characterized and several key players of 
apoptosis such as the Bcl-2 family members or caspases have been identified. In many 
pathways, however, regulatory factors and precise interplays within the signaling cascades 
remain elusive. 
In 2000, Brachat et al performed gene expression profiling to explore novel regulators of 
apoptosis and to shed light on apoptotic signaling pathways in FL5.12 cells. They investigated 
the transcriptional response in FL5.12 cells upon induction of apoptosis using cDNA 
microarrays (Brachat et al., 2000). Out of 105 genes induced under cytokine-deprived 
conditions, the alpha globin gene was found to be most prominently upregulated. Subsequent 
expression profiling of FL5.12 cells treated with different cytotoxic agents demonstrated, that 
alpha globin was also upregulated after treatment with cisplatin and methotrexate but not with 
STS, paclitaxel or campthotecin (Brachat et al., 2002); in summary, alpha globin was 
differentially regulated depending on the apoptotic stimulus, and appeared to be therefore a 
novel, promising candidate gene in PCD. 
Although cDNA microarrays are powerful tools for analyzing gene expression on a genome 
scale, the biological relevance of a regulatory event cannot be unequivocally deduced from 
expression profiling. Therefore, we first attempted to confirm the upregulation of alpha globin 
transcript in independent and repeated experiments by means of RT QPCR, a method that 
allows relative quantification of gene expression. Moreover, we wanted to show that the 
protein was present and regulated similarly to the transcript. To elucidate whether upregulated 
alpha globin formed hemoglobin, we investigated the expression of beta globin and beta-like 
globin genes, as well as the heme and hemoglobin contents. By means of both overexpression 
of ectopic alpha globin and downregulation of endogenous alpha globin we intended to 
evaluate, whether alpha globin was indeed involved in the apoptotic process or whether 
upregulation of alpha globin was an unrelated side effect. It was of further interest to 
ascertain, which cell death pathway was specifically promoted by alpha globin. A closing 
objective of the current work was to shed light on the regulatory mechanisms leading to 
elevated alpha globin levels during apoptotic cell death. 
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3 Results 
3.1 Upregulation of alpha globin promotes apoptotic cell 
death in the hematopoietic cell line FL5.12 
3.1.1 Alpha globin mRNA is highly expressed and upregulated in 
cytokine-deprived FL5.12 cells 
Incyte cDNA microarray experiments and Northern blot analyses have shown that alpha 
globin transcript was upregulated upon cytokine deprivation in FL5.12 cells (Brachat et al., 
2000a). We confirmed the results using the Affymetrix chip technology (Figure 1, upper 
panel). 
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Figure 1: Alpha globin mRNA expression profile of FL5.12 cells growing 
with or without IL-3. Gene expression analysis for alpha globin RNA 
samples prepared 0, 1, 8, 16, and 24 h after IL-3 removal (upper panel). 
The graphs represent one of two independent chip experiments. Alpha 
globin RNA expression levels measured with RT QPCR in FL5.12 cells 0, 
8, 12, 16, and 20 h after IL-3 deprivation (lower panel). Each bar 
represents the average of triplicate measurements. 
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In order to assess basal expression levels of alpha globin in FL5.12 cells and the profile of 
regulation after IL-3 deprivation, we performed quantitative Real Time RT PCR of FL5.12 
cells growing with or without IL-3 for 0, 8, 12, 16, and 20 h. 18S ribosomal RNA was used as 
endogenous control to normalize for differences in the amount of total RNA. GAPDH, 
another frequently used housekeeping gene, was found to be downregulated upon apoptosis 
induction and was therefore not suitable as a reference in RT QPCR (data not shown). Basal 
alpha globin expression levels in FL5.12 were relatively high. We measured a threshold cycle 
of 16 cycles for the housekeeping gene, 18S ribosomal RNA, compared to 22 cycles for alpha 
globin transcript. The largest incremental increase of alpha globin transcript of about 9.7-fold 
was observed within the first 8 h after IL-3 removal. Maximal expression of alpha globin (11-
fold induction) was reached after 12 h and then followed by a decrease 16 and 20 h after IL-3 
deprivation (Figure 1, lower panel). 
3.1.2 Other globins or globin-like genes are expressed at low or 
undetectable levels 
To check if other globin genes were expressed and regulated under death-inducing conditions, 
we analyzed expression patterns from chip experiments of IL-3-deprived FL5.12 and control 
FL5.12 cells. Transcript for myoglobin, a globin protein known to function as an oxygen 
carrier in muscles, heart and other tissues was not detectable in FL5.12 cells. Probes for 
neuroglobin, the oxygen carrier in the brain (Burmester et al., 2000) or cytoglobin, the most 
recently found globin (Burmester et al., 2002), were not spotted on the chip and were not 
further investigated. Additionally, neither zeta nor epsilon or gamma globin resembling the 
alpha-and beta-like globins and expressed in early embryonic life were detectable. Beta globin 
was not detected in FL5.12 cells as assessed by gene chip analysis. However, after cytokine 
removal the signal for beta globin was slightly increased, but according to Affymetrix chip 
analysis beta globin was still termed absent (Figure 2, upper panel). To confirm the chip 
results we performed RT QPCR using beta globin-specific primers and probe. In mouse, two 
copies of the beta globin gene exist, beta globin major (Hbb-b1) and minor chain (Hbb-b2), 
which share 96% homology at nucleotide level. Neither gene chip arrays nor RT QPCR could 
discriminate between beta major and minor chain. The very low expression levels for beta 
globin were confirmed by RT QPCR. The upregulation of beta globin message upon IL-3 
deprivation, however, appeared to be much stronger in RT QPCR than on Affymetrix chips 
suggesting that RT QPCR is the more sensitive method to detect gene expression (Figure 2, 
lower panel). For comparison, K562, a human chronic myeloid leukemia cell line, was 
analyzed. K562 cells are known to express only beta globin-like genes, epsilon and gamma 
globin, but not beta globin itself when forming embryonic and fetal hemoglobin (Rutherford 
et al., 1981). In RT QPCR experiments, the detection threshold for beta globin in K562 cells 
was reached after 30 cycles similar to our results for beta globin in FL5.12 cells. We therefore 
assume that beta globin expression in FL5.12 cells is negligible. 
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Figure 2: Beta globin mRNA expression profile of FL5.12 cells 
growing with and without IL-3. Gene chip expression analyses for 
beta globin RNA samples prepared 0, 1, 8, 16, and 24 h after IL-3 
removal (upper panel). The graphs represent one of two independent 
gene chip experiments. Beta globin RNA expression levels measured 
with RT QPCR in FL5.12 cells 0, 8, 12, 16, and 20 h after IL-3 
deprivation (lower panel). Each bar represents the average of triplicate 
measurements. 
3.1.3 Alpha globin protein is upregulated upon IL-3 deprivation 
In order to show that alpha globin protein was regulated similarly to its mRNA, we performed 
Western blot analysis and immunostaining with a hemoglobin antibody. First we tested the 
specificity of the hemoglobin antibody against alpha and beta globin. We transiently 
transfected HeLa cells with mouse GFP-alpha globin and GFP-Hbb-b1 and examined protein 
expression using an anti-GFP and the anti-hemoglobin antibodies in parallel blots. We 
ascertained that the hemoglobin antibody recognized both globin chains (Figure 3a, b). In 
general we found the hemoglobin antibody to be unspecific as it detected several unspecific 
background bands. Unfortunately, this was the only functional antibody, which was 
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commercially available, while all other antibodies against hemoglobin tested failed to detect 
alpha globin. 
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Figure 3: Alpha globin protein is upregulated upon IL-3 deprivation in 
FL5.12 cells and appears as a double band. Whole cell lysates of HeLa 
cells transfected with GFP, GFP-alpha globin or GFP-Hbb-b1 (a, b) 
served to evaluate the specificity of the hemoglobin antibody. Whole 
cell lysates of J2E control and FL5.12 cells (c) and FL5.12 cells 
growing in the absence of IL-3 for 0, 8, 12, 16, and 20 h (d) were 
prepared. All proteins were analyzed by SDS PAGE and Western 
blotting. Blots were probed with anti-GFP (a) or anti-hemoglobin 
antibody (b, c, d). Background bands are marked with asterisks. The 
38 kD background band, probably a degradation product of GFP-
globin, occurred in HeLa but not FL5.12 cells. 
Next we analyzed endogenous globin protein levels in FL5.12 cells growing in the absence of 
IL-3 for 0, 8, 12, 16, and 20 h. For the first time we were able to detect endogenous alpha 
globin at the protein level in FL5.12 cells. We found a comparable expression profile for the 
protein as seen for the transcript (Figure 3d). Interestingly, we observed two bands with 
approximately 0.5 kD difference. The intensity of both bands increased upon IL-3 
deprivation. We assumed that both protein bands most probably represent alpha globin since 
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beta globin mRNA was expressed at its detection limit in FL5.12 cells (compare 4.1.2). 
Further, the hemoglobin antibody detected a single band for alpha and beta globin deriving 
from mouse erythroid J2E cells (Figure 3c). The globin monomers in J2E cells corresponded 
to the smaller 14 kD globin band in FL5.12 cells. The slower migration of the 14.5 kD band 
could be due to unknown posttranslational, secondary modifications. 
Immunostaining of fixed FL5.12 cells was performed to study cellular localization of alpha 
globin. We demonstrated that alpha globin protein was predominantly expressed in the 
cytoplasm. However, the expression pattern of alpha globin did not appear to be homogenous 
but somewhat granular, especially in cells lacking IL-3 (Figure 4). Staining of FL5.12 cells 
with the secondary antibody, goat anti-rabbit Alexa Fluor 546, alone served as control, from 
which no background signal was detected (data not shown). 
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3.1.4 Alpha globin is localized to the cytoplasm and partly associates 
with the cytoskeleton after IL-3 deprivation 
To study more closely the localization of alpha globin in FL5.12 cells under normal as well as 
cytokine-deprived growth conditions we fractionated cells into cytosolic, membrane, nuclear, 
and cytoskeletal protein fractions. As indicated by immunoblotting, alpha globin was found 
mainly in the cytoplasm. In apoptotic, but not in healthy cells, the 14 kD alpha globin band 
appeared also in the cytoskeletal fraction (Figure 5a, b). The cytoskeletal proteins including 
alpha globin were the last fraction obtained in the fractionation protocol, while the fractions 
prepared between the cytosolic and the cytoskeletal fractions (membrane, nuclear) lacked 
alpha globin. We therefore exclude that the appearance of alpha globin in the cytoskeletal 
fraction reflected merely contamination of the cytoskeletal fraction with cytosolic proteins. 
 
 a 
  
 b 
Figure 5: The 14 kD alpha globin appears in the cytoskeletal fraction 
of FL5.12 cells lacking IL-3. FL5.12 cells were grown with or without 
IL-3 for 16 h. Cells were fractionated to soluble/cytosolic (S), 
membrane (M), nuclear (N), and cytoskeletal fractions (CS) using the 
Proteo Extract kit. Proteins were analyzed by SDS PAGE and Western 
blotting. The blots were probed with anti-hemoglobin antibody, 
stripped and reprobed with anti-actin antibody (a), or only probed with 
anti-hemoglobin antibody (b). 
3.1.5 Differential expression of alpha globin after cisplatin, 
doxorubicin, staurosporine, and cycloheximide/TNF alpha 
treatment 
Next, we quantified alpha globin message by RT QPCR after treatment with cytotoxic 
reagents. We used compounds known to induce cell death along different pathways. 
Treatment was continued until 50% of the FL5.12 cells were dead according to trypan blue 
staining. Both cisplatin and doxorubicin, two DNA-intercalating agents, induced alpha globin 
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weakly about 2.4-fold. In comparison, deprivation of IL-3 for 20 h increased alpha globin 
message approximately 8-fold (Figure 6, upper panel). The broad-spectrum protein kinase 
inhibitor, staurosporine (STS) (Bertrand et al., 1994), known to inhibit multiple kinase-
dependent survival pathways, triggered apoptosis faster than seen in cytokine-deprived cells, 
but did not change alpha globin levels after 4, 8 or 12 h (Figure 6, middle panel). Last, we 
examined the TNF alpha death receptor signaling pathway. This pathway triggers apoptosis 
without de novo transcription and translation (Abreu-Martin et al., 1995). TNF alpha 
(2 ng/ml) alone did not induce apoptosis. It has been shown earlier that FL5.12 cells need to 
be sensitized by translation inhibitor cycloheximide (CHX) to undergo apoptosis by TNF 
alpha treatment (Johnson and Boise, 1999; Fulda et al., 2000). While treatment with CHX 
(1 µg/ml) alone did not change the viability either, combined treatment of TNF alpha and 
CHX was toxic leading to 50% trypan blue-positive cells after 12 h. Neither TNF alpha nor 
CHX changed alpha globin transcript. In contrast, combined treatment with CHX/TNF alpha 
caused a decrease of transcript levels (Figure 6, lower panel). 
In summary, alpha globin was most strongly induced in apoptosis triggered by cytokine 
withdrawal as well as to some extent by DNA-damaging drugs (Johnson and Boise, 1999; 
Siddik, 2003), but not by death receptor stimulation or protein kinase inhibition (Jiang et al., 
1999). 
Alpha globin
0
2
4
6
8
10
 + IL3 Cisplatin Doxorubicin  - IL3
Re
lat
ive
 e
xp
re
ss
ion
 va
lue
s
 
Alpha globin
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
4 8 12
Time [h]
Re
lat
ive
 e
xp
re
ss
ion
 va
lue
s
Control
STS
 
  Results 
  39 
Alpha globin
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
5 8Time [h]
Re
lat
ive
 e
xp
re
ss
ion
 va
lue
s
Control
CHX
TNF alpha
CHX + TNF
 
Figure 6: Expression profile of alpha globin mRNA in FL5.12 cells 
undergoing apoptosis induced by different cytotoxic agents measured 
with RT QPCR. Total RNAs were isolated from FL5.12 cells treated 
with 20 µM cisplatin, grown without IL-3 or left untreated for 20 h or 
treated with 40 nM doxorubicin for 40 h (upper panel); FL5.12 cells 
treated with 20 nM STS versus untreated cells (middle panel); FL5.12 
cells treated with 1 µg/ml CHX, 2 ng/ml TNF alpha, with 1 µg/ml 
CHX plus 2 ng/ml TNF alpha (CHX + TNF), or left untreated (lower 
panel). 
3.1.6 Alpha globin is not associated with heme 
We next addressed the question whether alpha globin was associated with heme. We assumed 
that genes involved in heme biosynthesis should parallel alpha globin expression if alpha 
globin were associated with heme. Heme, the prosthetic group in globins, coordinately binds 
iron for oxygen transport (Hardison, 1996). We found that neither aminolevulinic acid 
synthase 1 (ALA-S1) (Figure 7, upper panel) nor porphobilinogen deaminase (PBGD) (Figure 
7, lower panel), two representatives of eight enzymes involved in heme biosynthesis, were 
upregulated in gene chip experiments. 
We conducted two experiments to verify this observation. First, we analyzed expression of 
heme oxygenase 1 (HO-1). HO-1, also called heat shock protein Hsp32, bears important 
functions in hemoglobin and especially heme degradation and prevention of cellular damage. 
HO-1 is dramatically induced upon cellular stress, caused by free heme, heavy metals, UV, 
low oxygen treatment or heat (Shibahara et al., 1987) and remains high for hours. We 
assumed that HO-1 would increase under IL-3-deprived conditions if alpha globin were 
associated with heme and would be degraded during apoptosis. While alpha globin levels 
increased in FL5.12 cells growing without IL-3, HO-1 remained unchanged. In contrast, cells 
treated with heme responded with induction of HO-1 (Figure 8, upper panel). Second, we 
measured cellular heme concentrations as described previously (Sassa, 1976). Detection of 
heme is based on the conversion of heme to its fluorescent porphyrin derivative by removal of 
heme iron under acidic reducing conditions. In parallel to FL5.12 cells growing with or 
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without IL-3, we analyzed K562 cells that have been reported to have increased globin 
expression and generate hemoglobin upon treatment with doxorubicin in subtoxic 
concentrations (Aries et al., 1996). In K562 cells, we found basal heme concentrations which 
were about 17-fold higher than in FL5.12 cells. Whereas heme levels increased significantly 
in K562 cells upon doxorubicin treatment, levels remained unchanged in growth factor-
deprived FL5.12 (Figure 8, lower panel). 
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Figure 7: ALA-S1 and PBGD are not upregulated in FL5.12 cells 
growing without IL-3. Gene chip expression analysis for ALA-S1 
(upper panel) and PBGD (lower panel) RNA samples prepared 0, 1, 8, 
16, and 24 h after IL-3 removal. The graphs represent one of two 
independent chip experiments. 
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Figure 8: Alpha globin is not associated with heme in FL5.12 cells. 
HO-1 transcript levels were measured by RT QPCR in FL5.12 cells 
growing with or without IL-3 for 0, 8, 12, 16, and 20 h or treated with 
25 µM heme for 8 and 20 h (upper panel). Heme contents were 
measured in FL5.12 growing with or without IL-3 for 12 h and K562 
cells treated with doxorubicin (40 nM) or left untreated for 60 h 
(lower panel). Graphs for HO-1 and heme represent triplicate 
measurements of three independent experiments. 
3.1.7 Cytokine-deprived FL5.12 cells neither produce hemoglobin nor 
differentiate down the erythroid lineage 
Next we measured intracellular hemoglobin concentration in K562 and FL5.12 cells using the 
method of Worthington (Worthington et al., 1987). The hemoglobin assay is based on the 
oxidation of 2,7-diaminofluorene (DAF) to fluorene blue by the pseudoperoxidase activity of 
hemoglobin in the presence of peroxide. The DAF staining method was found to reliably 
measure hemoglobin. Doubling the amount of K562 cells led to a 2-fold increase of fluorene 
blue. Treatment of K562 cells with doxorubicin increased hemoglobin levels about 9-fold. In 
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contrast, hemoglobin was not detected in FL5.12 cells growing with or without IL-3 (Figure 
9). 
It has been reported that differentiation of K562 cells is further characterized by reduced 
proliferation and an increase in cell size (Nyoung et al., 1994). Hence, we investigated 
morphology of K562 and FL5.12 cells after doxorubicin treatment and IL-3 deprivation, 
respectively (Figure 10a - d). As typical for K562 cells we detected an enormous increase of 
cell size under treatment with doxorubicin (Figure 10b) but not in control cells (Figure 10a). 
Differentiation was accompanied by slower proliferation but not cell death. In contrast, apart 
from a low percentage of cells, which were already committed to apoptosis, FL5.12 cells 
lacking IL-3 (Figure 10c) did not exhibit morphological changes as compared to cells growing 
with IL-3 (Figure 10d). This was further confirmed with Eosin G and Thiazine staining which 
is frequently used to assess the differentiation stage of hematopoietic cells. FL5.12 cells 
lacking IL-3 displayed moderate cell shrinkage, a decrease in nucleoli, and the occurrence of 
cell debris (Figure 10f) as compared to control cells (Figure 10e). Apart from the 
morphological changes typical for cells undergoing apoptosis, no signs of differentiation were 
detected. 
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Figure 9: FL5.12 cells do not synthesize hemoglobin upon deprivation 
of IL-3. Hemoglobin contents were measured of 7.5 x 105 and 1.5 x 
106 K562 control cells, of 7.5 x 105 K562 cells treated with 
doxorubicin (40 nM) for 60 h, and of 1.5 x 106 FL5.12 cells growing 
with or without IL-3 for 12 h. Each graph represents triplicate 
measurements of three independent experiments. 
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Figure 10: FL5.12 cells do not differentiate down the erythroid lineage 
upon deprivation of IL-3. K562 cells were treated with 40 nM 
doxorubicin (b) or left untreated for 60 h (a), FL5.12 cells were grown 
with (c) or without IL-3 (d) for 12 h. Cells were investigated with by 
light microscopy. FL5.12 cells growing with (e) or without IL-3 (f) for 
12 h were further stained with Eosin G and Thiazine dye and 
morphology was studied using light microscopy. 
3.1.8 AHSP does not change the viability of FL5.12 cells 
Recently the alpha hemoglobin stabilizing protein, AHSP, has been reported to function as a 
chaperone of alpha globin. AHSP forms a stable complex with alpha but not beta globin both 
in vitro and in vivo (Kihm et al., 2002). According to RT QPCR (data not shown) and 
Western blotting AHSP was not expressed in FL5.12 (Figure 11a). We asked whether 
Results 
44 
ectopically expressed AHSP could stabilize endogenous alpha globin and change the viability 
of FL5.12 cells. In the presence of a FLAG-AHSP IRES GFP expression construct alpha 
globin protein levels seemed to increase. On Western blot we found that especially the 
14.5 kD band of alpha globin increased both in FL5.12 cells growing with or without IL-3. 
Protein expression of the 14 kD band was not affected by AHSP (Figure 11b). Viability tests 
performed in the presence or absence of IL-3 demonstrated that DNA fragmentation was 
comparable in AHSP- and GFP-expressing cells as assessed by TUNEL staining (Table 1). 
Our very recent results, however, showed that AHSP was also detected by the hemoglobin 
antibody: we transiently transfected HeLa cells with a GFP-AHSP or GFP expression vector 
and prepared separate immunoblots using an anti-AHSP or the anti-hemoglobin antibody. 
With both antibodies we detected a protein band of 42 kD in GFP-AHSP but not in GFP 
expressing HeLa cells (Figure 12b). Thus it was not possible to conclude whether the increase 
of the 14.5 kD band in FL5.12 cells was entirely due to overexpressed FLAG-AHSP or at 
least in parts due to alpha globin stabilized by AHSP. 
 
 a 
  
 b 
Figure 11: Endogenous AHSP is not expressed in FL5.12 cells and the 
14.5 kD alpha globin band increases in FLAG-AHSP expressing cells. 
Whole cell lysates were prepared from J2E and FL5.12 cells (a) or 
from GFP or FLAG-AHSP transduced FL5.12 cells growing with or 
without IL-3 for 12 h (b). Proteins were analyzed by SDS PAGE and 
Western blotting. Blots were probed with anti-AHSP (a) or anti-
hemoglobin antibody (b). A background band is marked with an 
asterisk. 
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Table 1: Ectopically expressed FLAG-AHSP does not change the 
viability of FL5.12 cells. 
 Tunel-positive cells (% ± SD) 
 + IL3 - IL3 
GFP 0.91 ± 0.17 30.08 ± 0.76 
FLAG-AHSP 0.77 ± 0.11 26.40 ± 0.54 
GFP-α-
globin 1.21 ± 0.06 49.62 ± 0.94 
Cells were grown in the presence or absence of IL-3 for 12 h and were 
subsequently subjected to TUNEL staining. TUNEL-positive cells 
were monitored using a FACS Calibur. Each value represents an 
average of three independent measurements. 
  
 a 
 
 b 
Figure 12: The anti-hemoglobin antibody detects AHSP. HeLa cells 
were transiently transfected with GFP or GFP-AHSP. Whole cell 
lysates were prepared and proteins were analyzed by SDS PAGE and 
Western blotting. Blots were probed with anti-AHSP (a) or anti-
hemoglobin antibody (b). A background band is marked with an 
asterisk. 
3.1.9 NIH3T3, HeLa, and K562 cells differentially express alpha globin 
upon induction of apoptosis 
To study whether upregulation of alpha globin was unique to FL5.12 cells, we investigated 
other cell lines of different origin, differentiation status and species. The cells were treated 
with different cytotoxic compounds. The treatment was stopped and RNA was isolated when 
50% of the cells were dead according to trypan blue staining or microscopic observation. 
NIH3T3, an immortalized mouse fibroblast cell line, displayed similar regulation of alpha 
globin mRNA as FL5.12 cells except that the overall expression level of alpha globin was 
low. While in this cell line alpha globin levels remained low after treatment with STS, 
cisplatin dramatically induced alpha globin expression both at transcript (60-fold) and at 
protein level (Figure 13, upper and lower panel). 
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The human epithelial cervix cancer cell line, HeLa, displayed opposite expression profiles. 
While alpha globin was unaltered after treatment with cisplatin, it increased after STS 
treatment by more than 12-fold (Figure 14, upper panel). Cisplatin or STS did not induce 
apoptosis in K562 cells (Mc Gee et al., 2001; Dedoussis et al., 1999). However, combined 
treatment with TRAIL and STI571, an inhibitor of bcr-abl tyrosine kinase activity 
(Nimmanapalli et al., 2001), led to apoptosis with elevated alpha globin levels (Figure 14, 
lower panel). In summary, alpha globin expression increased in all four different cell lines 
after specific drug treatments. 
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Figure 13: Cisplatin induces expression of alpha globin mRNA and 
protein in NIH3T3 cells. NIH3T3 cells were treated with 20 µM cisplatin 
or left untreated (Control) for 30 h, or with 1 µM STS or DMSO for 24 h. 
Total RNA (upper panel) and whole cell lysates (lower panel) were 
isolated. Alpha globin transcript levels were measured by RT QPCR. Each 
graph represents triplicate measurements of three independent 
experiments. Proteins were analyzed by SDS PAGE and Western blotting. 
The blot was probed with anti-hemoglobin antibody. Background bands 
are marked with asterisks and served to prove equal loading. 
We then examined the cell lines for beta globin expression by RT QPCR. NIH3T3 and HeLa 
cells did not express beta globin under normal or apoptotic conditions. As already mentioned 
(4.1.2) beta globin is not expressed in K562 cells, so we measured very low levels of beta 
globin transcript with a detection threshold of 30 cycles. As for FL5.12 cells growing in the 
absence of IL-3, treatment of K562 cells with STI571/TRAIL, resulted in upregulated beta 
globin levels by a factor of 4 (Figure 14). 
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Figure 14: Expression of alpha and beta globin mRNA in HeLa and 
K562 cells. HeLa cells were treated with 0.5 µM STS (6 h), DMSO 
(6 h), 20 µM cisplatin (24 h) or left untreated (24 h) (upper panel). 
K562 cells were simultaneously treated with 250 ng/ml TRAIL plus 
500 nM STI571 for 48 h (lower panel). Total RNAs were isolated and 
alpha and beta globin transcript levels were measured by RT QPCR. 
Each graph represents triplicate measurements of three independent 
experiments. 
3.1.10 GFP-alpha globin expressing cells are difficult to enrich 
We investigated the effect of ectopically overexpressed alpha globin in FL5.12 cells. We 
combined retroviral transduction and subsequent fluorescent activated cell sorting (FACS) to 
enrich FL5.12 cells expressing alpha globin. In earlier experiments a construct expressing 
alpha globin with an N-terminal FLAG-tag and an internal ribosomal entry site for GFP 
(IRES GFP) was used (Brachat et al., 2002). Using this construct high level enrichment of 
GFP-positive cells was achieved. We tested the presence of alpha globin at both genomic and 
RNA level using intron 2 spanning, alpha globin-specific primers. PCR on whole cell lysates 
demonstrated that ectopic alpha globin was inserted into the genome of FL5.12 cells; in both 
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untransduced and FLAG-alpha globin transduced cells we detected a 402 bp fragment 
deriving from intron-containing, genomic alpha globin, whereas only the transduced cells 
exhibited a strong signal for intron-free alpha globin coding sequence (Figure 15, right panel). 
RT PCR of FL5.12 cells expressing FLAG-alpha globin showed a stronger band for alpha 
globin than control cells suggesting that the ectopic alpha globin was transcribed (Figure 15, 
left panel). However, FLAG-alpha globin was never detected on Western blot suggesting that 
the cells silenced exogenous FLAG-alpha globin. In our current experiments we used an 
N-terminal GFP-alpha globin fusion construct to overexpress alpha globin. In contrast to the 
IRES construct, the fusion construct ensured concomitant sorting of GFP and alpha globin. 
Transduction efficiencies were evaluated by means of GFP expression 96 h post transduction 
using the FACS Calibur. Transduction efficiencies of GFP-alpha globin were low. We 
measured 6% GFP-positive cells compared to 82% and 65% for GFP-Bax and GFP control 
clones, respectively (Figure 16). Two rounds of sorting were needed to enrich GFP-alpha 
globin expressing FL5.12 cells, whereas high expression levels of GFP-Bax were obtained 
without enrichment. To test the proliferation behavior of GFP, GFP-Bax, and GFP-alpha 
globin expressing cells as well as untransduced cells in the presence of IL-3, we investigated 
cell growth in the logarithmic phase over 36 h. Untransduced, GFP and GFP-alpha globin 
expressing FL5.12 cells displayed very similar proliferation rates. Cells expressing GFP-Bax 
proliferated slower during the first 14 h. After 20 and 36 h, however, cells adapted growth 
behavior comparable to GFP-alpha globin expressing and control cells (Figure 17). 
 
 
Figure 15: FLAG-alpha globin is inserted into the genome of FL5.12 
cells and is transcribed. Genomic DNA and total RNA was isolated 
from untransduced FL5.12 cells and cells transduced with FLAG-
alpha globin. Total RNA was reverse transcribed to generate cDNA. 
cDNA (left) and genomic DNA (right) were subjected to PCR using 
intron spanning alpha globin specific primers. PCR products were 
analyzed on a 1% agarose gel. 
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Figure 16: GFP-alpha globin is difficult to express in FL5.12 cells. 
GFP expression profiles of FL5.12 cells transduced with GFP and 
GFP-Bax prior to sorting, and GFP-alpha globin prior to sorting 
(black, 6%), after one (light grey, 10%) and two (dark grey, 72%) 
rounds of sorting. GFP expression was monitored in the FL1-H 
channel of a FACS Calibur. The markers depict GFP-positive cells in 
percentage (%). 
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Figure 17: FL5.12 cells expressing GFP-alpha globin display similar 
proliferation rate as control FL5.12 cells. Untransduced FL5.12 cells 
or cells expressing GFP, GFP-alpha globin or GFP-Bax were seeded 
at a density of 2 x 104 cells/ml. To assess cell viability and density, 
cells were stained with trypan blue and counted after 14, 20, and 36 h. 
Each data point represents triplicate measurements. 
3.1.11 GFP-alpha globin accumulates in the cytoplasm and tends to 
aggregate in FL5.12 cells  
Next, we investigated the localization of GFP-Bcl-xL, GFP-Bax, GFP, and GFP-alpha globin 
in FL5.12 cells by fluorescence microscopy. FL5.12 cells expressing GFP and GFP-Bax 
showed a homogenous distribution of green fluorescence (Figure 18b, c). In contrast, 
spontaneously dying GFP-Bax expressing cells, as assessed by DAPI staining, displayed a 
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dotted pattern of GFP, suggesting that GFP-Bax had translocated to the mitochondria (Figure 
18b) (Hsu et al., 1997). GFP-Bcl-xL was not evenly distributed in the cells. There were areas 
that displayed higher density of GFP (Figure 18a). Bcl-xL has been reported to localize partly 
to mitochondria, partly to ER but also to the cytosol under normal growth conditions 
(Gonzalez-Garcia et al., 1994). Further, overexpression of Bcl-xL often causes clustering of 
mitochondria. Thus we assumed that GFP-Bcl-xL was associated with membrane 
compartments in FL5.12 cells. 
GFP-alpha globin was mostly evenly distributed in the cytoplasm. In some cells, however, we 
observed aggregates of GFP. Immunostaining using the hemoglobin-specific antibody 
efficiently stained the aggregates (Figure 18d). Since a strong signal for GFP alone did not 
generate a signal in the red channel (Figure 18c) we concluded that the aggregates derived 
from precipitated overexpressed alpha globin. It has been reported that excess of alpha globin 
precipitates in erythrocytes and COS cells that do not express the chaperone AHSP, and these 
aggregates are toxic in erythropoietic cells (Kihm et al., 2002). As described above AHSP is 
not expressed in FL5.12 cells which may explain the difficulties in enriching GFP-alpha 
globin in FL5.12 cells. 
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3.1.12 GFP-alpha globin is not associated with heme 
In chapter 4.1.6 we have shown that endogenously upregulated alpha globin was not 
associated with heme. To test whether overexpressed alpha globin was in complex with the 
prosthetic group we measured heme contents in the twice sorted, GFP-alpha globin 
overexpressing FL5.12 cells. FL5.12 cells enriched for alpha globin by approximately a factor 
of 50 (data not shown) exhibited heme levels comparable to those in untransduced or GFP 
expressing control cells (Figure 19). 
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Figure 19: GFP-alpha globin is not associated with heme. Heme 
contents were measured in FL5.12 cells transduced with GFP or GFP-
alpha globin (Alpha globin) or untransduced FL5.12 cells and K562 
cells as control. The graph represents triplicate measurements of three 
independent experiments. 
3.1.13 GFP-alpha globin accelerates apoptosis induced by IL-3 
deprivation in a dose-dependent manner 
Next we followed apoptosis progression by TUNEL staining in transduced FL5.12 cells after 
cytokine deprivation. We compared cells expressing GFP-alpha globin which were enriched 
by one or two rounds of sorting, with cells expressing GFP, GFP-Bcl-xL and GFP-Bax. 
Protein expression was studied by Western blot using an anti-GFP antibody (Figure 20). Cells 
were grown in the presence or absence of IL-3 for 12 h, subjected to TUNEL staining and 
finally analyzed using a FACS machine. All transduced FL5.12 clones growing with IL-3 
were TUNEL negative (Figure 21a). Significant differences in the progression of apoptosis 
were observed after cytokine deprivation. GFP-Bax displayed obvious death-accelerating 
features; after 12 h 39% of the cells were TUNEL-positive (Figure 21b), while GFP-Bcl-xL 
very efficiently rescued cells from death (1% TUNEL-positive cells) (Figure 21b). GFP-alpha 
globin expressing cells which were sorted once (1x sorted), died slightly faster than GFP 
expressing cells (20% versus 13% dead cells) (Figure 21b). In contrast, FL5.12 cells 
expressing higher levels of GFP-alpha globin (2x sorted) displayed 31% TUNEL-positive 
cells (Figure 21b). 
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We asked whether the pro-apoptotic effect of GFP-alpha globin could be diminished by Bcl-
xL. After two rounds of GFP-alpha globin enrichment, we transduced FL5.12 cells with GFP-
Bcl-xL. Three percent of the cells stained TUNEL-positive after 12 h without IL-3. This 
indicates that GFP-Bcl-xL neutralized the pro-apoptotic effect of GFP-alpha globin 
completely. In summary, GFP-alpha globin accelerated cell death in a dose-dependent manner 
and this process was neutralized by coexpression of Bcl-xL. The potencies of GFP-alpha 
globin and GFP-Bax to induce apoptosis in cytokine-deprived FL5.12 cells were comparable. 
 
Figure 20: Control of expression of GFP fusion proteins in FL5.12 
cells. Whole cell lysates of FL5.12 cells transduced with GFP, GFP-
Bcl-xL (Bcl-xL), GFP-Bax (Bax), once and twice sorted GFP-alpha 
globin (α-globin 1x and α-globin 2x), and GFP-alpha globin plus 
GFP-Bcl-xL (α-globin 2x + Bcl-xL). Proteins were analyzed by SDS 
PAGE and Western blotting. The blot was probed with anti-GFP 
antibody. 
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3.1.14 GFP-alpha globin accelerates cell death in cisplatin-treated 
NIH3T3 cells 
Initial experiments with GFP-, GFP-alpha globin-, and GFP-Bax transduced NIH3T3 cells 
corroborated the observations made for FL5.12 cells. First, NIH3T3 cells tolerated 
accumulation of both alpha globin and Bax under normal growth conditions. Second, 
apoptosis induction with cisplatin caused faster cell death in NIH3T3 cells overexpressing 
GFP-alpha globin or GFP-Bax than in cells expressing GFP alone, as evaluated by ATP 
depletion in the CellTiter-Glo Luminescent Cell Viability Assay (Table 2). GFP-alpha globin 
expressing NIH3T3 cells showed lowest luciferase activity which was 80% of the activity 
observed in GFP control cells. In comparison, ATP content in GFP-Bax enriched cells was 
about 86% compared to GFP transduced cells. The assay is based on the theory that the 
mitochondrial membrane potential, which is the driving force for mitochondrial ATP 
synthesis, declines during apoptosis and results in decreased ATP levels (Richter et al., 1996). 
The added luciferase reacts with luciferin in the presence of cellular ATP. The generated 
fluorescent signal represents the number of viable cells in culture. 
Table 2: GFP-alpha globin and GFP-Bax accelerate cell death in cisplatin-treated 
NIH3T3. 
  Control  Cisplatin   
 
Luciferase 
signal (cps x 
1000)  
SD 
 
Luciferase 
signal (cps x 
1000)  
SD 
 
Ratio 
 
Relative 
activity 
GFP 384.5 22.5 138.2 11.2 0.36 1.00 
GFP-Bax 390.7 16.6 120.9 27.0 0.31 0.86 
GFP-α-globin 398.1 20.4 115.1 8.4 0.29 0.80 
GFP, GFP-alpha globin or GFP-Bax overexpressing NIH3T3 cells growing in a 96-well 
optical plate were treated with 20 µM cisplatin or left untreated for 20 h. Viability was 
assessed using CellTiter-Glo™ Luminescent Cell Viability Assay. Luminescence was 
measured in counts per second (cps x 1000). Luciferase signals represent triplicate 
measurements of three independent experiments. SD depicts the standard deviations; the 
Ratio indicates the ratio of the luciferase signal of cisplatin-treated versus control cells; 
Ratios obtained for GFP transduced cells served as reference and were set as 1. 
3.1.15 GFP-alpha globin reduces upregulation of endogenous alpha 
globin under cytokine-deprived conditions 
Interestingly, in FL5.12 cells overexpressing GFP-alpha globin we observed diminished 
upregulation of endogenous alpha globin at protein level (Figure 22). This suggests that the 
observed enhancement of apoptosis in transduced FL5.12 cells is due to the GFP-alpha 
globin, and upregulation of endogenous alpha globin might be prevented by negative 
feedback inhibition. 
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Figure 22: Ectopically expressed GFP-alpha globin reduces 
upregulation of endogenous alpha globin protein. FL5.12 cells 
ectopically expressing GFP, GFP-Bcl-xL (Bcl-xL), GFP-Bax (Bax) or 
twice sorted GFP-alpha globin (α-globin) were grown in the presence 
or absence of IL-3 for 14 h. Whole cell lysates were analyzed with 
12% SDS PAGE and blotted with anti-hemoglobin antibody. 
3.1.16 Pan caspase inhibitor, zVAD-fmk, delays apoptosis in FL5.12 
cells expressing GFP-alpha globin and GFP-Bax 
We next asked whether the activity of caspases was enhanced in apoptosis accelerated by 
GFP-alpha globin. To assess whether caspases in general were activated in cytokine-deprived 
FL5.12 cells, we first tested the inhibitory effect of zVAD-fmk, a broad-spectrum caspase 
inhibitor, compared to DMSO as control in untransduced FL5.12 cells. Cells treated with 
50 µM zVAD-fmk or DMSO displayed 29% and 50% TUNEL-positive cells, respectively, in 
the absence of IL-3 (Figure 23), i.e. a significant but moderate inhibition of apoptosis by 
zVAD-fmk was observed after cytokine-withdrawal from FL5.12 cells. Even higher doses of 
zVAD-fmk (100 µM and 200 µM) were not found to fully abrogate apoptosis (data not 
shown). This suggests that either caspase-independent processes were involved or that the 
concentration of zVAD-fmk was still too low. While pan-caspase inhibitor zVAD-fmk 
delayed apoptosis in IL3-deprived FL5.12 cells, zVAD-fmk did not prevent upregulation of 
alpha globin expression either at RNA (Figure 24, upper panel) or at protein level (Figure 24, 
lower panel). 
 
Figure 23: zVAD-fmk diminishes apoptosis after cytokine deprivation in FL5.12 
cells. FL5.12 cells were grown in the presence or absence of IL-3 for 12 h. Cells 
growing without IL-3 were either treated with 50 µM zVAD-fmk or DMSO as 
control. Cells were subsequently subjected to TUNEL staining and TUNEL-
positive cells were monitored using a FACS Calibur. The markers depict TUNEL-
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positive cells in percentage (%). The graphs represent triplicate measurements of 
three independent experiments. 
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Figure 24: zVAD-fmk does not prevent upregulation of alpha globin. 
FL5.12 cells were grown in the presence or absence of IL-3 for 12 h. 
Cells growing without IL-3 were either treated with 50 µM 
zVAD-fmk or DMSO as control. In parallel total RNA and protein 
were isolated. Alpha globin transcript levels were evaluated using RT 
QPCR (upper panel). Whole cell lysates were analyzed by SDS PAGE 
and Western blotting using the rabbit anti-hemoglobin antibody (lower 
panel). 
After we had shown that caspases were generally involved in IL-3 deprivation induced cell 
death we measured DNA degradation in FL5.12 cells expressing GFP, GFP-Bax, or GFP-
alpha globin in the presence of zVAD-fmk or DMSO after 0, 14, and 22 h by TUNEL 
staining. The effect of zVAD-fmk was most evident in the early phase of apoptosis in cells 
expressing GFP. Cells expressing GFP-alpha globin and GFP-Bax died significantly faster, 
3- and 3.6-fold, respectively, than GFP expressing cells. Moreover, cell death inhibition by 
zVAD-fmk was less pronounced in these cells than in GFP expressing cells. In the presence 
of zVAD-fmk, progression of apoptosis after 14 h was diminished by a factor of 4 in GFP 
compared to less than factor 2 in GFP-alpha globin and GFP-Bax expressing cells (Figure 
25). 
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Figure 25: The inhibitory effect of zVAD-fmk is less pronounced in 
FL5.12 cells overexpressing GFP-Bax or GFP-alpha globin under 
cytokine-deprived conditions. FL5.12 cells transduced with GFP, 
GFP-Bax (Bax), or GFP-alpha globin (alpha globin) were incubated 
without IL-3 either in the presence or absence of 50 µM zVAD-fmk 
(zVAD). After 0, 14, and 22 h cells were subjected to TUNEL 
staining and TUNEL-positive cells were analyzed using a FACS 
Calibur. Each bar represents triplicate measurements. 
3.1.17 Caspase-3 and -9 are highly activated, caspase-8 is 
moderately activated in GFP-alpha globin overexpressing cells 
in the absence of IL-3 
To study which caspases are involved in FL5.12 cells in IL-3 deprivation induced apoptosis, 
we performed caspase-profiling of caspases-2, -3, -8, and -9 using the ApoAlert Caspase 
Assay Plate. Untransduced FL5.12 cells, cells ectopically expressing GFP, GFP-Bcl-xL, GFP-
Bax, GFP-alpha globin (once and twice sorted), and cells cotransduced with GFP-alpha 
globin and GFP-Bcl-xL were grown with or without IL-3 for 12 h. Cell lysates were incubated 
with substrates for the corresponding caspases in the presence or absence of the specific 
caspase-inhibitor. According to profiling, caspase-3 and -2 were significantly activated. 
Caspase-8 was processed to only some extent, while caspase-9 was very weakly activated 
(Figure 26). The caspase inhibitors, especially those of caspase-8 and caspase-2 have been 
shown to prevent caspase activity inefficiently. For all activated caspases tested we found that 
GFP-Bax and GFP-alpha globin expressing cells displayed higher caspase activities than 
control cells. Both the dose-dependent effect of sequentially enriched alpha globin and the 
protecting properties of Bcl-xL in alpha globin expressing cells, as seen in the TUNEL 
staining, were confirmed. However, the caspase profiling plate provide only crude 
information about caspase activities; for example the substrate for caspase-2, VDVAD-AMC, 
can also be efficiently cleaved by recombinant caspase-3 ((Troy and Shelanski, 2003) and our 
own data, not shown) and caspase-7. Furthermore, caspase-7 and -3 share substrate 
specificity. 
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To ascertain which caspases were involved in apoptosis induced by IL-3 deprivation in 
FL5.12 cells, we studied caspase expression and activation using Western blot analysis. We 
used whole cell lysates of FL5.12 cells which were grown either in the presence or absence of 
IL-3 for 14 h. Executioner caspase-3 was processed and we observed cleaved caspase-3 in 
apoptotic but not in healthy FL5.12 cells (Figure 27). Caspase-7 was neither detected as full 
length nor as cleaved protein. The intensity of the 55 kD band representing full length 
caspase-2 decreased and an additional protein band of 16 kD, probably deriving from cleaved 
caspase-2, was detected in FL5.12 cells growing in the absence but not in the presence of IL-3 
(Figure 27). We therefore suggest slight activation of caspase-2 under cytokine-deprived 
conditions. As caspase-2 was only weakly activated according to Western blot results, we 
concluded that activated caspase-3 accounted at least partially for the strong activation of 
caspase-2 substrate in profiling. Further, caspase-9 was processed in cytokine-deprived but 
not control FL5.12 cells (Figure 27). This suggests that the cytochrome c/Apaf-1/caspase-9 
apoptosome was involved in apoptosis induced by IL-3 withdrawal in FL5.12 cells. 
Interestingly, cleaved caspase-8 was also detected on Western blot, thus confirming data from 
the caspase profiling experiment. We compared caspase-8 activation in FL5.12 cells after 
IL-3 deprivation and CHX/TNF alpha treatment and found that processing of caspase-8 in 
FL5.12 cells growing without IL-3 was weak compared to cells stimulated by CHX/TNF 
alpha. 
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Figure 26: Caspase profiling in cytokine-deprived FL5.12 cells. 
Untransduced FL5.12 cells, cells ectopically expressing GFP, GFP-
Bcl-xL (Bcl-xL), GFP-Bax (Bax), cells once and twice enriched for 
GFP-alpha globin (globin 1x, globin 2x) or cells cotransduced with 
GFP-alpha globin and GFP-Bcl-xL (globin + Bcl-xL) were grown with 
or without IL-3 for 12 h. Cell lysates were tested for the 
corresponding caspases in the presence or absence of the specific 
caspase inhibitor. Single measurements were performed for cells 
growing with IL-3 and cells growing without IL-3 plus the specific 
caspase inhibitor. Duplicates were analyzed for cells growing in 
medium lacking IL-3. Fluorescence intensity was monitored after 
1.5 h (405 nm excitation, 460 nm emission). The caspase profiling 
represents one of two independently performed experiments. 
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Figure 27: Caspase activation in cytokine-deprived FL5.12 cells. 
Caspase-2, -3, -9, and -8 are cleaved in FL5.12 cells after withdrawal 
of IL-3. Whole cell lysates of FL5.12 cells growing with or without 
IL-3 or treated with 1 µg/ml CHX plus 2 ng/ml TNF alpha for 14 h, 
were analyzed with SDS PAGE and Western blotting. Separate blots 
were prepared and in parallel probed with anti-caspase-2, anti-cleaved 
caspase-3, anti-caspase-8, and anti-caspase-9 antibody. 
3.1.18 Cytochrome c, Bid, and Bax are processed with faster kinetics 
in GFP-alpha globin expressing cells 
The observation of activated caspase-9, -8 and -2 prompted us to study other candidates that 
signal through the mitochondrial pathway. We performed a time course experiment with 
FL5.12 cells expressing GFP, GFP-alpha globin or GFP-Bax in the presence or absence of 
IL-3. After 0, 10, 14, and 22 h, we separated whole cell lysates into cytosolic and membrane 
protein fractions by ultracentrifugation and investigated protein expression and localization of 
Bid, Bax, and cytochrome c by Western blotting. In general, after 22 h without IL-3, 
apoptosis has progressed so far that almost all proteins were degraded. In Bax and alpha 
globin expressing cells full length Bid decreased faster than in GFP expressing cells (Figure 
28, upper panel). Truncated, pro-apoptotic Bid has been reported to translocate to 
mitochondria, recruit and oligomerize Bax and permeabilize mitochondria (Luo et al., 1998). 
Therefore, we investigated Bax localization and found that Bax translocated from the cytosol 
to the membrane fraction in all three investigated cell lines (Figure 28, upper and lower 
panel). Again translocation occurred with fastest kinetics in Bax overexpressing cells. Both 
endogenous and GFP-Bax redistributed from the cytosolic to the membrane fraction 
suggesting that ectopically expressed Bax promoted the apoptotic process. Accelerated Bax 
translocation was also detected in alpha globin but not in GFP expressing cells (Figure 28, 
Table 3). Last, we tested whether cytochrome c was released into the cytosol. In Bax as well 
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as in alpha globin expressing cells we observed cytosolic cytochrome c after 10 h, but after 
14 h in GFP control clones. 
In summary, under conditions without IL-3 in all cells cleavage of Bid and translocation of 
Bax and cytochrome c were observed. These phenomena occurred with faster kinetics in both 
GFP-alpha globin and GFP-Bax expressing FL5.12 cells. 
 
 
Figure 28: Translocation of Bax and cytochrome c, and cleavage of Bid occurs with faster 
kinetics in cells expressing GFP-alpha globin and GFP-Bax. FL5.12 cells transduced with 
GFP, GFP-alpha globin (α-globin), and GFP-Bax were grown in IL-3-free medium IL-3 for 0, 
10, 14, and 22 h. Cytosolic and membrane fractions were separated by ultracentrifugation. 
Proteins were analyzed by 12% SDS PAGE and Western blotting. The blot containing 
cytosolic proteins was successively probed with anti-cytochrome c, anti-Bid, anti-Bax, and 
anti-actin antibody (upper panel). The blot containing the membrane fraction was probed with 
anti-Bax, anti-calnexin and anti-actin (lower panel). Actin served as endogenous reference to 
normalize expression of cytosolic proteins. 
Table 3: Translocation of Bax and cytochrome c, and cleavage of Bid is faster in cells 
expressing GFP-alpha globin and GFP-Bax. 
 GFP GFP-α-globin GFP-Bax 
Time 0 h 10 h 14 h 22 h 0 h 10 h 14 h 22 h 0 h 10 h 14 h 22 h 
Cyt c 1.0 1.0 11.2 55.9 1.0 3.4 11.3 122 1.0 3.2 8.4 80.7 
Bid 1.0 1.0 0.7 0 1.0 0.7 0.4 0.6 1.0 0.7 0 0 
Bax 1.0 1.2 0.8 0 1.0 0.8 0.2 0.9 1.0 0.2 0 0 
The bands of the cytosolic proteins in figure 28 (upper panel) were quantitated using actin as 
endogenous reference to normalize expression. Expression values (n-fold) were calculated 
relative to expression at t = 0 h. 
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3.1.19 Antisense alpha globin decreases basal levels of alpha globin 
in FL5.12 cells and reduces induction of alpha globin under 
cytokine-deprived conditions 
Above we have shown that enrichment of ectopic GFP-alpha globin efficiently accelerated 
apoptosis in IL-3-deprived FL5.12 cells suggesting a role of alpha globin as a pro-apoptotic 
factor in PCD. On the other hand we asked whether silencing of alpha globin expression in 
FL5.12 cells could diminish apoptosis progression upon cytokine deprivation. We generated a 
retroviral antisense expression construct with an IRES for GFP and the reverse complement 
sequence of alpha globin containing a stop codon in the first codon. We demonstrated that 
antisense alpha globin efficiently reduced alpha globin protein. No band was detected in 
antisense alpha globin expressing cells as compared to GFP control cells in the presence of 
IL-3. In the absence of IL-3, however, we observed a slight increase of alpha globin protein 
(Figure 29). 
 
Figure 29: Antisense alpha globin reduces basal levels and upregulation of 
endogenous alpha globin protein in FL5.12 cells. FL5.12 cells transduced 
with GFP or antisense alpha globin (AS α-globin) were grown in the 
presence or absence of IL-3 for 14 h. Whole cell lysates were prepared and 
subjected to SDS PAGE and Western blotting. The blot was probed with 
anti-hemoglobin and anti-actin antibodies. 
3.1.20 Antisense alpha globin delays caspase-3 activation but not 
DNA fragmentation in FL5.12 cells 
In order to assess the biological effect of reduced alpha globin levels in FL5.12 cells we 
monitored the progression of apoptosis in cells expressing GFP or antisense alpha globin in 
the presence or absence of IL-3 for 14 h. In parallel we evaluated the amount of TUNEL-
positive cells and assayed activation of caspase-3, respectively. DNA fragmentation was 
comparable and below 2% in both cell lines growing in the presence of cytokine (Figure 30a). 
We therefore conclude that expression of antisense alpha globin is well tolerated in FL5.12 
cells. However, under IL-3-deprived conditions fragmentation of DNA was not delayed in 
antisense alpha globin expressing cells as compared to cells expressing GFP. GFP and 
antisense alpha globin transduced cells displayed 60% and 55% TUNEL-positive cells, 
respectively (Figure 30b). 
In contrast, experiments assessing the activity of caspase-3 indicated that antisense alpha 
globin transduced cells exhibited reduced caspase-3 activities as compared to GFP transduced 
cells lacking IL-3 (Table 4). Caspase-3 activity was reduced by a factor of approximately 2 in 
GFP-alpha globin expressing cells as compared to control cells. 
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Figure 30: Antisense alpha globin does not prevent DNA fragmentation in 
FL5.12 cells. Cells expressing GFP (a) or antisense alpha globin (b) were 
grown in the presence or absence of IL-3 for 12 h and were subsequently 
subjected to TUNEL staining. TUNEL-positive cells were monitored using 
a FACS Calibur. The markers depict TUNEL-positive cells in percentage 
(%). The graphs represent one of three independent measurements. 
Table 4: Antisense alpha globin prevents upregulation of endogenous 
alpha globin and reduces activation of caspase-3 in FL5.12 cells. 
  GFP  AS alpha globin 
 + IL3 - IL3 + IL3 - IL3 
% adjusted volume actin 21.0 11.0 15.5 15.2 
% adjusted volume α-globin 1.4 2.1 not present 0.8 
α-globin (n-fold induction) 1.0 2.8 n.a n.a 
caspase-3 activity (n-fold 
induction) 1.0 6.2 1.0 3.1 
FL5.12 cells, retrovirally transduced with GFP or antisense alpha globin 
were grown in the presence or absence of IL-3 for 14 h. Whole cell lysates 
were subjected to SDS PAGE and Western blotting. The blot was probed 
with anti-hemoglobin and anti-actin antibodies (Figure 29) and signal 
intensities were analyzed. Alpha globin content and caspase-3 activities 
were normalized using actin as endogenous reference. Values obtained from 
cells growing with IL-3 were set as 1. 
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3.2 Hematopoietic transcription factor GATA-2 promotes 
upregulation of alpha globin and cell death in FL5.12 cells 
3.2.1 GATA-2 transcription factor is significantly upregulated in 
cytokine-deprived FL5.12 cells 
Next we addressed the question of which regulatory processes account for the upregulation of 
alpha globin in FL5.12 cells under death inducing conditions. Several mechanisms may 
achieve elevated alpha globin levels such as stabilization at transcript or protein level or 
transactivation by transcription factors. We focused on transcription factors as potential 
inducers of alpha globin transcription. To examine which transcription factors might be 
involved under IL-3 deprivation we compared the transcriptional response of FL5.12 cells 
growing with or without IL-3 for 0, 1, 8, 16, and 24 h using Affymetrix gene chip arrays. 
Transcription factors that were induced or repressed by more than two-fold were suggested to 
be differentially regulated and were considered further as candidate genes. We found that 
GATA-2 and EKLF were the only factors that were significantly upregulated, 3.3- and 2.3-
fold, respectively (Table 5). Overall-expression levels of GATA-2 were high while the levels 
of EKLF were low in FL5.12 cells. GATA-2 ensures maintenance and proliferation of 
immature hematopoietic progenitors and can induce both alpha and beta globin expression 
(Ohneda and Yamamoto, 2002). EKLF is implicated in adult beta globin gene expression, the 
developmental switch from fetal gamma to adult beta globin, and as a cofactor of GATA-1. 
Due to capacity reasons and the fact that beta globin is barely expressed in FL5.12 cells, 
which possibly indicates a minor role of beta globin, we did not study further the role of 
EKLF. 
Next, we investigated whether other transcription factors, which are known to regulate 
transcript levels of alpha globin, were expressed and differentially regulated in death 
committed FL5.12 cells. In addition to transcription factors that were not differentially 
expressed such as ubiquitous factors CP-2 and trans-acting transcription factor Sp1, we found 
erythroid-specific transcription factors namely GATA-1, FOG-1, and NF-E2 to be 
upregulated, however, less than 2-fold (Table 5). Like EKLF, FOG-1 exhibits a GATA-1 
binding site in the GATA-1 promoter and is believed to act as a coactivator and cofactor of 
GATA-1. NF-E2 is important for high level expression of alpha and beta globin (Martin et al., 
1998). NF-κB, a family of transcription factors mediating immune response and suppressing 
apoptosis, and implicated in cellular differentiations including erythropoiesis, was described 
to inhibit expression of alpha-like genes by repression of NF-E2 (Liu et al., 2003). In 
accordance, NF-κB1 (p50/p105) was slightly downregulated in FL5.12 cells exhibiting 
increasing levels of alpha globin. GATA-3, the third member of the GATA transcription 
factor family in hematopoietic tissues, was not expressed (Figure 31). In summary, several 
transcription factors with binding sites in globin as well as other erythroid genes were 
elevated. 
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Table 5: Gene expression analysis of erythroid transcription factors in 
FL5.12 cells. 
 0 h 1 h 8 h 16 h 24 h Regulation Basal levels 
GATA-
1 
1.3 1.2 1.8 1.9 1.2 slightly up low 
GATA-
2 
1.1 2.0 2.9 3.3 2.8 upregulated high 
FOG-1 0.8 1.1 1.8 1.9 1.6 slightly up high 
EKLF 1.0 1.3 2.3 2.3 1.8 upregulated low 
NF-E2 1.0 1.3 1.6 1.7 1.7 slightly up high 
CP-2 1.0 1.2 1.2 1.0 1.4 not 
regulated 
low 
Sp1 1.0 1.0 1.3 1.3 1.3 not 
regulated 
low 
NF-κB1 0.8 0.9 1.0 0.8 0.6 slightly down high 
FL5.12 cells were grown in the presence or absence of IL-3 for 0, 1, 8, 16, and 
24 h. Total RNA samples were prepared according to the Affymetrix protocol. 
For analysis of relative expression values, the ratios of expression values of 
cells growing without IL-3 versus cells growing with IL-3 were evaluated for 
each time point and gene. Genes, differentially induced more than two-fold 
were termed “upregulated”; genes regulated between 1.5- and 1.9-fold were 
termed “slightly up” or “slightly down”; genes with expressions between 1- 
and 1.4-fold were termed “not regulated”. 
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Figure 31: Gene expression analysis of erythroid transcription factors 
GATA-1, -2, and -3 in FL5.12 cells using Affymetrix gene chip 
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arrays. FL5.12 cells were grown in the presence or absence of IL-3 for 
0, 1, 8, 16, and 24 h. 
3.2.2 GATA-1 and -2 are differentially expressed in various cell lines 
upon induction of apoptosis 
To confirm the results obtained from chip analysis and to further extend our investigations, 
we performed RT QPCR on FL5.12 cells treated with various cytotoxic compounds as well as 
on apoptosing NIH3T3, HeLa, and K562 cells. We found elevated GATA-1 and GATA-2 
transcript levels in cytokine-deprived FL5.12 cells as seen in chip experiments. After 20 h in 
the absence of IL-3, GATA-2 transcript levels increased 2.8-fold, compared to 1.9-fold for 
GATA-1 transcript (Figure 32, upper panel). Treatment of FL5.12 cells with cisplatin or 
doxorubicin resulted in approximately 2.4-fold induction of alpha globin message, which, 
however, was not associated with GATA-2 or GATA-1 upregulation (Figure 32, upper panel). 
GATA-1 was not expressed in NIH3T3 cells (Figure 32, middle panel). GATA-2 was 
expressed and strongly induced after treatment with cisplatin concomitant with alpha globin 
(Figure 32, middle panel). These results suggested that GATA-2, but not GATA-1, could be 
involved in induction of alpha globin expression in apoptosis. 
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Figure 32: Expression of alpha globin, GATA-2, and GATA-1 mRNA 
in FL5.12, NIH3T3, K562, and HeLa cells undergoing apoptosis 
induced by different cytotoxic agents. Expression was quantitated by 
RT QPCR. Total RNAs were isolated from FL5.12 cells treated with 
20 µM cisplatin, grown with (+ IL3) or without IL-3 (- IL3) for 20 h 
or treated with 40 nM doxorubicin or left untreated (Control) for 40 h 
(upper panel), NIH3T3 cells treated with 20 µM cisplatin or left 
untreated for 30 h (middle panel), K562 simultaneously treated with 
250 ng/ml TRAIL and 500 nM STI571 (48 h) or left untreated (48 h), 
and HeLa cells treated with 0.5 µM STS (6 h) or left untreated (6 h) 
(lower panel). Each bar represents the average of triplicate 
measurements. 
In contrast, K562 and HeLa cells, which have been found to upregulate alpha globin upon 
STI571/TRAIL and STS treatment, respectively, exhibited downregulation of GATA-2. 
GATA-1 levels were slightly down after 24 h (data not shown) and 48 h treatment with 
STI/TRAIL in K562 cells while GATA-1 was not expressed in HeLa cells (Figure 32, lower 
panel). 
3.2.3 NIH3T3, but not FL5.12 cells, ectopically expressing GATA-2, can 
be enriched 
Since GATA-2 was highly expressed and the most prominent upregulated transcription factor 
in FL5.12 cells and also present in NIH3T3 cells while GATA-1 was absent in NIH3T3 cells, 
we concentrated on GATA-2 for further investigations. We ectopically expressed and 
enriched GATA-2 in FL5.12 and NIH3T3 cells using retroviral transduction and FACS. We 
used an N-terminally GFP-tagged GATA-2 fusion construct, and a construct expressing 
GATA-2 with an N-terminal FLAG-tag and an IRES for GFP. Expression of GFP-positive 
FL5.12 cells was monitored 72 h after retroviral transduction before cells were sorted and 
again 48 h after sorting. Prior to sorting, GFP control cells exhibit 65%, FLAG-GATA-2 
40%, and GFP-GATA-2 8% GFP-positive cells (Figure 33). After one round of sorting 95% 
of the control cells expressed GFP. In contrast, GFP- and FLAG-GATA-2 could not be 
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successfully enriched by sorting. GFP-GATA-2 expressing cells displayed only 39% GFP-
positive cells. FLAG-GATA-2 transduced cells died immediately and could not be analyzed 
further (Figure 33). 
  
  
  
  
 
 
 
Figure 33: FL5.12 cells ectopically expressing GFP-GATA-2 cannot 
be enriched in FL5.12 cells. GFP expression profile of FL5.12 cells 
transduced with GFP, GFP-GATA-2 or FLAG-GATA-2 was 
monitored prior to or 48 h after sorting. The GFP signal was measured 
in the FL1-H channel of a FACS Calibur. The markers depict GFP-
positive cells in percentage (%). The graphs represent one of four 
independently performed transduction experiments. 
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Expression of ectopic GATA-2 was examined at both transcript and protein level. RT QPCR 
was used to assess GATA-2 mRNA expression levels. In untransduced FL5.12 cells the 
threshold cycle was exceeded after 22 PCR cycles indicating that GATA-2 was significantly 
expressed (data not shown). GATA-2 transcript levels were moderately elevated in both 
ectopic FLAG- and GFP-GATA-2 expressing FL5.12 cells (Table 6). 
In NIH3T3 cells endogenous GATA-2 was expressed at lower levels than in FL5.12 cells. 
The threshold cycle was detected after 26 PCR cycles. As NIH3T3 cells tolerated a second 
round of sorting, GATA-2 levels were dramatically elevated (Table 6). 
Table 6: Ectopic GATA-2 is expressed in FL5.12 and NIH3T3 cells. 
 Relative expression (n-fold) 
 GFP 
Range GFP-GATA-
2 
Range FLAG-GATA-
2 
Range 
FL5.12 1.0 0.9 – 1.1 12.1 10.9 – 13.4 15.5 14.2 – 16.8 
NIH3T3 1.0 0.9 – 1.1 401 365 - 441 288 239 - 349 
Total RNAs were isolated from FL5.12 and NIH3T3 cells retrovirally transduced 
with GFP, FLAG-GATA-2 or GFP-GATA-2. Transcript levels were measured 
using RT QPCR. Each value represents the average of triplicate measurements of 
two individual transduction experiments. The ranges indicate the variability around 
the average expression value. 
3.2.4 Ectopically expressed GATA-2 is localized to the nucleus in 
FL5.12 and NIH3T3 cells 
Next, we investigated GATA-2 protein expression and localization by Western blotting. 
Proteins of FL5.12 and NIH3T3 cells expressing GFP-GATA-2 were fractionated into 
cytosolic and nuclear fractions. Each fraction was subjected to SDS PAGE and 
immunoblotting. Unfortunately, none of the commercial GATA-2 antibodies detected GATA-
2 in our hands. Therefore we used anti-GFP antibody to detect the GFP-GATA-2 fusion 
protein. We detected GFP-GATA-2 exclusively in the nucleus of GATA-2, but not in GFP 
transduced cells (Figure 34a, b). 
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Figure 34: Ectopically expressed GATA-2 is localized to the nucleus 
in FL5.12 and NIH3T3 cells. FL5.12 (a) and NIH3T3 cells (b) were 
transduced with GFP or GFP-GATA-2 and sorted once using a FACS 
Calibur. Whole cell lysates were fractionated into soluble (S) and 
nuclear fraction (N) and analyzed by SDS PAGE and Western 
blotting. Blots were probed with anti-GFP antibody. Background 
bands are marked with asterisks. 
3.2.5 Overexpression of GATA-2 induces cell death in FL5.12 cells and 
causes a transient stress phenotype in NIH3T3 cells 
Overexpression and enrichment of GATA-2 in FL5.12 cells were accompanied by cell death. 
This was consistently observed in several independent transduction experiments. Forty-eight 
hours after sorting for GFP or GFP-GATA-2, cells were stained with DAPI and analyzed by 
fluorescence microscopy. Cells overexpressing GATA-2 displayed typical characteristics of 
apoptosis such as membrane blebbing and loss of nuclear membrane integrity while control 
cells expressing high amounts of GFP were unaffected (Figure 36). Further, staining with 
DNA intercalating propidium iodide (PI) demonstrated that cells expressing GFP-GATA-2 
lost plasma membrane integrity. Seventy-four percent stained PI-positive versus 3% in cells 
expressing GFP (Figure 35). 
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Figure 35: GATA-2 overexpression induces cell death in FL5.12 cells. 
FL5.12 cells were transduced with GFP or GFP-GATA-2. Forty-eight 
hours after sorting FL5.12 cells were stained with PI and PI-positive 
cells were analyzed in the FL2-H channel of a FACS Calibur. 
In parallel we studied NIH3T3 cells retrovirally transduced with GFP-GATA-2. NIH3T3 cells 
did not die and nuclei remained intact upon expression of GATA-2, however, the cells 
displayed a severe stress phenotype with spindle-like cells as well as dramatically enlarged 
cells with reduced proliferation rate. GFP expressing cells, in contrast, tolerated retroviral 
transduction without phenotypical changes (Figure 37). The stress phenotype, however, was 
transient and disappeared two weeks after transduction and sorting. 
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3.2.6 Ectopically expressed GATA-2 induces alpha globin expression 
in FL5.12 but not NIH3T3 cells 
To study whether the ectopically expressed GATA-2 was able to upregulate endogenous 
alpha globin in FL5.12 and NIH3T3 cells, we performed RT QPCR and Western blot 
analysis. FL5.12 and NIH3T3 cells were transduced with GFP, FLAG-GATA-2 or GFP-
GATA-2. As apoptosis occurred in FL5.12 cells after enriching GATA-2 by sorting, we 
processed cells immediately 48 h after transduction. In contrast, transduced NIH3T3 cells 
were sorted two times before RNA and proteins were isolated. For GATA-2 transduced 
NIH3T3 cells we did not detect elevated alpha globin levels (Figure 38, upper panel). FL5.12 
cells, however, exhibited a clear response at alpha globin transcript and protein level when 
ectopically expressing GATA-2 (Figure 38, upper and lower panel). We further found that 
FL5.12 cells expressing FLAG-GATA-2 contained twice as much alpha globin message as 
cells expressing GFP-GATA-2. Above we have shown that GATA-2 levels were higher in 
FLAG-GATA-2 than in GFP-GATA-2 expressing cells (Table 6), which could explain the 
stronger induction of alpha globin message. 
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Figure 38: Overexpressed GATA-2 induces endogenous alpha globin at 
transcript and protein level in FL5.12 but not in NIH3T3 cells. FL5.12 and 
NIH3T3 cells were transduced with GFP, FLAG-GATA-2 or GFP-GATA-
2. FL5.12 cells were left unsorted while NIH3T3 cells were sorted twice to 
enrich GFP-expressing cells. RNA was isolated and alpha globin message 
measured by RT QPCR using alpha globin specific primers and probe 
(upper panel). Each bar represents the average of triplicate measurements. 
Whole cell lysates of FL5.12 cells were prepared and subjected to SDS 
PAGE and Western blotting. The blot was probed with anti-hemoglobin 
antibody (lower panel). 
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The same dose-dependent effect was seen at protein level; FL5.12 cells expressing FLAG-
GATA-2 presented a more intensive band for alpha globin than GFP-GATA-2 expressing 
cells, while alpha globin levels were below detection in GFP transduced control cells (Figure 
38, lower panel). 
3.2.7 Antisense GATA-2 prevents upregulation of GATA-2 and 
reduces upregulation of alpha globin under apoptotic 
conditions in FL5.12 cells 
We observed that GATA-2 promoted upregulation of alpha globin and induced apoptosis in 
FL5.12 cells. Hereupon we asked whether silencing of GATA-2 could prevent the increase of 
alpha globin and change the outcome of apoptosis in FL5.12 cells growing without IL-3. We 
generated a retroviral expression construct with an IRES for GFP and the reverse complement 
sequence of GATA-2 containing a stop codon in the first codon. FACS was used to enrich 
antisense GATA-2 expressing clones. First, we performed RT QPCR to test whether the 
antisense GATA-2 could counteract the upregulation of GATA-2 under cytokine-deprived 
conditions. Under growth conditions without IL-3 we found that antisense GATA-2 prevented 
the increase of GATA-2 compared to GFP control cells (Figure 39, upper panel).  
Then we assessed expression of alpha globin in FL5.12 cells growing in the presence or 
absence of IL-3 for 14 h. Using RT QPCR we observed that basal levels of alpha globin 
remained unchanged in FL5.12 cells transduced with antisense GATA-2 as was the case for 
cells transduced with GFP. Contrasting, in the absence of IL-3, upregulation of alpha globin 
in antisense GATA-2 expressing FL5.12 cells was reduced by approximately 45% as 
compared to control cells (Figure 39, middle panel). In parallel, we investigated alpha globin 
expression at protein level by Western blotting (Figure 39, lower panel). We consecutively 
probed the same blot with anti-hemoglobin and anti-actin antibody. The intensities of the 
bands were quantified and the amount of alpha globin was normalized using actin as 
endogenous reference. The increase of alpha globin protein was diminished by a factor of two 
in cells expressing antisense GATA-2, which was in line with our RT QPCR results (Table 7). 
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Figure 39: Antisense GATA-2 reduces upregulation of endogenous 
GATA-2 and alpha globin in FL5.12 cells. FL5.12 cells transduced 
with GFP or antisense GATA-2 were grown in the presence or 
absence of IL-3 for 14 h. 1.5 x 106 viable cells, as assessed by trypan 
blue staining, were subjected to RNA isolation and RT QPCR using 
GATA-2 (upper panel) and alpha globin (middle panel) specific 
primers and probes. Each bar represents the average of triplicate 
measurements. In parallel, whole cell lysates were prepared and 
subjected to SDS PAGE and Western blotting. The blot was probed 
with anti-hemoglobin and anti-actin antibodies (lower panel). 
3.2.8 Antisense GATA-2 delays DNA fragmentation in FL5.12 cells 
deprived of IL-3 
In parallel to RT QPCR and Western blotting, we examined the effect of antisense GATA-2 
on progression of apoptosis in FL5.12 cells. FL5.12 cells ectopically expressing GFP or 
antisense GATA-2 were grown in the presence or absence of IL-3 for 14 h and subsequently 
subjected to TUNEL staining. Cells in the presence of IL-3 were TUNEL-negative indicating 
that expression of antisense GATA-2 was well tolerated in FL5.12 cells (Figure 40). Under 
IL-3-deprived conditions, however, fragmentation of DNA was significantly delayed in cells 
expressing antisense GATA-2 but not GFP. Antisense GATA-2 displayed 36%, GFP 60% 
TUNEL-positive cells during three independent experiments (Figure 40). Experiments 
assessing the activity of caspase-3 underlined the protecting effect of antisense GATA-2 in 
the absence of IL-3: antisense GATA-2 transduced cells exhibited reduction of caspase-3 
activities by 58% as compared to GFP transduced cells (Table 7). 
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Figure 40: Antisense GATA-2 diminishes DNA fragmentation in 
cytokine-deprived FL5.12 cells. FL5.12 cells transduced with GFP or 
antisense GATA-2 were grown in the presence or absence of IL-3 for 
14 h. Cells were subjected to TUNEL staining. The markers depict 
TUNEL-positive cells in percentage (%). Each graph represents 
triplicate measurements of three individual experiments. 
Table 7: Antisense GATA-2 reduces upregulation of endogenous 
alpha globin and reduces activation of caspase-3 in FL5.12 cells. 
 GFP AS GATA-2 
 + IL3 - IL3 + IL3 - IL3 
% adjusted volume actin 21.0 11.0 15.2 19.9 
% adjusted volume α-globin 1.4 2.1 1.6 3.1 
α-globin (n-fold induction) 1.0 2.8 1.0 1.4 
caspase-3 activity (n-fold 
induction) 1.0 6.2 1.0 2.6 
FL5.12 cells transduced with GFP or antisense GATA-2 were grown 
in the presence or absence of IL-3 for 14 h. Whole cell lysates were 
subjected to SDS PAGE and Western blotting. The blot was probed 
with anti-hemoglobin and anti-actin antibodies (Figure 39, lower 
panel) and signal intensities were calculated. Alpha globin content and 
caspase-3 activities were normalized using actin as endogenous 
reference. Values obtained from cells growing with IL-3 were set as 1. 
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3.2.9 Overexpression or silencing of GATA-2 does not affect GATA-1 
expression levels 
In erythroid cell development GATA-1 and GATA-2 are believed to follow auto- and cross-
regulatory processes. Especially GATA-2 has been shown to precede and transactivate 
GATA-1 expression (Visvader et al., 1995). In IL-3-deprived FL5.12 cells we also observed a 
significant upregulation of GATA-2, which preceded a slight increase in GATA-1. We asked 
whether ectopic GATA-2 induced its detrimental effect on FL5.12 cell viability at least to 
some extent via GATA-1. We compared endogenous GATA-1 transcript expression in 
FL5.12 cells expressing GFP or GFP-GATA-2. Both cell lines displayed comparable 
GATA-1 levels, i.e. overexpressed GATA-2 did not transactivate GATA-1 (Table 8). 
Similarly, antisense GATA-2 was found not to reduce basal GATA-1 expression (Table 8). In 
summary, alteration of GATA-2 levels by ectopic expression of sense and antisense GATA-2 
had no impact on endogenous GATA-1 levels. 
Table 8: Overexpression and silencing of GATA-2 does not affect 
GATA-1 expression levels. 
 
Relative 
expression range 
GFP 1.00 0.83 – 1.20 
GFP-GATA-
2 0.90 0.77 – 1.39 
AS-GATA-2 0.84 0.78 – 0.91 
GATA-1 transcript levels were measured in GFP, GFP-GATA-2 or 
antisense GATA-2 transduced FL5.12 cells growing in the presence of 
IL-3. Total RNAs were isolated and subjected to RT QPCR. Each 
value represents the average relative expression of triplicate 
measurements of two individual transduction experiments. Ranges 
indicate variability of the relative expression values. 
3.3 Beta globin exerts similar regulation trends as alpha globin 
As mentioned in chapter 4.1.2, we found beta globin to be expressed at its detection limit in 
FL5.12 cells. However, every time we detected regulation of alpha globin we also studied the 
expression of beta globin in parallel. Interestingly, basal beta globin mRNA expression levels 
of FL5.12 cells transduced with antisense alpha globin were reduced by a factor of five as 
compared to GFP transduced cells and even upregulation of beta globin in the absence of IL-3 
was diminished by about 50% (Table 9). GATA-2, known to bind to promotors and DNA 
regulatory sequences of several globin and erythroid genes, induced beta globin expression by 
a factor of five when overexpressed in FL5.12 cells (GFP-GATA-2, table 9). Antisense 
GATA-2 did not change basal beta globin expression. In the absence of IL-3 antisense 
GATA-2 caused a decrease of 29% (Table 9), i.e. the effect was less pronounced than seen for 
alpha globin (Figure 39b). Summarizing, we confirmed that beta globin was concomitantly 
regulated with alpha globin but at approximately 200-fold lower expression levels. 
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Table 9: Beta globin is regulated at low expression levels in FL5.12 cells. 
  + IL3  - IL3 
 Relative expression range Relative 
expression 
range 
GFP 1.00 0.83 – 1.20 10.8 9.57 – 12.7 
AS α-globin 0.24 0.20 – 0.28 1.59 1.49 – 1.69 
GFP-GATA-2 5.09 4.56 – 5.68 n/a n/a 
AS GATA-2 0.86 0.76 – 0.97 6.1 5.68 – 6.50 
Cells expressing GFP, antisense alpha globin, GFP-GATA-2 or antisense GATA-2 
were grown in the presence or absence of IL-3 for 12 h. Total RNAs were isolated 
and subjected to RT QPCR. Each value represents the average relative expression of 
triplicate measurements of two individual transduction experiments. Ranges indicate 
variability of the relative expression values. 
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4 Discussion 
4.1 Novel function of alpha globin promotes apoptotic cell 
death 
4.1.1 Characterization of endogenous alpha globin in PCD 
The hematopoietic cell line FL5.12 is derived from murine fetal liver and possesses 
characteristics of lymphoid/myeloid precursor cells (Haughn et al., 2003). It expresses genes 
characteristic for non-differentiated pro B cells such as IL-3R, small amounts of class I MHC 
antigens and high densities of AA4 antigens (McKearn et al., 1985). The cells were not found 
to be induced to differentiate along the erythroid or myeloid lineage. FL5.12 can be 
maintained long-term in culture when provided with IL-3, whereas withdrawal of the cytokine 
induces apoptosis usually within 6 h post-starvation (McCubrey et al., 1989). In gene 
expression profiling of cytokine-deprived FL5.12 cells alpha globin, a gene predominantly 
expressed in erythrocytes, was shown to be dramatically upregulated (Brachat et al., 2000). 
We confirmed that alpha globin was endogenously expressed and upregulated in the absence 
of IL-3. We showed that expression at transcript and protein levels correlated well as assessed 
by RT QPCR and immunoblotting, respectively, so we used RT QPCR, the more precise and 
reproducible method, to evaluate expression for most experiments. 
Alpha globin mRNA levels remained stable during the first hour of IL-3 deprivation. We 
observed a strong incremental increase, however, during the following 7 h. The maximal 
expression was reached after 12 h, and was then followed by a gradual decrease after 16 and 
20 h. From this kinetics we conclude that alpha globin is induced more like delayed-response 
genes (Coyle et al., 2003), rather than immediate-response genes such as transcription factors 
c-fos or the early growth response genes (EGR) (Ahmed, 2004). 
In addition to IL-3 deprivation, treatments with cisplatin and doxorubicin, two DNA-
intercalating compounds, or methotrexate, an inhibitor of dihydrofolate synthetase also 
induced upregulation of alpha globin in FL5.12 cells, however, at lower levels. These 
treatments all induce a block in DNA synthesis. In contrast, treatment with STS, a broad-
spectrum protein kinase inhibitor, camptothecin, a topoisomerase inhibitor inducing DNA 
strand breaks, or paclitaxel, a drug stabilizing microtubules, did not upregulate alpha globin 
expression (Brachat et al., 2002). Death receptor signaling induced by CHX/TNF alpha had 
the opposite effect, i.e. alpha globin expression decreased. Summarizing, in independent 
experiments we reproducibly observed that alpha globin was differentially expressed in 
FL5.12 cells depending on the apoptotic stimulus. We therefore propose that the changes in 
alpha globin levels are apoptosis-related, regulated events, rather than unspecific stress signals 
or artifacts associated with cell culture or sample preparation. 
Besides alpha globin, no other globin or globin-like genes were found to be significantly 
expressed in FL5.12 cells. Myoglobin, zeta, epsilon and gamma globin were completely 
absent as assessed by gene expression analysis. Using gene chip arrays we found beta globin 
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to be absent. However, after 16 h without IL-3 the signal increased, but remained below the 
detection level according to Affymetrix chip technology. By RT QPCR we were able to 
confirm that beta globin was expressed at the detection limit and that the expression was 
increased in apoptotic cells. From RT QPCR we estimated that beta globin was approximately 
200-fold lower expressed than alpha globin. We have to consider that this estimation is not 
precise but an approximation since the efficiency of the primers and probes for two different 
genes are not identical. In erythroid cells alpha and beta globin are expressed in a coordinate 
and balanced manner. We hypothesize that the expression of two globin chains, which are 
expressed at unequal level in FL5.12 cells, is still coupled to some extent in non-erythroid 
cells. 
It has often been reported that undifferentiated cells undergoing apoptosis change their 
differentiation program down a different lineage to the one they have initially been committed 
to (Solary et al., 1993). This significant imbalance of alpha and beta globin indicated that the 
assembly of the two globin chains to form functional hemoglobin was rather unlikely in the 
pro B cell line FL5.12. We confirmed the absence of both hemoglobinization and concomitant 
differentiation down the erythroid lineage under cytokine-deprived conditions, using 
established hematological tests. 
Very interestingly, we found that alpha globin was not associated with heme, the oxygen-
binding prosthetic group of globin proteins. First, we demonstrated that ALA-S1 and PBGD, 
two genes involved in the synthesis of heme, were not upregulated in cytokine-derived 
FL5.12 cells. Second, endogenous heme levels remained constant during progression of 
apoptosis, although alpha globin increased by a factor of approximately 10. In comparison, an 
increase of hemoglobin by a factor of nine in K562 treated with subtoxic concentrations of 
doxorubicin was paralleled by a 4-fold increase of heme indicating that the assay was 
sensitive. The heme level detected in FL5.12 cells is probably part of cellular cytochromes in 
mitochondria. We could further demonstrate that transcript levels of HO-1, which is a 
sensitive sensor of free heme, did not rise. We detected decreasing levels of alpha globin 
protein after 16 and 20 h of apoptosis and assumed that alpha globin was degraded. If alpha 
globin were in complex with heme, we would expect elevated amounts of free heme and 
therefore an increase of HO-1. Since alpha globin expressed in starved FL5.12 cells does not 
bind the prosthetic group in its hydrophobic pocket, it may have a different conformation than 
in erythrocytes or may bind another hydrophobic molecule instead. 
In summary, we suggest that upregulation of alpha globin is involved in a specific apoptotic 
program and that the role of alpha globin in death-committed FL5.12 cells is different to its 
well-established role in oxygen transport in erythrocytes (SCHOLANDER, 1960). 
Interestingly, we found that alpha globin expression and upregulation was also observed upon 
apoptosis induction in non-hematopoietic and differentiated cells such as NIH3T3, HeLa, and 
K562. As typical for an erythroid cell line, K562 expressed high levels of alpha globin, 
whereas NIH3T3 and HeLa cells had low endogenous levels. While alpha globin induction in 
the hematopoietic cells was moderate and about 3.5-fold, we detected a very strong increase 
in both differentiated cell lines. This suggests that upregulation of alpha globin is a common 
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phenomenon in apoptosis and that especially cells having low basal levels upregulate alpha 
globin dramatically. While NIH3T3 cells showed alpha globin upregulation after cisplatin and 
STS treatment as observed in FL5.12 cells, HeLa cells displayed the exactly opposite 
regulation; STS but not cisplatin led to increased alpha globin levels. This suggests that 
upregulation of alpha globin depends not only on the apoptotic pathway, but also on the cell 
type. 
Like FL5.12 also K562 cells expressed beta globin at the detection limit. As compared to 
alpha globin, which is expressed like a housekeeping gene in the CML cell line, beta globin 
was roughly 212-fold less expressed. Thus, beta globin expression levels were also negligible 
in K562 cells. NIH3T3 and HeLa cells did not express beta globin at all. Hence, these 
observations do not support a novel function of beta globin in PCD. 
Besides our findings suggesting a new role for alpha globin, other groups reported that alpha 
globin was implicated in processes other than oxygen transport. For instance, alpha globin has 
been found to be expressed in lens fibres in normal lenses and to be downregulated in the pre-
cataractous lens. Lenses undergo an apoptosis-like process during development, which results 
in removal of organelles and nuclei from their fibre cells. In cataractous lenses the organelles 
are not properly removed. This suggests a role of alpha globin in lens fibre differentiation 
(Wride et al., 2003). Also, Yoshida and colleagues found that extraerythrocytic hemoglobin 
played a novel role in wound healing. Hemoglobin and globin but not heme or 
protophorphyrin IX were able to stimulate plasminogen activator biosynthesis and to increase 
fibrinolytic activity in human fibroblasts (Yoshida et al., 2001). 
The molecular weights of alpha and beta globin monomers of erythroid cells are identical, and 
both chains appear as a single 14 kD protein band in Western blot analysis with the 
hemoglobin antibody we used (Spadaccini et al., 1998). In contrast, alpha globin in FL5.12 
cells appears as a double band; the two bands differ by 0.5 kD in size. The intensities of both 
bands increased when IL-3 was removed. The 14.5 kD protein possibly contains some 
posttranslational, secondary modifications. We analyzed the alpha globin protein using the 
Scan Prosite database (http://www.expasy.org/tools/scanprosite/) to search for potential 
modification sites. Besides patterns with a high probability of occurence including sites for 
phosphorylation by protein kinase C and casein kinase II, N-myristylation and amidation, we 
found no specific sequences for posttranslational modification in alpha globin. Alternatively, 
alpha globin may be modified by acetylation on basic lysine residues. In recent years, protein 
acetylation has been found to be a wide-spread mechanism to control and modulate the 
activity of proteins. In addition to histones (Davie and Spencer, 1999), a growing number of 
proteins such as Sp-1 (Braun et al., 2001) and p53 (Appella and Anderson, 2001) have been 
shown to be targeted by histone acetyltransferases. However, since we were not able to define 
the nature of the 14.5 kD band, we cannot fully exclude it being an unidentified cross-reactive 
protein, that is also upregulated under apoptotic conditions. 
In cell fractionation experiments we found the smaller, 14 kD alpha globin in the cytoskeleton 
of dying but not healthy FL5.12 cells. The cytoskeletal proteins containing alpha globin were 
obtained last from the fractionation protocol. Conversely, the fractions prepared earlier 
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including membrane and nuclear proteins lacked alpha globin. We therefore suggest that the 
appearance of alpha globin in the cytoskeletal fraction does not reflect a simple dose-
dependent event. It has been reported that alpha globin increases membrane rigidity and 
apoptosis in pathologic erythrocytes as found in sickle cell disease or beta-thalassemia 
(Fortier et al., 1988; Advani et al., 1992). Under these conditions alpha globin was found to 
form complexes with spectrin, an actin-binding protein and the major component of the 
cytoskeleton. Whereas spectrin alpha and beta I are restricted to erythroid cells, spectrin alpha 
and beta II, referred to as fodrin alpha and beta, are present in other somatic cells (Coleman et 
al., 1989). Disturbance of membrane-cytoskeletal integrity could therefore be one possible 
function of alpha globin in PCD. Unfortunately, the commercially available hemoglobin 
antibody failed in immunoprecipitation, and we therefore lack direct evidence for alpha 
globin-spectrin interaction. Immunostaining using hemoglobin and spectrin antibody, 
respectively, and subsequent confocal microscopy could shed light on protein localization and 
possible protein-protein interaction. 
Two years ago Kihm and Luzzatto et al reported that AHSP, a GATA-1 controlled erythroid-
specific chaperone, forms a stable complex with alpha but not beta globin both in vitro and in 
vivo independently of heme (Kihm et al., 2002) (Luzzatto and Notaro, 2002). Endogenous 
AHSP was not expressed in FL5.12 cells as assessed by RT QPCR and immunoblotting. We 
ectopically expressed FLAG-tagged AHSP to evaluate whether AHSP was able to stabilize 
alpha globin in FL5.12 cells. We detected increased basal levels of the 14.5 kD but not the 14 
kD form of alpha globin. The viability of FL5.12 cells expressing AHSP was not different 
from the viability observed in GFP expressing cells both in the presence and absence of IL-3. 
We found, however, that FLAG-AHSP had a molecular weight of 14.5 kD and was also 
detected by the hemoglobin antibody. We therefore could not conclude whether the increased 
band in FL5.12 cells was entirely due to overexpressed FLAG-AHSP or at least in parts due 
to alpha globin stabilized by AHSP. An AHSP expression construct of a different molecular 
size could be alternatively used in future experiments to test the alpha globin stabilizing 
properties of AHSP. 
4.1.2 Effects of overexpression and silencing of alpha globin in PCD 
Different from our earlier publication (Brachat et al., 2002), we now used an N-terminal GFP-
alpha globin fusion construct to overexpress alpha globin in FL5.12 cells instead of a 
construct expressing alpha globin with an N-terminal FLAG-tag and an internal ribosomal 
entry site for GFP. Using the latter construct sorting of GFP positive cells was easily 
achieved. We showed that ectopic FLAG-alpha globin was present both at genomic and 
transcript level indicating that this construct was integrated into the genome and transcribed. 
However, FLAG-alpha globin was never detected on Western blot indicating that the cells 
used mechanisms to silence exogenous FLAG-alpha globin protein. Furthermore, the 
progression of IL-3 deprivation-induced apoptosis of FL5.12 cells expressing FLAG-alpha 
globin was poorly reproducible. Phenotypes ranging from diminished to accelerated apoptosis 
were observed. In the current work we therefore chose a GFP-fusion construct, which ensured 
concomitant sorting of GFP and alpha globin. 
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High expression of GFP-Bax, a potent cell death inducer in many cell types, was obtained 
without sorting and was tolerated without cell death; only few spontaneously dying cells with 
GFP-Bax localized in mitochondria were observed. It has been reported earlier that Bax 
accumulation was readily achieved in FL5.12 cells in the presence of IL-3 (Zhang et al., 
1998). In contrast to GFP-Bax, enrichment of GFP-alpha globin was difficult in FL5.12 cells, 
necessitating two rounds of sorting. Ectopic expression of GFP-alpha globin in the presence 
of IL-3 was not accompanied by measurable apoptosis though. Even the proliferation rate of 
cells expressing GFP-alpha globin or GFP as control was comparable. Sporadically, we 
detected cells expressing higher levels of GFP-alpha globin and forming aggregates. We 
assume that clones expressing low levels of GFP-alpha globin were less affected by 
precipitated alpha globin and that these clones preferentially expanded. Excessive and non-
stabilized alpha globin is known to be harmful for erythrocytes and to induce apoptosis in 
erythroid precursors from patients with beta-thalassemia. Precipitation of alpha globin is 
assumed to be triggered by oxidation of heme-bound iron initiating structural perturbations 
that culminate in protein denaturation (Fessas et al., 1966) (Yuan et al., 1995). However, we 
found that FL5.12 cells overexpressing GFP-alpha globin did not display elevated heme 
levels indicating that ectopic alpha globin was not associated with the prosthetic group. We 
therefore conclude that malfolded rather than oxidized GFP-alpha globin precipitates in 
FL5.12 cells. 
Three kinase signaling cascades, the Jak/STAT, the Ras/Raf/MEK/ERK and the PI3K/Akt 
pathways, are important survival signaling pathways in FL5.12 cells triggered by IL-3. These 
pathways are interwoven and together they control cell death by phosphorylating several 
apoptotic and cell cycle regulatory proteins like caspase-9 (Cardone et al., 1998), BAD (Datta 
et al., 1997) and FKHRL1 (Brunet et al., 1999). The survival signaling cascade is 
immediately interrupted when IL-3 is removed, which leads to subsequent dephosphorylation, 
activation of pro-apoptotic factors, and release of cytochrome c from mitochondria. 
Upon IL-3 removal, FL5.12 cells expressing GFP-alpha globin displayed increased 
internucleosomal DNA fragmentation as assessed by TUNEL staining. Higher alpha globin 
enrichment in the sorted cells, was accompanied by a faster apoptotic process, indicating a 
dose-dependent effect of alpha globin on apoptosis. Expression of equivalent levels of GFP-
alpha globin and GFP-Bax in FL5.12 cells resulted in a comparable decrease of viability in 
the absence of IL-3. The fact that endogenous alpha globin is strongly upregulated in 
cytokine-deprived FL5.12 cells and that ectopic alpha globin significantly accelerates PCD, 
clearly demonstrate the pro-apoptotic feature of alpha globin. 
Interestingly, after deprivation of cytokine we observed that endogenous levels of alpha 
globin increased less in FL5.12 cells expressing GFP-alpha globin than in control cells. This 
suggests that the transduced GFP-alpha globin accelerates apoptosis and exerts negative 
feedback inhibition on synthesis of endogenous alpha globin. 
To elucidate which apoptosis pathways are specifically promoted by alpha globin in FL5.12 
cells, we investigated the role of caspases more closely. It was reported earlier that cell death 
in FL5.12 cells induced by IL-3 deprivation was independent of caspases (Bojes et al., 1999). 
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In contrast, we demonstrated that pan caspase inhibitor, zVAD-fmk, moderately but 
significantly delayed apoptosis triggered in the absence of cytokine. However, since we could 
not prevent apoptosis completely even with high doses of zVAD-fmk, we suggest that 
caspase-independent processes may be indeed involved. We further found that inhibition of 
apoptosis by zVAD-fmk was less efficient in cells expressing GFP-alpha globin or GFP-Bax 
than in GFP expressing cells. This led to the conclusion that either caspase-independent 
processes were involved, or that the levels of active caspases were too high to be efficiently 
neutralized by the caspase inhibitor in FL5.12 cells transduced with GFP-alpha globin or 
GFP-Bax. 
It has not been investigated so far which caspases are particularly activated in IL-3-deprived 
FL5.12 cells. We therefore analyzed the activities of caspase-2, -3, -8, and -9 using a caspase-
profiling plate to shed light on the caspases involved, especially in GFP-alpha globin 
accelerated cell death. Abrogated phosphorylation of caspase-9, as well as increased activity 
of the mitochondrial pathway was reported to cause strong caspase-9 activation (Cardone et 
al., 1998). In the apoptosome, pro-caspase-9 becomes cleaved upon assembly with 
cytochrome c, Apaf-1, and ATP or dATP (Zou et al., 1999). 
Caspase-8 is primarily involved in death receptor signaling. Depending on the intensity of the 
stimulus, caspase-8 triggers apoptosis via the mitochondrial amplification pathway (Kuwana 
et al., 1998) or directly through downstream caspase cascades (Scaffidi et al., 1998). Recently, 
the PI3K/Akt survival signaling pathway was shown to regulate the expression of FLIP, a 
natural inhibitor of caspase-8 in endothelial cells (Skurk et al., 2004). This points to a 
potential connection between caspase-8 and Akt signaling and could explain activation of 
caspase-8 upon cytokine deprivation in FL5.12 cells. 
Caspase-2 is widespread and highly expressed in hematopoietic cells (Johnson, 1998) and can 
trigger apoptosis via the non-mitochondrial and the mitochondrial pathway with cytochrome c 
release. There is growing evidence that caspase-2 plays a central role in IL-3 dependent 
signaling. E.g. antisense caspase-2 has been reported to prevent apoptosis induced by cytokine 
removal in IL-3 dependent FDC-P1 cells, suggesting an essential role of caspase-2 in cell 
death induced by cytokine deprivation (Kumar, 1995). So far it has not been fully elucidated 
which mechanisms lead to caspase-2 activation (Lassus et al., 2002; Troy and Shelanski, 
2003). In cell-free systems, however, caspase-9 has been shown to be required for the 
activation of caspase-2 and other downstream caspases (Slee et al., 1999). 
Caspase-3 is the major executioner caspase. Data exist supporting the idea that pro-caspase-3 
resides in the mitochondrial inner membrane space and is released together with cytochrome c 
upon disruption of mitochondria (Blalock et al., 1999). Besides cleavage of at least 42 of 58 
known caspase substrates, caspase-3 can activate caspase-2, -6, -7, and -9 and autoactivate 
itself (Porter and Janicke, 1999). 
In our profiling experiments, caspase-3 and 2 were dramatically activated. Caspase-8 was 
processed to some extent, while caspase-9 seemed to be very weakly activated. We found that 
GFP-Bax and GFP-alpha globin expressing cells displayed higher activities of all caspases 
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tested than control cells. Further, both the dose-dependent effect of differentially enriched 
alpha globin and the protecting properties of Bcl-xL in alpha globin expressing cells were 
confirmed as seen in TUNEL staining. However, the assessment of caspase activity via 
cleavage of caspase substrates provides only crude information, since the substrates are 
unspecific. On the other hand, it is well accepted that caspases, which appear to be cleaved in 
immunoblots, are activated. Therefore, we extended our investigations on Western blot 
analysis. We observed strong activation of caspase-3 and weak activation of caspase-8 as seen 
on the profiling plate. In contrast, caspase-2 was only slightly processed as assessed in 
immunoblots. We therefore conclude that caspase-3 accounted for the cleavage of the 
caspase-2 substrate in the profiling experiment to a significant extent. Different from our 
profiling results we found strong activation of caspase-9 suggesting that the assay conditions 
for caspase-9 in the profiling experiment were suboptimal. Summarizing the data from both 
experiments, GFP-Bax and GFP-alpha globin significantly promote the activation of 
caspase-3 and -8. Caspase-9 activation is probably promoted by both proteins, while no 
conclusions can be made in terms of caspase-2. 
Our results derived from the caspase experiments indirectly suggest that the mitochondria 
probably play an important role in death signaling in FL5.12 cells upon removal of IL-3. For 
direct evidence we investigated Bid, Bax, and cytochrome c, three pro-apoptotic proteins with 
functions in mitochondrial signaling. Full-length Bid is inactive and resides in the cytoplasm. 
Upon apoptosis induction, two caspases are known to cleave and activate Bid, caspase-2 and 
-8. Both caspases were found to be activated in IL-3-deprived FL5.12 cells in our 
experiments. tBid is known to translocate to mitochondria and promote conformational 
change, oligomerization and recruitment of Bax to the mitochondria (Eskes et al., 2000). 
Subsequently cytochrome c is released to assemble in the apoptosome (Luo et al., 1998). 
In FL5.12 cells transduced with GFP-alpha globin or GFP-Bax these three essential steps in 
the mitochondrial pathway were enhanced as compared to control cells; we detected 
disappearance of full-length Bid from the cytosol, Bax translocation from the cytosol to 
mitochondria, and release of cytochrome c. In GFP-Bax overexpressing cells, both endo-
genous and ectopic GFP-Bax translocated from the cytosol to the membrane fraction. We 
therefore suggest that overexpressed, translocated Bax was the predominant factor enhancing 
the release of cytochrome c in the cell death process. In contrast, ectopic alpha globin did not 
translocate to mitochondria although all markers for enhanced mitochondrial signaling were 
present. 
We have shown that Bcl-xL efficiently inhibited apoptosis accelerated by alpha globin. Both 
caspase activation and DNA fragmentation were found to be blocked in FL5.12 cells 
coexpressing alpha globin and Bcl-xL. Bcl-xL is known to counteract the pro-apoptotic effects 
of Bax and to prevent cytochrome c release induced by ectopically expressed Bax (Zha et al., 
1996), (Finucane et al., 1999). We have shown earlier that also Bcl-2 acts as a potent inhibitor 
of alpha globin-induced apoptosis in FL5.12 cells (Brachat et al., 2002). Anti-apoptotic Bcl-2 
resides in membranes of mitochondria, endoplasmatic reticulum and the nuclear envelope, 
and prevents Bax translocation to the mitochondria and subsequent cytochrome c release 
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(Murphy et al., 2000). Thus Bcl-xL is now the second member of the Bcl-2 family that 
counteracts the pro-apoptotic effect of alpha globin. Since both anti-apoptotic proteins 
neutralize apoptosis mainly at the mitochondrial level our observations emphasize the 
importance of alpha globin in stimulation of the mitochondrial apoptosis pathway. 
An approach to further elucidate the importance of alpha globin in signaling apoptosis was 
through silencing of endogenous alpha globin using an antisense alpha globin construct. It has 
been reported that the generation of double stranded RNA can trigger antiviral defense 
mechanisms. In this context the double-stranded RNA-dependent protein kinase (PKR) has 
been reported to promote subsequent apoptosis (Gil and Esteban, 2000). However, we did not 
observe any changes in cell viability or proliferation in transduced FL5.12. Antisense alpha 
globin reduced basal alpha globin protein levels under normal growth conditions very 
efficiently, but could not completely prevent its upregulation in the onset of apoptosis. The 
phenomenon of incomplete silencing is a common problem associated with antisense 
approaches. It suggests either insufficient compensation of upregulated alpha globin message 
by the antisense construct or stabilization of alpha globin at protein level as a mechanism to 
overcome silencing. Under cytokine-deprived conditions, antisense alpha globin was not able 
to slow down apoptosis as assessed by TUNEL staining. In contrast, caspase-3 activity was 
reduced in antisense alpha globin transduced FL5.12 cells. Probably even the small 
incremental increase of alpha globin was sufficient to promote the apoptotic process. 
Having shown that overexpressed alpha globin enhanced cell death in FL5.12 cells growing 
without IL-3, we asked whether overexpressed alpha globin also promoted PCD in NIH3T3 
fibroblasts treated with cisplatin. We showed that NIH3T3 cells tolerated accumulation of 
both alpha globin and Bax under healthy growth conditions and that cell death progressed 
with faster kinetics in GFP-alpha globin and GFP-Bax transduced cells than in GFP control 
cells. We used the CellTiter-Glo Luminescent Cell Viability Assay instead of the well 
established TUNEL assay. TUNEL staining failed in trypsinized NIH3T3 cells. 
In summary, there is strong evidence that the function of alpha globin is not restricted to 
oxygen transport in erythroid cells. Rather alpha globin seems to be involved in pro-apoptotic 
processes in a wide range of cells. These findings are reminiscent of observations made for 
another small protein, cytochrome c. Cytochrome c was initially believed to function 
exclusively as an electron carrier in the respiratory chain of mitochondria. Eight years ago, 
Liu et al found that cytochrome c was an essential component of the apoptosome (Liu et al., 
1996). 
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4.2 GATA-2 promotes upregulation of alpha globin and 
apoptosis in FL5.12 cells 
4.2.1 Expression and regulation of hematopoietic transcription factors 
in PCD 
After having shown the significance of alpha globin as a pro-apoptotic factor we searched for 
transcriptional or regulatory processes that drive alpha globin expression under apoptotic 
conditions. In erythroid cells the globin gene clusters are subject to several levels of 
regulation to ensure fine-tuned globin expression during defined periods of development, 
assuring correct balances of alpha and beta globin chains for hemoglobin assembly. This 
control depends on the complex interplay of chromatin structure, regulatory DNA sequences, 
and transcription factors (Cao and Moi, 2002). In this context, erythroid transcription factors 
have been intensively investigated and a model evolved suggesting a hierarchy of 
transcription factors according to the number of genes and circuits they regulate. GATA-1 and 
-2 are described to act on large numbers of erythroid genes at different stages of 
differentiation. They are therefore believed to act as master regulators. In contrast, other 
transcription factors such as EKLF, FOG-1 or Sp1 control a limited number of erythroid 
genes and often exhibit the function of coactivators for GATA transcription factors. The 
transcription factors that transactivate alpha and beta globin gene expression are partly 
overlapping (GATA-1, GATA-2, Sp-1, NF-E2) and partly unique to each globin gene. While 
transcription factors CP-2, NF I, and NF-κB transcription factors are believed to pre-
dominantly act on alpha globin expression, EKLF and FOG-1, both cofactors of GATA-1, are 
mentioned in the context of beta globin transactivation. In terms of globin gene expression, it 
is hard to distinguish whether GATA-1 or GATA-2 exerts the regulatory mechanisms. In 
principle both GATA transcription factors can bind and transactivate globin genes. But since 
GATA-1 is more abundantly expressed in later erythroid cells it is usually presumed that 
GATA-1 is the protein acting at these sites. However, GATA-1 gene ablation studies in 
proerythroblasts and mice showed that GATA-2 could successfully substitute functions 
believed to be exclusive for GATA-1 (Weiss et al., 1997; Weiss and Orkin, 1995b). 
In the current work, we focused on transcription factors, which were concomitantly regulated 
with alpha globin in apoptosis using Affymetrix gene chip arrays; i.e. our studies did not 
account for transcription-independent processes like protein stabilization or posttranslational 
modifications of transcription factors such as de-/phosphorylation (Towatari et al., 1995), 
dissociation from complexing inhibitory proteins (Brunet et al., 1999) or modulation of the 
redox state (Toledano and Leonard, 1991). 
Analyzing the transcriptional response of IL-3-deprived and control FL5.12 cells, we found 
several upregulated erythroid transcription factors such as GATA-1, GATA-2, EKLF, FOG-1 
and NF-E2, which could all theoretically promote alpha globin expression. These 
transcription factors can also regulate beta globin expression, which is probably why beta 
globin was found to be absent under normal growth conditions and exceeded the critical 
detection threshold upon IL-3 deprivation. We further found that NF-κB1 was slightly 
downregulated in apoptosis. NF-κB1 generally induces the expression of antiapoptotic genes, 
Discussion 
94 
including Bcl-xL, cIAP2, and c-FLIP and it has been described to inhibit the expression of 
alpha globin-like genes in early erythroid progenitors (Liu et al., 2003). I.e. downregulation of 
NF-κB1 in death-committed FL5.12 cells possibly promotes apoptosis in two ways: by a 
decrease of pro-survival factors and concomitant upregulation of alpha globin. 
We detected high level expression for GATA-2 in FL5.12 cells, whereas GATA-1 was 
expressed only at low level. This was in line with findings that GATA-2 is predominantly 
expressed in hematopoietic progenitor cells while GATA-1 is preferentially expressed in 
mature erythroid cells (Yamamoto et al., 1990; Ohneda and Yamamoto, 2002). Further, 
GATA-2 displayed the earliest and strongest transcriptional response towards cytokine 
deprivation; within one hour after IL-3 removal, GATA-2 was upregulated by a factor of two 
indicating an immediate early response. In contrast, upregulation of GATA-1, EKLF, FOG-1, 
and NF-E2 was delayed and first detected after 8 hours. The latter four transcription factors 
all contain GATA binding sites in their promotors, which suggests that their own transcription 
can be regulated by GATA factors (Anderson et al., 2000). In erythroid cells, a model has 
been proposed, in which GATA-2 binds to the GATA box in the promotor of GATA-1 and 
promotes GATA-1 expression in the early stage of erythroid differentiation (Orkin, 1995). We 
therefore suggest that GATA-2 may possibly trigger both direct activation of alpha globin 
transcription and indirect activation through the transcriptional activation of other alpha 
globin-specific transcription factors. In contrast to cytokine deprivation, treatment with 
cytotoxic compounds such as cisplatin or doxorubicin did not lead to upregulated GATA-2 
levels in FL5.12 cells even though alpha globin was upregulated. We propose two alternative 
mechanisms: first, a transcription factor other than GATA-2 transactivates alpha globin in 
cisplatin- or DOXO-treated cells; second, stabilization and accumulation of alpha globin 
message is responsible for the 2- to 3-fold upregulated alpha globin levels. 
Next we wanted to find out whether the upregulation of GATA transcription factors was 
unique to FL5.12 cells. We therefore examined the expression of GATA-1 and GATA-2 
under apoptotic conditions that caused elevated alpha globin levels in NIH3T3, HeLa, and 
K562 cells. As seen in FL5.12 cells, increased GATA-2 transcript levels were also measured 
in NIH3T3 cells. In contrast, GATA-1 was not expressed in the non-hematopoietic NIH3T3 
cell line. Concerning GATA-2, the two human cancer cell lines, HeLa and K562, exerted the 
opposite regulatory effects; GATA-2 levels decreased dramatically under death-inducing 
conditions. GATA-1 was not expressed in HeLa and was slightly downregulated in K562 
cells. We therefore suggest that enhanced transcription of alpha globin in HeLa and K562 are 
regulated independently of GATA transcription factors. 
4.2.2 Effects of overexpression and silencing of GATA-2 on apoptosis 
and alpha globin expression 
To elucidate whether GATA-2 acts as a transcription factor of alpha globin, we overexpressed 
GATA-2 in FL5.12 and NIH3T3 cells. In both cell lines, ectopically expressed GATA-2 was 
localized to the nuclei, the correct destination of a transcription factor. NIH3T3 cells 
overexpressing GATA-2 demonstrated a dramatic stress phenotype with reduced proliferation 
rate especially at low cell densities. This phenotype was transient, however, and cells reverted 
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to a normal morphology within two weeks post transduction. A second round of sorting was 
well tolerated without phenotypical changes. Despite high level expression of GFP-GATA-2 
in NIH3T3 cells, we failed to detect increased alpha globin levels. We suggest three possible 
explanations for the missing transactivation of alpha globin: first, NIH3T3 cells adjust to 
increased GATA-2 expression levels and establish a negative feedback mechanism that 
counteracts upregulated alpha globin levels; second, erythroid genes in fibroblasts are 
compacted in inactive chromatin and are therefore not accessible for transcription factors; or 
third, GATA-2 alone is not able or not sufficient to activate alpha globin expression. 
According to Dubart et al, GATA-1 overexpression in NIH3T3 cells had a similar negative 
effect on the proliferation as GATA-2 in our experiments. The substantial impairment of 
proliferation was transient and was especially seen at low cell densities. It was further 
observed that overexpressed GATA-1 failed to transactivate its erythroid-specific target genes 
(Dubart et al., 1996). 
Overexpression and enrichment of GATA-2 in FL5.12 cells led to immediate cell death. The 
cells displayed characteristics of cells undergoing apoptosis such as membrane blebbing and 
loss of plasma membrane integrity. To date, GATA transcription factors are primarily 
believed to regulate processes supporting survival, differentiation, and proliferation of cells 
(Ohneda and Yamamoto, 2002; Ting et al., 1996). During erythropoiesis, committed erythroid 
precursors arrest at the proerythroblast stage of development and undergo apoptosis in the 
absence of GATA-1 (Weiss et al., 1997). In the erythropoietin-dependent cell line, AS-E2, 
erythropoietin triggers proliferation and survival by maintaining high GATA-2 and Bcl-xL 
expression (Tsushima et al., 1997). Induction of apoptosis by death receptor ligands results in 
caspase-mediated degradation of GATA factors (De Maria et al., 1999). And finally, in the 
FL5.12 related cell line, BaF3, GATA factors are believed to transduce the survival signal of 
IL-3 (Yu et al., 2002). These findings are reminiscent of our observations in HeLa and K562 
cells. GATA-1 and GATA-2 levels were strongly downregulated in HeLa and K562 cells 
undergoing apoptosis, suggesting that GATA factors play a role in signaling proliferation and 
survival and that they are downregulated in death-committed cells. 
Conversely, there is evidence that overexpression of GATA transcription factors exert 
negative effects on proliferation and survival. GATA-2 transcript levels were upregulated by a 
factor of 3.5 in the human epidermoid carcinoma cell line A431 after treatment with the 
tyrosine kinase inhibitor PTK166 for 24 h. A431 cells overexpress epidermal growth factor 
receptors (EGF-R) and were found to undergo apoptosis upon EGF-R inhibition by PTK166 
(Adrian Brüngger, Novartis Basel, personal communication). Persons and colleagues found 
that enforced expression of GATA-2 in bone marrow cells blocked both their amplification 
and differentiation. However, cells remained viable and were negative in apoptosis assays 
(Persons et al., 1999). Induction of estrogen and tamoxifen-inducible forms of GATA-2 but 
not GATA-1 in IL-3 dependent FDC-P1 cells blocked factor-dependent self-renewal. 
GATA-2 activation was further accompanied by differentiation down the monocytic and 
granulocytic lineage (Heyworth et al., 1999). Similarly, Ikonomi and colleagues observed that 
overexpression of GATA-2 in K562 cells had a negative effect on cell proliferation (Ikonomi 
et al., 2000). This phenotype, however, was not further investigated. Iwasaki et al reported 
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that enforced expression of GATA-1 was accompanied by apoptosis in pro B and 
myelomonocytic cells. The death-inducing effect of GATA-1 was not even abrogated in cells 
ubiquitously expressing human Bcl-2 (Iwasaki et al., 2003). This prompts us to test whether 
Bcl-2 or Bcl-xL can prevent GATA-2-induced apoptosis in FL5.12 cells in future experiments. 
In parallel to viability tests, we assessed the expression of alpha globin in FL5.12 cells 
transduced with GATA-2. In contrast to NIH3T3 cells we measured significantly upregulated 
alpha globin levels in GATA-2 expressing cells. FLAG- and GFP-GATA-2 transduced 
FL5.12 cells displayed 6- and 3-fold elevated endogenous alpha globin levels, respectively, as 
compared to GFP expressing cells. Upregulation of alpha globin was probably not sufficient 
to induce the apoptotic phenotype, since overexpression of alpha globin in the presence of 
IL-3 alone was tolerated without induction of cell death. Further evidence that GATA-2 
triggers upregulation of endogenous alpha globin in FL5.12 cells in the absence of IL-3 
derived from experiments using antisense GATA-2. Antisense GATA-2 did not reduce basal 
expression of alpha globin under normal growth conditions. In the absence of cytokine, 
however, induction of alpha globin protein was diminished by a factor of 2 as compared to 
GFP expressing cells. Concomitantly, both the progression of cell death and the caspase-3 
activity were significantly reduced by 40% and 58%, respectively. This suggests that 
endogenous GATA-2 is involved in the upregulation of alpha globin after IL-3 removal but 
not in the basal expression under normal growth conditions. 
As mentioned above, GATA transcription factors have been reported to exert cross-regulatory 
transactivation. To clarify whether ectopic GATA-2 transactivated GATA-1 and whether the 
apoptotic phenotype was at least partly mediated through co-activated GATA-1, we assessed 
the expression of GATA-1 in both GATA-2-overexpressing cells and cells expressing the 
antisense GATA-2. We showed that endogenous GATA-1 levels were entirely unaffected in 
both experimental set ups suggesting that GATA-1 is not involved in GATA-2-induced 
apoptosis signaling. However, we cannot conclude, whether this model reflects the 
endogenous situation in FL5.12 cells. The mechanisms how GATA-2 induces cell death 
should be elucidated in future studies. Especially gene expression profiling experiments using 
FL5.12 cells expressing GATA-2 under a Tet-inducible/repressible promotor could shed light 
on other factors which are under control of GATA-2. 
In summary, we have shown that GATA-2 triggers apoptosis and induces transcription of 
alpha globin in the hematopoietic cell line FL5.12. However, GATA-2 probably acts as a 
transcription factor also for pro-apoptotic factors other than alpha globin, since FL5.12 cells 
overexpressing GATA-2 died by apoptosis even in the presence of IL-3, whereas alpha globin 
overexpression accelerated apoptosis only in the absence of the cytokine. Furthermore, it 
appears that also mechanisms or transcription factors other than the GATA factors exist to 
control the regulation of alpha globin in apoptosis, especially in HeLa and K562 cells. 
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The concluding model summarizes our findings on alpha globin and GATA-2 in apoptotic 
cell death in FL5.12 cells: 
 
GATA-2 and alpha globin in IL-3 deprivation induced apoptosis. IL-3 deprivation leads to 
upregulation of GATA-2, which in turn transactivates alpha globin (α) and probably other, 
unknown pro-apoptotic factors. Alpha globin accelerates the mitochondrial pathway possibly 
by interfering with the processing of caspases, or Bid to truncated Bid (tBid), or with the 
translocation of Bax. Alpha globin may be posttranslationally modified. Small amounts of 
unmodified alpha globin translocates to the cytoskeleton. Ectopic GFP-alpha globin (GFP-α) 
accelerates apoptosis and reduces synthesis of endogenous alpha globin. AS GATA-2 
diminishes the upregulation of GATA-2 and alpha globin and decelerates the apoptotic 
process; GFP-GATA-2 induces upregulation of alpha globin and cell death. Anti-apoptotic 
Bcl-2 and Bcl-xL prevent the pro-apoptotic effect of alpha globin. Unknown signaling paths 
are depicted by dashed lines. Black circles show cytochrome c. 
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5 Materials and Methods 
5.1 Cell lines, treatments 
Murine fibroblast cell line, NIH3T3, was obtained from ATCC (Rockville) and grown in 
MEM Alpha medium supplemented with 15% heat-inactivated fetal bovine serum (HyClone), 
1% sodium pyruvate, (Invitrogen), 1% non-essential amino acids, (Invitrogen), 2 mM 
L-glutamine (Invitrogen), and 10 mg/l gentamicin (Invitrogen). NIH3T3 cells were 50% 
confluent when treatment with cisplatin (20 µM) and staurosporine (STS) (1 µM) was started. 
Controls were left untreated or grown in the presence of DMSO. 
293T-derived Phoenix Eco packaging cell line and HeLa cells were grown in Dulbecco`s 
modified Eagle`s medium (DMEM) supplemented with 10% fetal calf serum (FCS) 
(BioConcept) and 1% Penicillin-Streptomycin-Fungizone (250 ng/ml) (BioConcept). 
Treatment with cisplatin (20 µM) and STS (0.5 µM) was started when HeLa cells were 50% 
confluent. Cells growing in normal medium or treated with DMSO (1:500 dilution) served as 
controls. 
Human K562 cells were cultured in RPMI 1640 medium with 10% FCS (BioConcept). 
Treatment of K562 cells with hemin (Sigma) (Taketani et al., 1998), TRAIL (Sigma) 
(250 ng/ml in phosphate buffered saline (PBS)), STI571, imatinib mesylate (500 nM in 
DMSO) (Jürgen Mestan, Novartis), or DMSO  as control was started at a cell density of 
5 x 105 cells/ml. 
Mouse erythroleukemic J2E cells were kindly provided by Thomas Bittorf (University 
Rostock). Cells were cultured in DMEM supplemented with 10% HyClone II FCS. 
Murine FL5.12neo cells stably transfected with a vector for G418 resistance were kindly 
provided by Dr. Korsmeyer. These cells were used in all experiments and are referred to as 
FL5.12 cells. Cells were grown in RPMI 1640 medium with 10% heat-inactivated FCS 
(BioConcept), 1% Penicillin-Streptomycin-Fungizone (BioConcept), 100 µM β-mercapto-
ethanol (Invitrogen), G418 sulfate (200mg/l), and mouse, recombinant interleukin 3 (IL-3) 
(1 ng/ml) (Sigma). For treatment FL5.12 cells were seeded at a density of 2 x 105 cells/ml and 
subjected to cisplatin (20 µM in H2O), STS (20 nM in DMSO), doxorubicin (DOXO) (40 nM 
in H2O), or tumor necrosis factor alpha (TNF alpha) (2 ng/ml in PBS containing 1% bovine 
serum albumin (BSA)) and cycloheximide (CHX) (1 µg/ml in DMSO). All compounds were 
purchased from Sigma Aldrich, St. Louis, Missouri, USA. For IL-3 deprivation experiments 
cells were washed three times with medium lacking IL-3 before they were cultured in IL-3-
free medium. Control cells growing in medium containing IL-3 were subjected to the same 
washing. Pan caspase inhibitor zVAD-fmk (Sigma) (50 µM in DMSO) were used to assess 
caspase inhibition in IL-3-deprived FL5.12 cells. 
All cell lines were cultivated at 37°C in a 5% CO2 humidified atmosphere. 
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5.2 Transient transfection of HeLa cells 
HeLa cells were grown to 40 - 60% confluency in a T75 cell culture flask and were then 
transfected with GFP, GFP-alpha globin, GFP-beta globin major chain or GFP-AHSP using 
FuGene 6 (Roche). Briefly, 20 µl FuGene were mixed with 300 µl OptiMEM (Gibco) and 
incubated for 5 min at room temperature. The mixture was then dropwise added to 5 µg 
plasmid DNA and incubated for additional 15 min. The final mix was pipetted to the cells, 
swirled, and incubated in a 37°C incubator for 48 h. 
5.3 Gateway expression cloning and retroviral transduction 
Genes of interest were synthesized with PCR. cDNA, derived from total RNA of FL5.12 or 
HeLa cells, served as a template. The template for mouse AHSP was a gift of Mitchell Weiss. 
Oligonucleotide primers contained attB sites at their respective 5` ends (forward primer: 
GGGG ACA AGT TTG TAC AAA AAA GCA GGC TCC, reverse primer: GGGGAC CAC 
TTT GTA CAA GAA AGC TGG GTA) to render cDNA templates compatible with the 
GATEWAYTM cloning technology (Life Technologies). Primers for human bcl-xL 
(5`ATGTCTCAGAGCAACCGGGAGCTGG, 5`CTATTTCCGACTGAAGAGTGAGCCC-
AGCAG), human bax (5`ATGGACGGGTCCGGGGAGCAGCCCAGAGGC, 5`CTAGCCC-
ATCTTCTTCCAGATGGTGAGCGAGGC), mouse alpha globin (5`ATGGTGCTCTCTGG-
GGAAGAC, 5`CTAACGGTACTTGGAGGTCAGCAC), antisense mouse alpha globin (5` 
TAAACGGTACTTGGAGGTCAGCACGGTG, 5` ATGGTGCTCTCTGGGGAAGACAAA-
AGCAAC), mouse beta globin major chain (5`ATGGTGCACCTGACTGATGCTGAG, 
5`TTAGTGGTACTTGTGAGCCAGGGC) mouse GATA-2 (5`ATGGAGGTGGCGCCTGA-
GCAGCCTCGC, 5` GCCCATGGCAGTCACCATGCTGG), antisense mouse GATA-2 (5` 
TAACTAGCCCATGGCAGTCACCATGCTG, 5`ATGGAGGTGGCGCCTGAGCAGC), 
mouse AHSP (5` ATGGCCCTTTTCAGAGCAATAAGGATC, 5` TTATGAGGAGGGCAG-
TGTATTGCTTGG) were used. 
In the BPTM clonase reaction PCR products were first cloned into the pDONRTM (Life 
Technologies) vector and were then verified by sequencing. In the second LRTM clonase 
reaction cDNA inserts were transferred into retrovirus-derived expression vectors called 
destination vectors. Two destination vectors, CRU5-FLAGgw-IRES-GFP (Figure 1, upper 
panel) and CRU5-N-term-GFPgw (Figure 1, lower panel), were used which were both 
generated by Dr. Benoit Pierrat (Novartis Basel). Both vectors contained a beta-lactamase 
gene rendering ampicillin resistance (AmpR), a constitutive cytomegalo virus (CMV) 
promotor, sequences from long terminal repeats (5`RU, 3`LTR) rendering the plasmid a 
retroviral vector, Gateway recombination cassettes (attR), and enhanced GFP (eGFP). For 
simplicity reasons eGFP is referred to as GFP. Using the CRU5-FLAGgw-IRES-GFP vector 
the genes of interest, AHSP and GATA-2, were expressed as N-terminal FLAG-tagged 
proteins with an internal ribosomal entry site (IRES) for GFP. With the CRU5-N-term-
GFPgw vector all other genes of interest used in the current work were expressed as N-
terminal GFP fusion proteins. 
Once constructs had been verified by restriction digest they were transfected using the 
calcium-phosphate method into Phoenix packaging cells expressing an ecotropic envelope 
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protein. Virus containing supernatants were then used to transduce FL5.12 or NIH3T3 cells 
(Swift et al., 1999). Efficiency of transduction was followed by monitoring GFP expression 
levels in a FACS Calibur instrument (Becton Dickinson). One to two rounds of cell sorting 
were used to enrich GFP-expressing cells. 
 
 
Figure 1: Plasmid constructs of retrovirus-derived, Gateway-
compatible destination vectors, CRU5-FLAGgw-IRES-GFP (upper 
panel) and CRU5-N-term-GFPgw (lower panel) (redrawn from Vector 
NTI). 
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5.4 Proliferation test 
FL5.12 cells ectopically expressing GFP, GFP-Bax or GFP-alpha globin as well as 
untransduced FL5.12 cells were seeded at a density of 2 x 104 cells/ml. Cell viability and 
density was assessed by trypan blue staining and counting after 14, 20, and 36 h using a 
Neubauer hemocytometer. For each cell line three separate T25 cell culture flasks were grown 
and independently analyzed. 
5.5 TUNEL assay 
To study DNA fragmentation, 1 x 106 cells were subjected to terminal deoxynucleotidyl 
transferase dUTP nick end labeling (TUNEL) staining using the In Situ Cell Death detection 
kit (Roche). Protocol was performed as described by the manufacturer: Cells were washed 
with PBS, fixed with 2% paraformaldehyde (PFA) in PBS, pH 7.4 for 1 h at room 
temperature, and then permeabilized with 0.1% Triton-X 100 in 0.1% sodium citrate for 2 min 
on ice. The TUNEL reaction with terminal deoxynucleotidyl transferase (TdT) and TMR red 
labeled nucleotides was performed for 1 h at 37°C in humidified atmosphere and stopped by 
washing with PBS. TUNEL-positive cells were monitored using a FACS Calibur (Becton 
Dickinson) (FL2-H, 550/30nm). 
5.6 Caspase Profiling 
The ApoAlertTM Caspase Assay Plate (Becton Dickinson) was used to assay the apoptotic 
activity of caspase-2, -3, -8, and -9 in a 96-well format. Briefly, transduced FL5.12 cells were 
allowed to grow with and without IL-3 for 12 h. 2 x 105 cells per well were analyzed. Single 
measurements were performed for cells growing with IL-3 and cells growing without IL-3 
plus the specific caspase inhibitor. For cells growing in medium lacking IL-3 duplicates were 
analyzed. Cells were lyzed on ice for 10 min with lysis buffer provided with the ApoAlertTM 
kit, transferred to the caspase assay plate coated with immobilized, fluorogen-labeled caspase 
substrates and incubated at 37°C for 1.5 h. Fluorescence intensity was monitored after 0 and 
1.5 h using the Analyst® GT Reader (405 nm excitation, 460 nm emission) (Bucher Biotec). 
Caspase profiling was repeated once and each caspase status was further confirmed by 
Western blotting. 
5.7 Caspase-3 Assay 
FL5.12 cells ectopically expressing GFP, antisense GATA-2 or antisense alpha globin were 
grown in the presence or absence of IL-3 for 14 hours. Caspase-3 activity was measured using 
the Caspase-3 Colorimetric Assay kit (BioVision). Briefly, 1.5 x 106 cells were lyzed in 70 µl 
cell lysis buffer. 10 µl lysates were mixed with 40 µl cell lysis, 50 µl 2x reaction buffer, and 5 
µl 4 mM DEVD-pNA (200 µM final concentration) and incubated at 37°C for 1.5 h in a 96-
well optical plate (Nalge Nunc). Triplicates were read at 405 nm using a Analyst® GT Reader. 
5.8 CellTiter-Glo™ Luminescent Cell Viability Assay 
NIH3T3 cells ectopically expressing GFP, GFP-alpha globin or GFP-Bax were seeded in a 
96-well optical plate at a density of 4000 cells per well. 24 hours after seeding medium was 
replaced with fresh medium (control) or medium containing 20 µM cisplatin. Viability of 
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transduced NIH3T3 cells was assessed 20 hours after incubation using CellTiter-Glo™ 
Luminescent Cell Viability Assay (Promega). Briefly, CellTiter-Glo™ buffer and substrate as 
well as the plate containing the cells were equilibrated at room temperature for 30 min. 
CellTiter-Glo™ reagent was prepared by dissolving CellTiter-Glo™ substrate (luciferin) in 
the buffer. 100 µl of the complete reagent were added to each well. The plate was mixed and 
then incubated for 2 and 10 min, respectively, to stabilize the luminescent signal. 
Luminescence was measured using a Tecan Ultra Evolution reader (Tecan). Cell culture 
medium alone served as fluorescent background control. 
5.9 Total RNA isolation 
Total RNAs were purified from FL5.12, NIH3T3, HeLa, and K562 cells using an RNeasy 
spin column system according to the manufacturer`s instructions (Qiagen). Briefly, cells were 
pelleted, lyzed with RLTTM lysis buffer and subsequently homogenized using QIAshredderTM 
spin columns (Qiagen). Isolation of total RNA was performed with a silica-gel-based 
membrane technology (RNeasy Mini Kit, Qiagen). RNase-free DNase (Qiagen) kit was used 
to avoid DNA contamination in the isolated RNA. RNA quality assessing 18S and 28S 
ribosomal bands was analyzed in an Agilent 2100 LabChip Bioanalyzer using RNA 6000 
Nano ChipsTM (Agilent Technologies). RNA concentration and purity (A260/A280nm) were 
measured using the BioSpec-miniTM spectrophotomer (Shimadzu). 
5.10 Affymetrix gene expression arrays 
Total RNA was converted into double-stranded cDNA using Superscript II reverse 
transcriptase and an oligo(dT) primer with a T7 RNA polymerase promoter site at the 5` end 
(Invitrogen). 5 µg cDNA were used in an in vitro transcription in the presence of biotinylated 
ribonucleotides and T7 RNA polymerase to produce labeled cRNA (Enzo diagnostics of 
Farmingdale). 15 µg cRNA were randomly fragmented by incubating in 40 mM Tris-acetate, 
pH 8.1, 100 mM potassium acetate, and 30 mM magnesium acetate at 94°C for 35 min. 
Affymetrix Murine Genome U74v2 gene chips (Affymetrix, San Jose, CA) were hybridized, 
washed, and stained according to the protocol (Mahadevappa and Warrington, 1999). 
Fluorescence intensities for the individual oligonucleotide probes on the arrays were 
determined with a GeneChip system confocal scanner (Hewlett Packard) and analyzed using 
the Demon Novartis proprietary software program. All chips were prepared and analyzed in 
duplicates.  
5.11 Quantitative polymerase chain reaction, RT QPCR 
Total RNA was reverse transcribed using OmniscriptTM RT kit (Qiagen) and rRNasin® RNase 
inhibitor (Promega). cDNAs were subjected to 40 rounds of amplification in the presence of 
TaqMan® Master Mix (Applied Biosystems) using the ABI Prism 7700 sequence detection 
system as described by the manufacturer (Applied Biosystems). Sequence-specific primers 
and probes labeled with a reporter, 6-carboxyfluorescein (6-FAM), and a quencher, 
6-carboxytetramethylrhodamine (6-TAMRA), were designed with the primer express 
software (Applied Biosystems) or ordered as ready to use primer and probe mixes (Assay on 
Demand, Applied Biosystems). The following specific primer/probe sets were used: 
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mouse alpha globin forward primer: 5`GCCTTGTCTGCTCTGAGCG, reverse primer: 5` 
CTTGAAGTTGACGGGATCCAC, probe: 5`CCTGCATGCCCACAAGCTGCG; human 
alpha globin forward primer: 5`TCCCCACCACCAAGACCTAC, reverse primer: 
5`CCTTAACCTGGGCAGAGCC, probe: 5`CCCGCACTTCGACCTGAGCCA; mouse 
AHSP forward primer: 5`TTGTGGTTCATGACTGGGTGA, reverse primer: 
5`CCTGTCTTGCTCCTCCTGCT, probe:  5`ACCAACTATTACAAGAAGCTCGTGCATG; 
mouse heme oxygenase 1 forward primer: 5`CTCACTGGCAGGAAATCATCC, reverse 
primer: 5`ACCTCGTGGAGACGCTTTACA, probe: 5` CCTGGAGGAGGAGATTGAG-
CGCAAC; mouse beta globin: Assay-on-Demand Gene Expression product, 
Mm00731743_mH; human beta globin: Assay-on-Demand Expression product, 
Hs00747223_g1; mouse GATA-2: Assay-on-Demand Gene Expression product, 
Mm00492300_m1; human GATA-2: Assay-on-Demand Gene Expression product, 
Hs00231119_m1; mouse GATA-1: Assay-on-Demand Gene Expression product, 
Mm00484678_m1; human GATA-1: Assay-on-Demand Gene Expression product, 
Hs00231112_m1; eukaryotic ribosomal RNA (18S rRNA): Genomic Assay, 4310892E. 
10 ng cDNA were used as template for RT QPCR. Specific amplification was detected as an 
increased fluorescence signal of 6-FAM during the amplification cycle. The relative quantity 
of specifically amplified cDNAs were calculated using the comparative-threshold cycle 
method with interspecific 18S ribosomal RNA as endogenous reference according to the 
manufacturer’s instructions (Applied Biosystems, User Bulletin #2, ABI PRISM 7700). No 
template controls (NTC) and no reverse transcriptase controls (noRT) were always performed 
in parallel to exclude transcript unspecific amplification. 
5.12 PCR on genomic DNA 
2 x 105 FL5.12 cells transduced with FLAG-alpha globin IRES GFP were washed twice with 
PBS and subsequently resuspended and lyzed for 1 h at 37°C in 50 µl 1x Taq PCR reaction 
buffer (Roche) containing 0.05% SDS and 50 µg/ml proteinase K. Proteinase K was then 
heat-inactivated for 20 min at 85°C. Cell lysates were diluted 1:10 in Taq polymerase buffer. 
1 µl of the dilution served as template in the following PCR. The PCR reaction mix contained 
10% DMSO (Sigma), 10% Taq PCR reaction buffer, 200 µM desoxynucleotidyltriphosphates 
(dNTP) (Roche), 100 nM 5` alpha globin specific primer (5’ AGCCACGGCTCTG-
CCCAGG), 100 nM 3` alpha globin specific primer (5’ GAGGTCAGCACGGTGCTC-
ACAG), and 5 units Taq polymerase (Roche). The reaction mix was denatured 3 min at 95°C, 
followed by 30 PCR cycles: 30 sec at 95°C denaturation, 40 sec at 57°C annealing, and 30 sec 
at 72°C elongation. PCR products were analyzed on a 1% agarose gel using DNA Molecular 
marker VI to assess product size. 
5.13 Western blotting 
For preparation of whole cell lysates cells were washed once with ice-cold PBS and then 
lyzed in ice-cold NET buffer containing 0.05 M Tris-HCl, 50 mM NaCl, 5 mM EDTA, and 
1% Nonidet P-40 both supplemented with Complete protease inhibitor cocktail (Roche 
Diagnostics). To obtain soluble proteins cells were centrifuged at 14 000 x g to remove 
cellular debris. 
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For fractionation of FL5.12 cells into cytosolic, membrane, nuclear, and cytoskeletal fraction 
the ProteoExtract™ Subcellular Proteome Extraction kit (Calbiochem) was used to analyze 
alpha globin localization. The protocol was followed according to the instructions of the 
manufacturer. 
Separation of cytosolic and membrane proteins was done to evaluate localization of Bax, Bid, 
and cytochrome c. 2 x 106 FL5.12 cells were washed in PBS and resuspended in 200 µl STE 
buffer containing 0.25 M sucrose, 20 mM Tris-HCl, pH 8, and 0.1 mM EDTA supplemented 
with protease inhibitor cocktail. Cells were homogenized with a pellet pestle (Kontes Glass 
Company, NJ, USA) and a 30G1/2 Microlance needle (Becton Dickinson). Cell debris, intact 
cells and nuclei were removed by centrifugation at 1000 x g for 5 min at 4°C. The 
supernatants were centrifuged at 80 000 x g for 1 h in a Beckman Airfuge to pellet the 
mitochondrial and microsomal fraction. Supernatants were precipitated with 14% 
trichloroacetic acid on ice for 30 min, centrifuged and washed twice with cold acetone. All 
pellets were dissolved in 30 µl Laemmli sample buffer, boiled for 3 min and 20 µl from each 
fraction were loaded in 12% sodiumdodecylsulfate polyacrylamide (SDS PAGE) gels. 
To assess GATA-2 localization cytosolic and nuclear fractions were prepared as follows: 
1.5 x 106 FL5.12 cells were washed in PBS and resuspended in 200 µl STE buffer (as 
described above). Cells were homogenized with a pellet pestle (Kontes Glass Company, NJ, 
USA) and a 30G1/2 Microlance needle (Becton Dickinson). Nuclei were removed by 
centrifugation at 610 x g for 5 min at 4°C. The nuclear pellets were resuspended with ice-cold 
Extraction buffer III and treated with Benzoenase (≥ 375 U) for 10 min on ice. Both reagents 
derived from the ProteoExtract™ Subcellular Proteome Extraction kit (Calbiochem). The 
supernatants contained cytosolic proteins. Cytosolic and nuclear proteins were taken up in 
Laemmli sample buffer, and boiled for 3 min. 
For all Western blots either 12% SDS PAGE or NuPage® 4 - 12% Bis-Tris gels (Invitrogen) 
were used. Gels were blotted onto Protran® nitrocellulose transfer membrane (Schleicher & 
Schuell) using a Trans-Blot semidry blotting apparatus (BioRad). Membranes were blocked 
with 5% milk powder (Rapilait, Migros, Switzerland), 1% Tween 20 (Fluka) in TBS (TRIS-
buffered saline), and probed with anti-Actin polyclonal 1:1000 (Santa Cruz I-19), anti-Bax 
polyclonal 1:3000 (Santa Cruz N-20), anti-Green fluorescent protein (GFP) monoclonal 
1:1000 (Roche), anti-Calnexin polyclonal 1:500 (Santa Cruz C-20), anti-cytochrome c 
monoclonal 1:500 (BD Pharmingen), anti-hemoglobin polyclonal 1:1000 (ICN Cappel), anti-
Bid polyclonal 1:1000 (Cell Signaling), anti-caspase-2 monoclonal 1:500 (Alexis 
Biochemicals 11B4), anti-cleaved caspase-3 (Asp175) polyclonal 1:1000 (Cell Signaling), 
anti-caspase-7 polyclonal 1:100 (Santa Cruz K-20), anti-caspase-8 monoclonal 1:500 (Alexis 
Biochemicals 1G12), anti-caspase-9 monoclonal 1:500 (Stressgen Biotechnologies), and anti-
AHSP monoclonal 1:3000 (friendly gift from Mitchell Weiss, Children`s Hospital 
Philadelphia) antibodies. Secondary antibodies (BioRad) were HRP-conjugated goat anti-
mouse IgG 1:5000, goat anti-rabbit IgG 1:5000, goat anti-rat IgG 1:5000, and rabbit anti-goat 
IgG 1:1000. All antibodies were diluted in TBS + 1% Tween 20 or blocking buffer. The 
proteins were visualized using Lumi-LightPLUS Western Blotting Substrate (Roche) or ECL 
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Western Blotting Detection Reagents (Amersham). Intensities of the signals were evaluated 
using a BioRad Imager and the Quantity One software program (BioRad). Blots were stripped 
for reuse using Re-Blot Western Blot Recycling (Chemicon) for 10 min at room temperature.  
5.14 Immunostaining, DAPI staining and fluorescence 
microscopy 
FL5.12 cells transduced with GFP-alpha globin, GFP-Bax, GFP or untransduced cells were 
grown with or without IL-3 for 12 h. Cells were washed once with PBS, resuspended in 
300 µl PBS, spun on object trays with a Cytospin (Shandon Southern), and fixed with 
4% PFA for 15 min. Thereafter the cells were permeabilized and blocked for 20 min with 
PBS containing 0.1% Triton® X-100 (BioRad) and 10% FCS. Wildtype FL5.12 cells growing 
with or without IL-3 and GFP-alpha globin expressing cells were stained with anti-
hemoglobin polyclonal antibody (ICN Cappel) diluted 1:200 in the blocking solution for 
30 min. Cells were washed three times with PBS, then incubated with goat anti-rabbit IgG-
Alexa Fluor 546 (Molecular Probes) diluted 1:200 in PBS containing 0.1% Triton X-100 and 
1% FCS for 30 min, and washed three times PBS. 
To assess cellular localization of ectopically expressed GATA-2, FL5.12 and NIH3T3 cells 
were transduced with GFP-GATA-2, FLAG-GATA-2, or GFP, and subsequently sorted using 
a FACS Calibur (Becton Dickinson). NIH3T3 cells were seeded and grown on cover slips. 
FL5.12 cells were cytospun on object trays immediately prior immunostaining. FL5.12 and 
NIH3T3 cells were fixed, permeabilized, and blocked as described above. Wildtype NIH3T3 
cells and FLAG-GATA-2 expressing cells were stained with anti-FLAG monoclonal antibody 
(Sigma) diluted 1:500 in the blocking solution for 30 min. Cells were washed three times with 
PBS, then incubated with goat anti-mouse IgG-Alexa Fluor 546 diluted 1:200 in PBS 
containing 0.1% Triton X-100 and 1% FCS for 30 min, and finally washed with PBS. 
All cells were coverslipped using DAKO mounting medium containing 4',6-diamidino-2-
phenylindole (DAPI) (1 µg/ml). Cells were analyzed using a Nikon Eclipse TE 2000-S 
equipped with a Nikon digital camera DXM1200. eGFP was excited at 460 to 500 nm, Alexa 
Fluor 546 at 510 to 560 nm, and DAPI at 340 to 380 nm. To avoid cross-talk between 
fluorescence signals and to reject non-specific fluorescence a 510 to 560 nm band-pass filter 
was used for eGFP, a 590 nm filter for Alexa Fluor 546, and a 435 to 485 nm bandpass filter 
for DAPI (Chroma Technology Corporation). 
5.15 Determination of heme, hemoglobin, and differentiation 
stage of FL5.12 cells 
Detection of heme was performed according to the protocol described by Sassa et al. (Sassa, 
1976). 1 x 106 cells were pelleted, mixed with 0.5 ml 1 M oxalic acid, and immediately heated 
for 30 min at 95°C. Cells in 1 M oxalic acid without heating served as negative control. After 
cooling triplicates of 150 µl were analyzed fluorometrically using the Analyst® GT Reader 
(excitation = 400 nm, emission = 662 nm). Dilutions of 125 nM - 2.5 nM hemin in a solution 
of methanol and 0.01 N KOH (1:1), containing 1% BSA served to evaluate a standard curve. 
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Hemoglobin assay was performed as described by Worthington et al. (Worthington et al., 
1987). Briefly, 1 x 106 cells were washed twice with PBS, and permeabilized in 500 µl water 
containing 0.01% Nonidet® P-40 (Fluka). Hemoglobin standard was freshly prepared by 
dissolving human hemoglobin (Sigma) in water. 2,7-diaminofluorene (DAF), (Sigma) stock 
solution was prepared by dissolving 10 mg/ml DAF in 90% glacial acetic acid. To initiate the 
color reaction 1.5 ml DAF working solution containing 100 µl DAF stock solution, 60 µl 30% 
hydrogen peroxide, and 6 M urea in 10 ml 0.1 M Tris buffer, pH 7, were added to the cell 
suspension or the hemoglobin standards, respectively, vortexed and incubated at room 
temperature for 10 min. All reactions were performed in polypropylene tubes. Generation of 
fluorene blue was detected by measuring the absorbance at 610 nm. 
The differentiation stage of FL5.12 cells growing with and without IL-3 was evaluated by 
May-Grünwald-Giemsa staining using Diff-Quik® (Dade, Behring). 
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6 Abbreviations 
18S 18 S ribosomal RNA 
AHSP alpha globin stabilizing protein 
AIF Apoptosis inducing factor 
ALA-S1 aminolevulinic acid synthase 1 
AP-1 activating protein 1 
Apaf-1 apoptotic protease activating factor 1 
AS antisense 
AUF-1 AU-rich destabilizing elements binding/degradation factor 1 
Bcl B cell lymphoma 
BH Bcl-2 homology 
BSE bovine spongiform encephalopathy 
C. elegans Caenorhabditis elegans 
CARD caspase recruitment domain 
casp caspase 
caspase cysteine aspartyl protease 
CBP CREB-binding protein 
CD95 cluster of differentiation 95 
cDNA copy desoxyribonucletidyl acid 
ced cell death defective 
c-FLIP cellular FLICE inhibitory protein 
CFU colony-forming unit 
CHX cycloheximide 
cIAP cellular inhibitor of apoptosis protein 
CML chronic myeloid leukemia 
CO carbon monoxide 
CpG cytosine and guanine connected by a phosphodiester bond 
CPP32 32-kDa putative cysteine protease 
CRE C-rich element 
CREB cAMP response element-binding protein 
CS cytoskeleton 
CT threshold cycle 
C-terminal carboxy terminal 
CYGB cytoglobin  
cyt c cytochrome c 
DAF 2,7-diaminofluorene 
DAPI 4’,6-diamidino-2-phenylindole 
DcR decoy receptor 
DD death domain 
DED death effector domain 
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DIABLO direct IAP binding protein 
DISC death-inducing signaling complex 
DMSO dimethylsulfoxide 
DOXO doxorubicin 
DR death receptor 
EDRF erythroid differentiation-related factor  
eGFP enhanced green fluorescent protein 
EKLF erythroid krueppel like factor 
ER endoplasmic reticulum 
ERAF erythroid association factor 
ErEN erythroid enriched endoribonuclease 
ERK extracellular signal-regulated kinase  
FACS  fluorescent activated cell sorting 
FADD Fas-associated death domain 
Fas Fibroblast-associated 
FL fetal liver 
FOG-1 Friend of GATA-1 
Foxo forkhead transcription factor 
GAPDH glyceraldehyde-3-phosphate dehydrogenase 
Hb hemoglobin 
Hbb-b1 beta globin major chain 
Hbb-b2 beta globin minor chain 
HO-1 heme oxygenase 1 
HS DNase I hypersensitive site 
Hsp heat shock protein 
IAP inhibitors of apoptosis 
ICE interleukin converting enzyme 
IL interleukin 
IL-3 Rβ interleukin 3 receptor beta 
Jak Janus kinase 
kD kilo Dalton 
LCR locus control region 
LT lymphotoxin 
M molar 
M membrane 
m milli 
MAPK mitogen-activated protein kinase 
Mb myoglobin  
MEK MAP kinase kinase 
mRNA messenger ribonucleic acid 
n nano 
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N nuclear 
NF I nuclear factor I 
NF-E2 nuclear factor erythroid 2 
NF-κB nuclear factor kappa B 
NGB neuroglobin  
nt nucleotide 
N-terminal amino terminal 
p90S6K p90 ribosomal S6 kinase 
PABP poly-A binding protein 
PBGD porphobilinogen deaminase 
PBS phosphate buffered saline 
PDC programmed cell death 
PDK 1 phosphatidylinositol-dependent kinase 1 
PFA paraformaldehyde  
PI(3,4,5)P3 phosphatidylinositol (3,4,5)-tris-phosphates 
PI(4,5)P2 phosphatidylinositol (4,5)-bisphosphate 
PI3K phosphatidylinositol 3-kinase 
PKB protein kinase B 
PLAD pre-ligand binding assembly domain 
PP2A protein phosphatase 2A 
PTP permeability transition pore 
PUMA p53-upregulated modulator of apoptosis 
QPCR quantitative polymerase chain reaction 
RIP receptor-interacting protein 
Rsk ribosomal S6 kinase 
RT QPCR quantitative reverse transcriptase polymerase chain reaction 
S soluble 
SD standard deviation 
SODD silencer of death domain 
STAT signal transducers and activators of transcription 
STS staurosporine 
T tyrosine 
TdT deoxynucleotidyl transferase 
TM trans membrane 
TMR tetramethylrhodamine 
TNF α tumor necrosis factor alpha 
TNF-R tumor necrosis factor receptor 
TRADD TNF-R-associated death domain 
TRAF TNF-R-associated factor 
TRAIL TNF-related apoptosis-inducing ligand 
TRAIL-R TNF-related apoptosis-inducing ligand receptor 
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TUNEL  terminal deoxynucleotidyl transferase dUTP nick end labeling 
v-FLIP viral FLICE inhibitory protein 
zVAD-fmk valine-alanine-aspartic acid fluoromethyl ketone 
α-complex alpha-complex 
αCP alpha globin poly(C)-binding protein 
αPRE α-globin positive regulatory element 
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